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ABSTRACT 
The atm of this thesis was to study the functional interaction between 
serotonin (5-hydoxytryptamine; 5-HT) and N-methyl-D-aspartate (NMDA) 
receptors in vitro in a rat neocortical slice preparation. A quantitative 
pharmacological assay was developed using grease-gap recording to investigate this 
problem. The specific aims were: 1) to characterize the 5-HT receptor mediating 
facilitation of the NMDA response; 2) to elucidate the mechanism underlying the 
5-HT facilitation 3) to examine the 5-HT facilitation in senescent rats; and 4) to 
compare the action of 5-HT with other agonists that activate G-protein coupled 
receptors that utilize phospholipase C signal transduction. 
Depolarization of cortical neurons by NMDA, but not quisqualate or 
kainate, was facilitated by 5-HT (1-100 J.lM) giving a bell shaped concentration-
response curve. Methysergide, ritanserin and sp1perone antagonized the 5-HT 
facilitation suggesting mediation by 5-HT 2A receptors. The facilitation was 
mimicked by DOl, a 5-HT2A receptor agonist, but not by TFMPP, a 5-HT2c and 5-
HT1B receptor agonist, or 8-0H-DPAT, a 5-HT1A receptor agonist. The 5-HT 
facilitation was not mimicked by activating protein kinase C or occluded by 
blocking K+ currents. 
The 5-HT 2A receptor exhibited both acute and long term desensitization. 
111 
Inhibition of protein kinase C reduced acute desensitization as did blocking 
receptor internalization with concanavalin A. Calmodulin antagonists prevented 
long term desensitization. 5-HT induced heterologous desensitization of the 
phenylephrine and carbachol facilitation which was eliminated by myo-inositol. 
Myo-inositol (1-1 0 mM) potentiated the 5-HT facilitation in a concentration 
dependent manner. 
Thapsigargin, cyclopiazonic acid and A23187 mimicked the 5-HT 
facilitation with respect to the dependence on external Ca++, this facilitation was 
inhibited by nifedipine and eliminated by BAPT A-AM. A mixture of prazosin, 
scopolamine, D,L-AP3, ritanserin and tetrodotoxin reduced, but did not abolish the 
facilitation produced by thapsigargin, cyclopiazonic acid or A23187. 
The 5-HT and DOl facilitation was absent in senescent rats. In contrast, 
agonists at muscarinic cholinoceptors, a 1-adrenoceptors and metabotropic glutamate 
receptors facilitated the NMDA depolarization in senescent rats. Inhibitors of 
protein kinase C restored the 5-HT facilitation in senescent rats. In situ 
hybridization histochemistry revealed that 5-HT2A receptor mRNA was present in 
pyramidal neurons in both young adult and senescent rats. 
The metabotropic glutamate receptor agonists quisqualate and 1 S,3R-ACPD, 
like 5-HT, facilitated the NMDA induced depolarization. D,L-AP3 and D,L-AP4 
lV 
inhibited the 1 S,3R-ACPD facilitation non-competitively. Desensitization of the 
1S,3R-ACPD facilitation was not observed. The facilitation was not altered by 
inhibiting or activating protein kinase C nor was it mimicked by 8-bromo-cAMP, 
8-bromo-cGMP or arachidonic acid. However, the facilitation was potentiated by 
myo-inositol and exhibited heterologous desensitization by 5-HT. The facilitation 
induced by 1 S,3R-ACPD and carbachol was insensitive to removal of external 
Ca++. BAPTA-AM, but not nifedipine, eliminated the 1S,3R-ACPD induced 
facilitation. 
It is concluded that 5-HT2A receptors mediate facilitation of the NMDA 
depolarization through a direct action on cortical pyramidal (projection) neurons. 
5-HT 2A receptors activate phospholipase C, which in turn generates inositol 1 ,4,5 
triphosphate leading to a rise in intracellular Ca++. A rise in intracellular Ca++, 
whether induced by agonists such as 5-HT, Ca++ ionophores or blockers of Ca++-
ATPase (e.g. thapsigargin) underlies the facilitation. How a rise inCa++ translates 
into a larger NMDA response remains to be answered. During aging 5-HT2A 
receptors are present, but the 5-HT2A facilitation is inhibited due to activation of 
protein kinase C. 
KEYWORDS: Serotonin, 5HT 2A receptor, NMDA receptor, 
neurotransmitter interaction, protein kinase C, neocortex, 
aging, metabotropic glutamate receptors. 
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CHAPTER 1 
INTRODUCTION 
1.1 Statement of the research problem 
Serotonin (5-hydroxytryptamine; 5-HT) acting at numerous receptor subtypes 
has been identified as a neurotransmitter/neuromodulator in a wide variety of 
physiological and behavioral processes (Aghajanian et a/., 1987, 1990; Jacobs, 
1991; Jacobs and Fornal, 1991, 1993; Jacobs and Azmitia, 1992; McCormick, 
1992). This is not surprising considering the almost ubiquitous distribution of 5-
HT containing fibres and terminals throughout the mammalian central nervous 
system (Jacobs and Fornal, 1993). 
Recently, 5-HT has been implicated as a neuromodulator with respect to 
the excitability of cortical pyramidal neurons (Neuman, 1986; Neuman and 
Zebrowska, 1992). The term "neuromodulation" may be defined as the ability of 
neurons to alter their electrical properties in response to intracellular biochemical 
changes resulting from synaptic or hormonal stimulation (Kaczmarek and Levitan, 
1987). Generally, modulatory effects involve a second messenger system (Nicoll 
et a/., 1990). Results from both systemic and iontophoretic application of 5-HT 
antagonists are consistent with 5-HT2A receptors mediating the modulatory activity 
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of 5-HT on cortical pyramidal neurons (Neuman and Zebrowska, 1992). A 
possible interaction between glutamate activated N-methyl-D-aspartate (NMDA) 
receptors and 5-HT receptors was proposed to underlie this process (Neuman and 
Zebrowska, 1992), but this remains to be confirmed. In vitro, 5-HT has been 
shown to facilitate the NMDA depolarization of neocortical neurons (Nedergaard 
et a!., 1986, 1987; Reynolds et a!., 1988). However, with regards to the 
facilitation, 5-HT receptor characterization and the underlying mechanism were not 
determined. Therefore, the present investigation was aimed at examining the 
modulatory role of 5-HT with respect to facilitating the NMDA depolarization. To 
this end, this thesis has undertaken a quantitative pharmacological study concerning 
the interaction between 5-HT receptors and NMDA receptors and the underlying 
mechanism by which 5-HT facilitates the NMDA depolarization in vitro. Effects 
of other neurotransmitters/neuromodulators on the NMDA response have also been 
examined. In the first part of the thesis, characterization of the 5-HT receptor, 
regulation of the 5-HT receptor in mediating the interaction, and the underlying 
mechanism of interaction are examined. In the second part of this thesis, changes 
in 5-HT 2A receptor activity are examined in senescent rats. In the final section of 
the thesis, the facilitation induced by 5-HT is compared with that induced 
principally by metabotropic glutamate receptor agonists and also muscanntc 
cholinoceptor and a 1-adrenoceptor agonists. 
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1.2 5-HT system in the central nervous system 
1.2.1 Historical background 
5-HT is an endogenous substance, derived from an indole nucleus and is, 
therefore, classified as an indoleamine. Physiologists of the 19th century were 
aware of a substance in blood serum that caused constriction of blood vessels and 
increased vascular tone (Stevens and Lee, 1884; Brodie, 1900). In 194 7, Rapport 
and colleagues identified a serum-borne substance, which caused vasoconstriction 
and named it "serotonin" (serum tonic). Subsequently, the substance isolated, 
purified and identified as an active component of their crystalline complex was the 
chemical 5-hydroxytryptamine (Rapport et al., 1948; Rapport, 1949). Erspamer 
and Asero (1952) in Italy, had identified a substance found in high concentrations 
in enterochromaffin cells of the intestinal mucosa in the gut, which they termed 
"enteramine," that later was found to be identical with serotonin. Serotonin was 
synthesized chemically (Hamlin and Fisher, 1951) as the indolealkylamine. 
Following the isolation and synthesis of 5-HT in the early 1950s, there was 
increasing interest in the physiological function of this indoleamine. Twarog and 
Page (1953) soon detected 5-HT in the mammalian brain and in subsequent studies 
5-HT was proposed to be a neurotransmitter in the central nervous system (Amin 
et al., 1954; Bogdanski et a/., 1956; Brodie and Shore, 1957). The accumulated 
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evidence suggests that 5-HT fulfils the criteria formulated by Iversen (1975) for a 
putative neurotransmitter in the central nervous system (Fuxe, 1965~ Carlsson et 
a/., 1969). Interest in the physiological role of 5-HT in the central nervous system 
has preoccupied neurobiologists since that time. Numerous reports show that 5-HT 
affects various functions of the central nervous system, including sleep (Jouvet, 
1967; Koella, 1988), learning and memory (Altman and Normalie, 1988; McEntee 
and Crook, 1991), motor activity (Gershon and Baldessarini, 1980; Sternbach, 
1991; Jacobs and Fornal, 1993), thermoregulation (Myers, 1981), feeding (Blundell, 
1977, 1984; Marazziti et a/., 1988; Curzon, 1990) sexual behavior (Fernandez-
Guasti eta/., 1987; Gorzalka eta/., 1990), neuroendocrine regulation (Fuller, 1990; 
Cowen eta/., 1990; Van de Kar, 1991) and biological rhythms (Wesemann and 
Weiner, 1990). 
1.2.2 5-HT neurons 
The 5-HT system, originally mapped by Dahlstrom and Fuxe (1964), is one 
of the most extensive monoaminergic systems in the brain as demonstrated by 
studies in rat, cat and monkey (Dahlstrom and Fuxe, 1964, 1965; Fuxe, 1965; 
Anden et a/., 1966; Fuxe and Jonsson, 1974; Azmitia and Segal, 1978; Lidov et 
a/., 1980; Parent eta/. 1981; Steinbush, 1981). The 5-HT system consists of a 
morphologically diverse group of neurons, whose cell bodies are located in the 
5 
brain stem raphe nuclei and some regions of the reticular formation, and complex 
axonal systems which innervate virtually all regions of the central nervous system 
(Stein bush, 1981; Azmitia and Gannon, 1986; Mulligan and Tork, 1988; Tork, 
1990). 
However, there are variations m the nomenclature of 5-HT cell groups 
(Tork, 1990; Jacobs and Azmitia, 1992) out ofwhich the most recent nomenclature 
of 5-HT cell groups has been adopted in this thesis (Mamounas eta/., 1992). Fig. 
1 shows that 5-HT neurons are roughly divided into two groups: 1) an ascending 
group of neurons in mesencephalon and pons which projects rostrally innervating 
the forebrain, designated raphe dorsalis (B7, and its caudal extension B6), 
median us (or nucleus centralis superior; B8 and B5) and B9 cell group; 2) a 
descending group of neurons in the pons and medulla which projects caudally to 
the brain stem and spinal cord, designated raphe pallid us (B 1 ), obscurus (B2, B4) 
and magnus (B3) . The raphe dorsalis and medianus project widely to the cerebral 
cortex (Azmitia and Segal, 1978; Lidov et a/., 1980; Steinbush, 1981). The 
laminar distribution of 5-HT fibres has been described in the cerebral cortex of rat, 
cat and monkey (see Tork, 1990; Jacobs and Azmitia, 1992; Mamounas et a/., 
1992, for review). For example, in rat parietal cortex, 5-HT fibres innervate all 
layers, but form a dense band in the upper part of layer V (Blue et a/., 1988). In 
monkeys, 5-HT innervation was found to have the highest densities in layers I and 
Figure 1. Schematic diagram illustrating the distribution of the mam 5-HT 
containing pathways in the rat central nervous system, after Cooper et at., ( 1991 ). 
Abbreviations: Ext. capsule, external capsule~ N. Caudate, caudate nucleus; Stria. 
term., stria terminalis; Stria. med., stria medullaris; MFB, medial forebrain bundle; 
Med. long. fasc., medial longitudinal fasciculus. For nomenclature of 5-HT cell 
groups see text. 
Cerebral cortex 
Cerebellum 
Ext. 
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IV (see Jacobs and Azmitia, 1992, for review). The most highly laminar 
distribution of all neocortical areas in the monkey is found in the visual cortex 
(Jacobs and Azmitia, 1992). Recently, morphologically different fine and beaded 
5-HT axons have been found arising from the dorsal raphe and median raphe 
nuclei, respectively (Kosofsky and Molliver, 1987). Pharmacological studies show 
that only the fine fibres, originating from the dorsal raphe, are destroyed by drugs 
such as parachloroamphetamine and methylenedioxyamphetamines. Fibres from 
the median raphe are resistant to this effect suggesting differential vulnerability of 
the two axon types in cerebral cortex (Mamounas et al., 1992). 
1.2.3 Oassification and Nomenclature of 5-HT receptors 
The pioneering work of early investigators in the 5-HT field found 
pharmacological evidence for the existence of multiple 5-HT receptors (Rocha e 
Silva eta/., 1953; Gaddum and Hameed, 1954) and laid the foundation for the 
current understanding of 5-HT pharmacology. Subsequently, Gaddum and Picarelli 
(1957) demonstrated two distinct 5-HT receptor mediated effects in smooth muscle 
of the guinea pig ileum. The two presumed receptors causing these effects were 
labelled M and D receptor based on the ability of morphine and dibenzyline 
(phenoxybenzamine) to block 5-HT induced contraction of intestinal smooth 
muscle. 
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The advent of receptor binding studies confirmed the pharmacological 
evidence for multiple receptors by revealing the existence of multiple binding sites 
for 5-HT in rat brain (Peroutka and Snyder, 1979). This methodology allowed a 
preliminary classification of 5-HT receptors, but identification of subtypes was 
limited by the poor selectivity of the available agonists and antagonists. Bradley 
et al., (1986) proposed three major 5-HT receptor classes on the basis of an 
interaction with receptor agonists. These are 5-HT1-like, 5-HT2 and 5-HT3 . 5-HTc 
like was proposed for the heterogenous group of receptors including the 5-HT1A, 
5-HT1B, 5-HT1c, 5-HTm and 5-HTlE which demonstrate a high affinity for 5-HT 
and 5-carboxyamidotryptamine (5-CT), and are antagonized by methiothepin and 
methysergide (Pazos eta!., 1984; Peroutka, 1986; Heuring and Peroutka, 1987; 
Leonhardt et a!., 1989). 5-HT 2 was proposed for the D (Gaddum and Picacarelli, 
1957) receptor and corresponds to the cortical 5-HT 2 binding site (Peroutka and 
Snyder, 1979). These receptors were characterized by their low affinity for 5-HT 
and high affinity for the 5-HT antagonists ketanserin, methysergide, mianserin and 
metergoline (Bradley et al., 1986; Glennon, 1987). The 5-HT 3 receptor 
corresponds to the M receptor (Gaddum and Picarelli, 1957). ICS 205 930 and 
MDL 72222 are high affinity antagonists at 5-HT3 receptors (Fozard eta!., 1979; 
Fozard, 1984; Richardson et a!., 1985). Evidence for four additional 5-HT 
receptors (5-HT 4 through 5-HT 7) in the CNS has appeared over the last few years 
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(Shenker et al., 1987; Dumuis et al., 1988; Andrade and Chaput, 1991; Bockaert 
et al., 1992; Hoyer et al., 1994). 
Using molecular biological techniques, more 5-HT receptors have been 
identified. Therefore, the classification of 5-HT receptors has been modified by 
the Serotonin Club Receptor Committee and approved by the International Union 
of Pharmacological Societies (IUPHAR) Commission on Serotonin Nomenclature 
(Humphrey eta/., 1993; Hoyer et al., 1994). The new system classifies 5-HT 
receptors on the basis of three characteristics: i) operational (drug related), ii) 
transductional (receptor-coupling) and iii) structural (primary amino acid sequence). 
Based on these criteria, the currently recognized 5-HT receptors can be subdivided 
into seven receptor subtypes. Following this classification, 5-HT2 and 5-HT1c 
receptors have been renamed as 5-HT2A and 5-HT2c. Table I summarizes the most 
recent classification of 5-HT receptor subtypes together with their anatomical 
location and most specific agonists and antagonists (Humphrey et al., 1993, Hoyer 
et a/., 1994; Martin and Humphrey, 1994). In this thesis, the new nomenclature 
has been adopted. 
1.2.4 Localization of 5-HT receptors 
Pharmacological, biochemical, functional and in situ hybridization studies 
have revealed the location of multiple of 5-HT receptors in the central nervous 
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Table L Classification of 5-HT receptors by modified nomenclature in mammlian brain 
Receptor 5-HT1A 5-HT18 5-HT10 5-HT1E 5-HT,F 
subtype 
Previous 5-HTlE~J 
name 5-HT6 
Effector -kAMP J..cAMP -!.cAMP -kAMP J..cAMP 
pathways K+ channel 
Selective 8-0H-DPAT CP93129 Sumatriptan 
agonists 
Selective WAY100135 
antagonists 
Structure 42laa human 386aa rat 377/390aa 365aa human 366aa rat 
422aa rat human 
Receptor 5-HT2A 5-HT28 5-HT2c 5-HT3 5-HT4 
subtype 
Previous name D,5-HT2 5-HT2y 5-HT1c M 
Effector IP/DAG IP/DAG IP/DAG Cation channel fcAMP 
pathways 
Selective a-methyl a-methyl a-methyl 2-methyl 5MeOT 
agonists 5-HT 5-HT 5-HT 5-HT 
Selective Ritanserin LY53857 Mesulergine ICS205930 GR113808 
antagonists Ketanserin LY53857 Ondansetron 
Structure 47laa human 479aa rat 458aahuman 487aa mouse 
47laa rat 460aa rat 
Receptor 5-HT5A 5-HT58 5-HT6 5-HT7 
subtype 
Previous name 5-HT sa 5-HT511 
Effector Unknown Unknown tcAMP tcAMP 
pathways 
Selective 
agonists 
Selective 
antagonists 
Structure 357aa rat 371aa rat 436aa rat 445aa human 
Modified after Humphrey eta/., 1993~ Martin and Humphrey, 1994; Hoyer et al, 
1994. 
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system (Pazos eta/., 1985; Pazos and Palacios, 1985a; Andrade and Chaput, 1990; 
Aghajanian eta/., 1990; Palacios eta/., 1992; Peroutka, 1993; Hoyer eta!., 1994; 
Pompeiano et a/., 1994; Zifa and Fillion, 1992). Because of the importance and 
relevance of 5-HT2A, 5-HT2c and 5-HT1A receptors to this thesis, only these 
subtypes of 5-HT receptors are reviewed. Localization and distribution of 5-HT2A 
receptors have been reported for the rat (Pazos et a/., 1985) and human brain 
(Hoyer eta/., 1986b; Biegon eta/., 1986; Pazos eta/., 1987b). Species differences 
(rat vs human) in receptor localization have been reported by receptor 
autoradiography. 5-HT2A recognition sites occur at high concentrations in rat 
neocortex, claustrum, olfactory tubercle, olfactory nucleus and piriform cortex 
(Pazos eta/., 1985; Schotte eta/., 1983). In the neocortex, high densities are found 
in the frontoparietal motor and sensory cortex. Layer V of this area is reported to 
contain the highest densities of 5-HT zA receptors (Pazos et a/., 1985). High 
densities of recognition sites are also observed in layer III and IV depending upon 
the cortical area (Pazos et a/., 1985). High to intermediate concentrations are 
found in layer I. Intermediate to low concentrations are observed in all other brain 
regions (Pazos et al., 1985). The laminar distribution of messenger ribonucleic 
acid (mRNA) for 5-HT2A receptors in rat brain is consistent with that of the 
binding sites (Pompeiano eta/., 1994). In human brain, 5-HT 2A binding sites are 
present at very high concentration in layer III and V (Hoyer eta/., 1986b; Biegon 
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et a/., 1986; Pazos et a/., 1987b ). 
5-HT zc receptors are found at high concentrations in the choroid plexus of 
rat, mouse and human (Yagaloff and Hartig, 1985; Peroutka, 1986; Mengod eta/., 
1990; Hoyer et a/., 1986b) and low levels in most other regions of the brain 
including cerebral cortex (Pazos eta/., 1985b; 1988) with some notable exceptions. 
Thus, for example, very high concentrations of 5-HT2c binding sites are found in 
layers II-III and the deep part of layer V of retrosplenial cortex (Pazos and 
Palacios, 1985a). Intermediate to low densities of 5-HT zc recognition sites are 
found in the internal layers of anterior cingulate cortex (Pazos and Palacios, 
1985a). The distribution of mRNA for 5-HT 2c receptors is in keeping with the 
binding studies (Molineaux eta/., 1989; Hoffman and Mezey, 1989; Pompeiano et 
a/., 1994). 
Localization of 5-HT1A receptors has been studied in rat, mouse, guinea pig 
and human brain (Pazos and Palacios, 1985a; Weaber et a/., 1989; Hoyer et a/., 
1985b; Pazos eta/, 1987a). In rat, 5-HT1A receptors are found in high densities 
in entorhinal cortex, hippocampus, some nuclei of amygdaloid complex, and the 
dorsal and median raphe, which contain 5-HT cell bodies. Intermediate densities 
of 5-HT1A binding sites are present in claustrum and olfactory tubercle (Pazos and 
Palacios, 1985a). Intermediate to low concentrations of 5-HT1A binding sites are 
present in cerebral cortex and nucleus caudate-putamen. The distribution of 
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mRNA for 5-HT IA receptors IS compatible with that of the binding sites 
(Pompeiano et a/., 1992). 
1.2.5 Electrophysiology of 5-HT receptors 
Understanding of the electrophysiology of 5-HT has progressed with the 
development of selective agonists and antagonists for these receptors. Between 
two and three decades ago, single cell recording from neurons in the cerebral 
cortex and brain stem indicated that multiple 5-HT receptors were present in the 
central nervous system (Roberts and Straughan, 1967; Haigler and Aghajanian, 
1974). Subsequently, three 5-HT receptor subtypes were proposed to account for 
the early experimental observations (Aghajanian, 1981; Haigler, 1981 ). The first 
subtype facilitated the depolarizing action of glutamate at facial motoneurons 
(McCall and Aghajanian, 1980) and spinal motoneurons (White and Neuman, 
1980). This excitatory action of 5-HT on motoneurons was antagonized by 
classical 5-HT antagonists such as methysergide, cinanserin and cyproheptadine 
(Haiglar and Aghajanian, 1974; Aghajanian and Wang, 1978; Aghajanian, 1981). 
The inhibition produced by 5-HT in forebrain regions including neocortical neurons 
was attributed to the second 5-HT receptor subtype (Reader et a/., 1979; 
Aghajanian, 1981 ). Classical 5-HT antagonists were not consistently effective in 
blocking this receptor (Aghajanian, 1981). The third subtype of receptor ·was the 
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presynaptic autoreceptor, which was located in the somatodendritic region of 5-HT 
neurons in the dorsal and median raphe nuclei. Activation of these receptors by 
5-HT inhibited 5-HT neurons and as a consequence 5-HT neurotransmission was 
reduced (Aghajanian, 1981). Classical 5-HT antagonists were ineffective at this 
receptor. Can the three types of receptors be fit into current understanding of 5-
HT receptors and if so which receptors are responsible for each action? 
The 5-HT2A, and in some cases the 5-HT2c, receptor subtype most closely 
approximate the first subtype. Activation of presumed 5-HT2A receptors causes 
neuronal excitation on motoneurons and pyramidal neurons (VanderMaelen and 
Aghajanian, 1982: Davies et a/., 1987) and agonists at these receptor are often 
hallucinogenic (Glenon, 1990). At cortical neurons, 5-HT 2A receptors enhance cell 
excitability by : i) a direct membrane depolarization; and ii) modulation of the slow 
voltage and calcium-activated membrane currents present in these cells (Andrade 
and Chaput, 1991). The slow depolarization of cortical neurons is associated with 
a decreased resting K+ conductance and reduction of the slow 
afterhyperpolarization (Davies et a/. , 1987; McCormick and Williamson, 1989; 
Araneda and Andrade, 1991; Tanaka and North, 1993). 5-HT2A receptors in the 
prefrontal cortex are also capable of regulating slow voltage and Ca++ activated 
currents by membrane depolarization and potentiate the effect of excitatory inputs 
onto these cells (c.f. Andrade and Chaput, 1991). Classical 5-HT receptor 
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antagonists block all of the above actions but in most cases the concentrations 
employed are not appropriate to discriminate between 5-HT 2A and 5-HT 2c subtypes. 
As with pyramidal neurons, stimulation of the presumed 5-HT2A receptors 
on facial motoneurons evokes a slow depolarization, increases input resistance, and 
increases excitability, probably through a decrease in resting membrane 
conductance to potassium (Vandermaelen and Aghajanian, 1980, 1982; Rasmussen 
and Aghajanian, 1990). The action of 5-HT in the facial nucleus can be blocked 
by the classical 5-HT antagonists metergoline, methysergide, cyproheptadine and 
cinanserin (McCall and Aghajanian, 1980). Similar observations with respect to 
5-HT2A receptors have been made in nucleus accumbens neurons (North and 
Uchimura, 1989). In piriform cortex, 5-HT2A receptors are also excitatory, but 
instead of being located on pyramidal neurons they are found on inhibitory 
interneurons (Sheldon and Aghajanian, 1990). Thus, activation of 5-HT 2A receptors 
induces inhibitory postsynaptic potentials (IPSPs) on layer II neurons. The IPSPs 
are in turn blocked by a gamma-aminobutyric acid-A (GABAA) receptor antagonist 
bicuculline (Sheldon and Aghajanian, 1990). 5-HT2c receptors are present in high 
concentration in the piriform cortex where they appear to be located on layer II 
cells. These 5-HT2c receptors are directly excitatory on layer II neurons in the 
piriform cortex. When 5-HT 2c receptor mRNA is injected into Xenopus oocytes, 
it stimulates Ca ++ release which in turn induces a Ca ++ dependent chloride current 
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(Lubbert eta/., 1987). 5-HT2A receptor mRNA has the same action in Xenopus 
oocytes suggesting the 5-HT 2c receptors on central nervous system neurons are 
likely to mimic the action of 5-HT 2A receptors, although whether this is true in all 
respects remains to be established. In summary, the electrophysiological evidence 
is uniformly consistent that 5-HT2A and 5-HT2c receptors are excitatory on neurons, 
although depending on the type of neurons on which they are found, the net effect 
of their activation may be excitatory or inhibitory . 
In contrast with the 5-HT2A and 5-HT2c receptors, activation of 5-HT1A 
receptors results in an inhibitory hyperpolarization. The 5-HT1A receptor mediated 
hyperpolarization has been reported in neurons of the frontal cortex (Araneda and 
Andrade, 1991), cingulate cortex (Tanaka and North, 1993), hippocampus (Andrade 
and Nicoll, 1987; Colino and Halliwell, 1987), dorsal raphe (Aghajanian and 
Lakoski, 1984; Williams et al., 1988), and superior cervical ganglia (Ireland and 
Jordan, 1987). The 5-HT1A receptor mediated hyperpolarization is consistently 
associated with an increased potassium conductance (Araneda and Andrade, 1991; 
Tanaka and North, 1993) dependent on a pertussis toxin sensitive guanylate 
nucleotide binding protein (Andrade and Nicoll, 1987). 5-HT IA selective agonists 
including 8-hydroxy-dipropylaminotetralin HBr (8-0H-DPAT) and ipsapirone 
mimic the inhibitory effect of 5-HT on postsynaptic sites as well as on 
somatodendritic autoreceptors on dorsal raphe neurons (Andrade and Chaput, 
1991). 
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Antagonists at 5-HT IA receptors can block the 5-HT induced 
hyperpolarization at postsynaptic sites as well as the reduction in excitability on 
dorsal raphe cell firing (VanderMaelen et a/., 1986; Sprouse and Aghajanian, 
1987). Thus, subtypes 2 and 3 of Aghajanian (1981) appear to most closely 
resemble the 5-HT IA receptor subtype . Much less is known regarding the 
electrophysiological action of the remaining 5-HT receptors found in the central 
nervous system with the exception of the 5-HT3 receptor (Hoyer et a/., 1994). 
Unlike other 5-HT receptors, 5-HT3 receptors have a rapid excitatory action which 
has been demonstrated in a number of cells including cultured mouse hippocampal 
and striatal neurons (Yakel and Jackson, 1988). 5-HT3 receptors are directly 
coupled to a nonspecific cation channel, i.e. the response is not mediated by a 
second messenger. It is the direct coupling which allows for the rapid excitatory 
action. Like 5-HT 2A receptors, the 5-HT 4 receptor mediates a membrane 
depolarization and reduction in afterhyperpolarization, at least in rat hippocampal 
neurons (Andrade and Chaput, 1991a). 
1.2.6 5-HT receptor activated second messengers 
It is well established that 5-HT receptors are linked to two major second 
messenger systems in mammalian central nervous system. The two systems 
transmitting extracellular signal or receptor activation across the plasma membrane 
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are the adenylate cyclase/cyclic AMP cascade and phospholipase C/ 
phosphoinositide (PI) hydrolysis cascade (Chuang, 1989). These signals modify 
cellular systems largely through the common mechanism of phosphorylation 
(Cooper et al., 1991). Based on second messenger systems, 5-HT receptors can be 
divided into three categories, those which inhibit (5-HT 1) or stimulate (5-HT 4, 5-
HT6 and 5-HT7) the adenylate cyclase/cyclic AMP system and those which 
stimulate phospholipase C/phosphoinositide hydrolysis (5-HT 2A, 5-HT 28 and 5-
HT2c; Martin and Humphrey, 1994; Hoyer et al., 1994). 
Among the 5-HT1 receptor family, activation of the 5-HT1A receptor subtype 
has been found to produce inhibition of forskolin stimulated adeny late cyclase in 
the central nervous system of rat, guinea pig and mouse (see Zifa and Fillion, 
1992; Hoyer et al., 1994, for review) . However, activation of 5-HT1A receptors has 
also been shown to couple positively to adenylate cyclase (see Hoyer and 
Schoeffter, 1991; Zifa and Fillion, 1992, for review). Limited reports suggest 5-
HT IA receptors may also influence second messenger processes such as 
phosphoinositide turnover and liberation of arachidonic acid (Claustre et al., 1988, 
1991). The remaining 5-HT receptors (5-HTIB to 5-HT1p) appear to be negatively 
linked with adenylate cyclase in the central nervous system (Hoyer et al., 1994 and 
above Refs.). 
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5-HT2A and 5-HT2c receptors stimulate PI hydrolysis, again demonstrating 
the similarity between these two receptors (Kendall and Nahorski, 1985; Conn and 
Sanders-Bush, 1984, 1986, 1987; Hide et a/., 1989; Hoyer et a/., 1989). 5-HT 2A 
receptors couple to phospholipase C (PLC) through a guanylate nucleotide binding 
protein (G-protein). When PLC is activated, it metabolizes phosphoinositide 4,5-
biphosphate (PIP2) to produce at least two second messengers, inositol 1,4,5-
triphosphate (IP3) and diacylglycerol (DAG; see Berridge, 1987; Nishizuka, 1988; 
Chuang, 1989 for review). IP3 acting at an IP3 receptor on smooth endoplasmic 
reticulum releases calcium (Taylor and Richardson, 1991) and DAG activates 
protein kinase C (Nishizuka et al., 1991). There are other inositol phosphates 
formed, but whether these are significant for signalling remains to be established. 
However, the released Ca++ activates a number of enzymes which phosphorylate 
cellular proteins (Kennedy, 1992). How this phosphorylation alters neuronal signal 
transduction processes is still unclear. Protein kinase C (PKC) is involved in the 
phosphorylation reactions (Nishizuka et al., 1991; Stabel and Parker, 1993) and 
regulates receptor function (Roth et al., 1986; Aghajanian, 1990). In cortical slices, 
activation of 5-HT 2A receptors induces a concentration and time related 
translocation of protein kinase C through a Ca ++ dependent mechanism (Wang and 
Friedman, 1990). 5-HT can also stimulate phospholipase A2 and subsequent 
release of arachidonic acid in hippocampal and cortical neurons via 5-HT 2 which 
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presumably are 5-HT 2A receptors (Felder eta/., 1990). Similarly, 5-HT 2c receptor 
activation in the choroid plexus and the hippocampus leads to the stimulation of 
PLC and accumulation of inositol phosphates (see Hoyer eta/., 1994, for review). 
Hartig eta/., (1990) reported that activation of 5-HT 2c receptors also regulates the 
production of cGMP in the choroid plexus. 
5-HT4, 5-HT5, 5-HT6 and 5-HT7 are present in the central nervous system 
and except for 5-HT 5, appear to couple positively to adeny late cyclase. The action 
of 5-HT5 is not known (see Hoyer eta/., 1994, for review). An extensive review 
of these receptors is beyond the scope of this thesis. 
1.2. 7 Molecular biology of 5-HT receptors 
Molecular biological data have unequivocally confirmed the existence of 
multiple 5-HT receptors (Boess and Martin, 1994 ). Indeed, the multiplicity of 5-
HT receptor subtypes, both within and between species, has exceeded most of the 
predictions that might have been made on the basis of pharmacological data 
(Peroutka, 1994). So far, fourteen subtypes of 5-HT receptors including 5-HT1A> 
5-HTm, 5-HTm, 5-HT1E, 5-HT1p, 5-HT2A, 5-HT2B, 5-HT2c, 5-HT3, 5-HT4, 5-HT5A, 
5-HT5B, 5-HT6 and 5-HT7 have been cloned (see Boess and Martin, 1994, for 
review). However, only an overview of the most relevant subtypes, 5-HT 2A, 5-
HT2c and 5-HT1A will be presented. 
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All three cloned receptors are single subunit proteins and members of the 
G-protein receptor family. This family of receptors is characterized by the 
presence of seven transmembrane domains and by the ability to activate G protein 
dependent processes such as activation or inhibition of adenylate cyclase (i.e. 5-
HT 1.J, or stimulation of phosphoinositide hydrolysis (see Julius eta/., 1990; Boess 
and Martin, 1994; Martin and Humphrey, 1994, for review). Gene structure and 
primary amino acid sequence comparisons indicate that the 5-HT1A receptor has 
evolved from the family of adrenergic receptors, whereas the 5-HT 2A and 5-HT 2c 
receptors define a separate gene family (Huang and Julius, 1991). The 5-HT2A 
receptor shows homology to the 5-HT2c receptor ( 53% overall sequence identity, 
80% identity in transmembrane domain), whereas the 5-HT2A receptor is only 41% 
identical to the 5-HT1A receptor (Julius eta/., 1990; Saltzman eta/., 1991; Boess 
and Martin, 1994). The human 5-HT 2A receptor is also homologous with the rat 
receptor (87%), with the highest amino acid homology (98%) found within the 
transmembrane regions (Julius et al., 1990). The amino acid sequence for both the 
5-HT 2A and 5-HT 2c receptors reveals the presence of numerous serine/threonine 
residues which may be possible targets for phosphorylation (Boess and Martin, 
1994) and potential sites at which receptor activity can be controlled. 
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1.2.8 Regulation of 5-HT2A recepton 
Since the present thesis deals mainly with the 5-HT2A receptor, this section 
focuses only on this subtype. 5-HT2A receptors are regulated by a large number 
of exogenous and endogenous factors (Roth et a/., 1990; Leysen and Pauwels, 
1990). Like classical G-protein coupled receptors (i.e. f3-adrenoceptors), 5-HT 2A 
receptors are regulated by agonist induced down-regulation. For example, exposure 
to 5-HT2A receptor agonists or partial agonists reduces binding to the 5-HT2A 
receptor (Ley sen et a/., 1989; McKenna eta/., 1989; Pranzatelli, 1991 ). However, 
unlike other receptors, 5-HT2A receptors undergo down-regulation following chronic 
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exposure to antagonists (Leysen and Pauwels, 1990). Such down-regulation is 
evidenced not only by a decrease in 5-HT2A receptor density, but also by a 
subsensitive phosphoinositide response (Zifa and Fillion, 1992). Chronic 
administration of many antidepressants causes down-regulation of the 5-HT 2A 
binding sites (Peroutka and Snyder, 1980; Kendall and Nahorski, 1985; Mizuta and 
Segawa, 1989) which is accompanied by decreased IP3 production (see Zifa and 
Fillion, 1992 for review). On the other hand, administration of electroconvulsive 
shock, an effective treatment for depression, increases the number of 5-HT 2A 
receptors (Kellar et al., 1981). 5-HT2A receptors may also be down-regulated by 
treatment with many antipsychotic agents which bind to 5-HT2A receptors (Roth et 
a/., 1990; Roth and Ciaranello, 1991). 
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Aging also appears to alter regulation of 5-HT 2A receptors. Thus, 5-HT 2A 
labelled binding sites decrease in number during aging in both rat (Battaglia eta/., 
1987; Gozlan eta/., 1990) and human brain (Wong eta/., 1984; Marcusson eta/., 
1984; Reynolds et a/., 1984; Gross-Isseroff et a/., 1990). Moreover, coupling 
between 5-HT2A receptors and G-proteins is also altered with aging (Robson eta/., 
1993). These intriguing findings raise the question as to whether age related 
cognitive deficits observed in both rats and humans might result in part from 
altered 5-HT 2A receptor activity . 
1.2.9 Role of 5-HT in neuropsychiatric disorders 
In recent years, evidence has emerged to suggest that altered 5-HT receptor 
mediated function is associated with the pathophysiology of diverse psychiatric 
conditions (Siever eta/., 1991; Sandyk, 1992). Evidence implicating abnormalities 
of 5-HT function have been reported for disorders including: I) Alzheimer's 
disease (Cross et al., 1986; Reynolds et a/., 1984; Cross, 1990, Cheng et a/., 
1991); 2) Parkinsonism (Cheng ei a/., 1991); 3) suicidal behaviour (Mann eta/., 
1990; Coccaro and Astill, 1990); 4) schizophrenia (Kahn and Davidson, 1993); 5) 
depression (Cowen, 1990, 1993; Plaznik et a!., 1989; Meltzer, 1990); 6) anxiety 
(Iverson, 1984; Gardner, 1986; Kahn eta/., 1988; Nutt and George, 1990; Hamon, 
1994; Bison and Bison, 1994); and 7) obsessive compulsive disorders· (Zak eta/., 
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1988; Insel eta/., 1990; Murphy et al., 1992). Furthermore, drugs affecting 5-HT 
transmission or 5-HT receptors are widely used for a number of clinical conditions. 
For example, selective serotonin reuptake inhibitors (SSRis) are effective in the 
treatment of major depression and obsessive-compulsive disorder (see Fuller, 1991, 
Blier and Montigny, 1994, for review). 5-HT2A receptor antagonists such as 
mianserin and ritanserin appear to be effective antidepressants (Sleight eta/., 1991; 
Bersani et al., 1991). 5-HT2A receptor antagonists, either alone or in combination 
with a neuroleptic, reduce negative symptoms in patients with schizophrenia 
(Gelders, 1989; Castelao et al., 1989; Leysen et al., 1993). Thus, understanding 
the pharmacology of 5-HT receptors has potentially important therapeutic 
implications. 
1.2.10 5-HT and alteration of neocortical excitability 
In vivo studies 
In keeping with the widespread distribution of 5-HT containing fibres in the 
mammalian cortex (see section 1.2.2), 5-HT has been observed to profoundly alter 
cortical excitability . Epitomizing this is the growing body of evidence that 5-HT 
mediates atropine resistant cortical desynchronization (low voltage fast activity) 
(Vanderwolf and Baker, 1986; Vanderwolf, 1988; Vanderwolf et a/., 1989 ). 
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In urethane anaesthetized rats, noxious stimulation reliably elicits cortical 
desynchronization, providing 5-HT transmissive processes remain functional. 
Depletion of 5-HT, blockade of dorsal raphe unit activity, or administration of 5-
HT 2A receptor antagonists prevents induction of cortical desynchronization by 
noxious stimulation (Neuman, 1986; Neuman and Thompson, 1989; Thompson et 
al., 1991). This action of 5-HT is mediated cortically, since iontophoretic release 
of 5-HT2A receptor antagonists onto layer V pyramidal neurons eliminates cortical 
desynchronization in response to noxious stimulation. Moreover, the underlying 
cellular event responsible for desynchronization, i.e. transformation of unit activity 
from burst-pause to continuous (Creutzfeldt and Houchin, 1974), is also abolished 
by such treatment (Neuman and Zebrowska, 1989, 1992). These findings are in 
accord with a high density of 5-HT2A binding sites in layer V of the cortex (Pazos 
et a/., 1985; Appel eta/., 1990; Pompeiano eta/., 1994) and the observations that 
dorsal raphe 5-HT fibres are in register with 5-HT2A receptors in layer V (Blue et 
al., 1988). The role of 5-HT2A receptors in cortical desynchronization appears to 
be state dependent. In urethane anaesthetized rats, the desynchronization is readily 
blocked by 5-HT2A receptor antagonists (Neuman and Zebrowska, 1992). The slow 
waves observed in animals anaesthetized with urethane resemble the slow wave 
activity observed during sleep. Moreover, 5-HT 2A receptor antagonists readily 
prolong slow wave sleep in both rats and humans which is in keeping with 5-HT 2A 
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receptor antagonists preventing cortical desynchronization (Neuman and 
Zebrowska, 1992). However, in awake freely moving animals, 5-HT ZA receptor 
antagonists do not prevent cortical desynchronizations (Vanderwolf, 1988). Indeed, 
the 5-HT receptor(s) mediating this response in awake animals remains to be 
determined. 
NMDA receptors are involved in generating spontaneous bursting at cortical 
neurons (Flatman et a/., 1983). These spontaneous bursts of spikes produced by 
layer V pyramidal neurons are blocked by D-2-amino-5-phosphonopentanoic acid 
(AP5), an NMDA receptor antagonist, and promoted by iontophoresis of NMDA 
(Armstrong-James and Fox, 1988; Fox and Armstrong-James, 1986). Both 
anatomical and functional evidence suggest that NMDA receptor mediated input 
to layer V pyramidal neurons arises from the intralaminar nucleus of the thalamus 
(Fox and Armostrong-James, 1986). This input exhibits a pacemaker role to elicit 
bursting activity in cortical neurons (Fox and Armostrong-James, 1986). The effect 
of noxious stimulation on cortical neurons appears to result from enhancement of 
NMDA responses which is manifest as an increase in the number of spikes per 
burst. However, the mechanism(s) responsible for 5-HT induced alteration of 
cortical unit activity remains to be established. 
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In vitro studies 
5-HT typically depolarizes cortical layer V neurons with hyperpolarization 
observed less frequently in rat, guinea pig and human neocortex (Davies et al., 
1987; Araneda and Andrade, 1991; Tanaka and North, 1993; McCormick and 
Williamson, 1989). The depolarization involves 5-HT 2A receptors and results from 
a decrease in K+ conductance whereas the hyperpolarization involves 5-HT IA 
receptors and results from an increased K+ conductance. The depolarization found 
with 5-HT undergoes homologous desensitization (Araneda and Andrade, 1991). 
5-HT also blocks the slow afterhyperpolarization (AHP) at high concentrations. 
Both the depolarization and the slow AHP are mimicked by phorbol esters which 
activate PKC (Araneda and Andrade, 1991 ). This is consistent with the evidence 
that activation of 5-HT2A receptors stimulates PI hydrolysis and the resulting 
second messenger cascade (Berridge, 1987; Chuang, 1989). 5-HT2A receptor 
antagonists block the depolarizing response revealing an underlying 
hyperpolarization (Araneda and Andrade, 1991). An unmasking of inhibition by 
5-HT2A antagonists is consonant with in vivo findings (Lakoski and Aghajanian, 
1985; Neuman and Zebrowska, 1992). 
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1.3 Excitatory amino acid receptors - an oveiView 
Excitatory amino acid (EAA) receptors are the major class of excitatory 
neurotransmitter receptors in the vertebrate central nervous system (Collingridge 
and Lester, 1989; Monaghan et al., 1989; Barnes and Henley, 1992; Hollmann and 
Heinemann, 1994). They are membrane spanning proteins that mediate the 
stimulatory actions of glutamate and possibly other related endogenous amino acids 
(Barnes and Henley, 1992). EAA receptors play an important role in many 
neuronal functions in the central nervous system (see Monaghan et al., 1989; 
Collingridge and Lester, 1989; Schoepp et al., 1990; Schoepp and Conn, 1993; 
Nakanishi, 1992; McBain and Mayer, 1994 for review). The diverse functions of 
EAA neurotransmission are mediated by a variety of EAA receptors that are 
classified into two distinct groups: 1) ionotropic types; and 2) metabotropic types 
(Collingridge and Lester, 1989; Monaghan et al., 1989; Schoepp et al., 1990). 
The ionotropic receptor can be further subdivided into NMDA, a-amino-3-hydroxy-
5-methyl-4-isoxazolepropionate (AMPA) and kainate receptors. The AMPA 
receptor is also activated by quisqualate and was formerly called the quisqualate 
receptor (Collingridge and Lester, 1989; Watkins et al., 1990). Both AMPA and 
kainate receptors are ligand-gated, cation specific ion channels (Masu et al., 1993) 
composed of several subunits similar to the well characterized nicotinic and 
GABAA receptors (see Gasic and Hollmann, 1992; Hollmann and Heinemann, 1994 
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for review). 
The metabotropic glutamate receptors (mGluRs) are G-protein linked 
receptors which activate intracellular second messengers (Schoepp et al., 1990; 
Schoepp and Conn, 1993; Hollmann and Heinemann, 1994). The mGluRs form 
a family of at least seven subtypes termed mGluR1-mGluR7 which differs in 
sequence and signal transduction mechanisms (Masu et al., 1991, 1993; Tanabe et 
al., 1992, 1993; Abe et al., 1992; Okamoto et al., 1994; Nakanishi et al., 1994). 
For example, mGluR1 and mGluRS subtypes couple positively to PLC-PI pathway, 
whereas the other five subtypes are linked to the inhibition of the cAMP cascade. 
These receptor subtypes show differences in regional distributions in the brain, e.g. 
the mGluR1 is abundantly present in cerebellum, whereas mGluRS is found in 
cerebral cortex and hippocampus (see Masu et al., 1993; Hollmann and 
Heinemann, 1994 for review). 
An additional class of EAA receptors that is sensitive to the glutamate 
analogue L-2-amino-4-phosphonobutyric acid (L-AP4) has been reported 
(Collingridge and Lester, 1989; Watkins et al., 1990). This L-AP4 sensitive 
receptor may be a presynaptic autoreceptor (Williams eta/., 1991). 
1.3.1 NMDA recepto~ 
The NMDA receptor complex contains a number of distinct -recognition 
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sites for endogenous and exogenous ligands. These include binding sites for 
glutamate and the co-agonist glycine, a regulatory or allosteric modulatory site 
which binds polyamines, a voltage dependent Mg ++ binding site, an inhibitory 
divalent cation site that binds Zn ++ and a site in the ion channel which binds open 
channel blockers such as phencyclidine, ketamine and MK 801 (see Barnes and 
Henley, 1992; McBain and Mayer, 1994, for review). The NMDA receptor gated 
ion channel has characteristics that clearly distinguish it from other EAA receptor 
associated channels (Monghan eta/., 1989). The ion channel is permeable to Na+, 
K+ and Ca++ and is blocked by Mg++ in a voltage dependent manner (Nowak et al., 
1984; Ascher and Nowak, 1988). The influx of Ca++ that accompanies receptor 
activation is believed to be involved in many cellular responses mediated by 
NMDA receptors, including the generation of long term potentiation(LTP) (Nicoll 
et a/., 1988; Collingridge and Lester, 1989). The Mg ++ blockade is relieved by 
membrane depolarization conferring on the current-voltage relationship a negative 
slope region. The voltage dependent Mg ++ blockade of the NMDA receptor 
channel is thought to be a key switch in controlling the induction of L TP during 
tetanic stimulation (Madison et a/., 1991 ). 
Molecular cloning of the NMDA receptor has identified a subunit termed 
NMDAR1 and four additional subunits NMDAR2A-2D (Moriyoshi et al., 1991; 
Nakanishi, 1992; Monyer et a/., 1992; Kutsuwada et a/., 1992; Sugihara et a/., 
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1992; Ishii eta/., 1993). NMDAR1 is the key subunit that possesses all properties 
of the NMDA receptor gated channel complex, including agonist and antagonist 
selectivity, glycine modulation, voltage dependent Mg ++ blockade, Ca ++ 
permeability and inhibition by zn++ (Moriyoshi eta/., 1991; Sughihara eta/., 1992; 
Karp et a/., 1993). NMDAR2A-2D subunits have no channel activity in the 
homomeric configuration but potentiate the NMDA receptor activity when 
combined with NMDARI (Ishii et a/., 1993). The NMDAR1 mRNA is 
ubiquitously expressed in almost all neuronal cells throughout the brain whereas 
the mRNA for the NMDAR2 subunits show overlapping but different expression 
patterns in various brain regions (Moriyoshi et a/., 1991; Ishii et a/., 1993). 
Functionally distinct NMDA receptor subtypes are heteromeric assemblies of 
NMDAR1 with NMDAR2 subunits (Masu eta/., 1993). NMDA receptor subunits 
contain consensus phosphorylation sites for protein kinases at the cytoplasmic 
domain (Masu eta/., 1993): 
Based on binding studies, at least three distinct subclasses of NMDA 
receptor have been proposed (Ebert eta/., 1991; Monghan and Anderson, 1991; 
Monghan and Beaton, 1991). These are as follows: I) the striatal or agonist 
preferring NMDA receptor, 2) the thalamic or antagonist preferring NMDA 
receptor, and 3) the cerebellar class ofNMDA receptor (Barnes and Henley, 1992). 
However, the recent isolation and sequencing of different molecular species (see 
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above) of NMDA receptor suggest that at least two pharmacologically distinct 
types exist in the central nervous system (Stone, 1993)~ the NMDA-1 receptors 
present in the spinal cord and cerebellum and NMDA-2 receptor present in the 
neocortex, hippocampus, and striatum (Stone, 1993). 
1.3.2 Modulation of NMDA receptors 
The NMDA receptor complex is subject to modulation by : i) ligands 
binding to the NMDA receptor complex, and ii) transmitters, including glutamate 
which binds with other receptors. 
Allosteric modification of the NMDA receptor complex occurs as a 
response to ligand binding, and as such represents a major target for drug action, 
e.g. glycine (Thomson, 1989) and the polyamines (Williams et al., 1991). Glycine 
has been shown to enhance the effects of NMDA in both electrophysiological 
(Johnson and Ascher, 1987~ Thomson, 1989) and biochemical studies (see 
Reynolds, 1990 for review). It has been demonstrated that nanomolar 
concentrations of glycine enhance the frequency of NMDA receptor channel 
opening in a strychnine insenstive manner (Johnson and Ascher, 1987) suggesting 
a distinct glycine binding site. Glycine has been reported to prevent desensitization 
of the NMDA receptor during prolonged exposure to agonists (Mayer et al., 1989; 
Vyklick:y et al., 1990), and by an acceleration of recovery of the receptor. from its 
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desensitized state. It is now well established that glycine acts as a co-agonist at 
the NMDA receptor complex (see Thomson, 1990; McBain and Mayer, 1994, for 
review). 
The polyamine recognition site has been implicated as a novel activator or 
positive allosteric modulator of the NMDA receptor complex (Reynolds, 1990; 
Williams et a/., 1991 ). The endogenous polyamines spermine and spermidine 
increase the binding of open channel blockers and enhance NMDA elicited currents 
in cultured neurons (Williams eta/., 1991a). 
There is now unequivocal evidence that transmitters acting at non-NMDA 
receptors profoundly influence the responsiveness of glutamate mediated synaptic 
transmission at NMDA receptors (Reynolds, 1990). This form of modulation is 
mediated by transmitter activated second messengers. Examples of 
neurotransmitter modulation of NMDA responses include cholinergic (Markram 
and Segal, 1990, 1992), noradrenergic (Segal et al., 1991; Mouradian et al., 1991), 
serotonergic (Nedergaard et al., 1986, 1987; Reynolds et al., 1988), metabotropic 
glutamatergic (Aniksztejn eta/., 1991, 1992; Harvey and Collingridge, 1993), 
GABA-ergic (Walden et al., 1989), and peptidergic modulation (Monnet et al., 
1990). However, it is still unclear as to how the activated second messengers 
account for the modulation in each case. There may be one or more common 
pathways activated by second messenger systems which induce facilitation of the 
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NMDA response (see below). McCall and Aghajanian (1979) first obtained 
evidence for the modulatory interaction of 5-HT and norepinephrine (NE) with 
glutamate (likely acting at NMDA receptors) at facial motoneurons. They found 
that 5-HT and norepinephrine alone had no detectable effect on firing, whereas 
they facilitated glutamate induced excitation. Similarly, 5-HT and NE were found 
to have no detectable effects on the spontaneous firing of spinal motoneurons, yet 
they greatly enhanced the glutamate induced excitation of motoneurons suggesting 
a modulatory interaction among these neurotransmitters (White and Neuman, 1980; 
Neuman and White, 1982). 
In neocortical neurons, 5-HT alone has been reported to have little or no 
effect on membrane potential or input resistance of layer V pyramidal neurons and 
yet the NMDA induced depolarization and underlying inward current were 
enhanced by 5-HT (Nedegaard et al., 1986, 1987; Reynolds et al., 1988; Mally et 
al., 1991). 5-HT mediated facilitation is selective for NMDA receptors in rats 
(Reynolds et al., 1988), but not in cats, where the quisqualate induced 
depolarization is also enhanced (Nedergaard et al., 1987). 5-HT mediated 
facilitation is blocked by the 5-HT antagonist cinanserin in cat (Nedergaard eta/., 
1987). The enhancement is not only observed with exogenous NMDA but the 
NMDA component of the EPSP is also facilitated by 5-HT (Reynolds eta/., 1988; 
Read et al., 1990). With regard to mechanism, 5-HT mediated facilitation of facial 
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motoneurons was initially attributed to the blockade of a resting K+ conductance 
(McCall and Aghajanian, 1979). However, this mechanism is unlikely to operate 
in neocortical neurons, since 5-HT mediated facilitation was observed in the 
presence of potassium channel blockers tetraethylamonium, 4-aminopyridine and 
cesium and under voltage clamp conditions (c.f. Reynolds et a/., 1988). 
Furthermore, the 5-HT mediated facilitation is suggested to be a direct effect, since 
5-HT enhances the NMDA induced inward current in the presence of tetrodotoxin 
(Reynolds et a!., 1988). Consistent with these findings, 5-HT facilitation of cat 
pyramidal neurons takes place in the presence of tetrodotoxin, tetraethy lam onium 
and Mg ++ depletion (Nedergaard et a!., 1987). 
In the hippocampus, acetylcholine (ACh) and carbachol acting on 
muscarinic cholinoceptors and norepinephrine acting on a 1-adrenoceptors also 
facilitate the NMDA response (Markram and Segal, 1990, 1992; Segal et al., 1991). 
Moreover, 1S,3R-ACPD, an agonist at mGluR (see section 1.3) potentiates the 
NMDA induced depolarization in spinal motoneurons (Birse et a!., 1993), and 
hippocampal neurons (Aniksztejn et a/., 1991, 1992; Harvey and Collingridge, 
1993) . 
The PI pathway has been implicated as being responsible for the potentiation 
of NMDA responses in hippocampal neurons (Segal et al., 1991; Markram and 
Segal., 1992; Harvey and Collingridge, 1993). In particular, the IP 3 induced rise 
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of intracellular Ca ++ is thought to be of importance (Markram and Segal, 1992; 
Harvey and Collingridge, 1993). Extracellular Ca++ may also contribute to the 
potentiation of NMDA responses by cholinergic and mGluR agonists in 
hippocampal neurons (Markram and Segal, 1991, 1992; Harvey et al., 1991; 
Harvey and Collingridge, 1993). 
1.4 Rationale and objectives 
The foregoing synopsis draws attention to the many pteces of evidence 
indicating a physiologically significant interaction between 5-HT and other 
neuromodulators on the one hand and NMDA receptors on the other. However, 
many questions remain to be answered. The present investigation was aimed at 
resolving the following questions regarding the interaction between NMDA and 5-
HT and other G-protein coupled receptors in rat neocortex: i) which is the subtype 
of 5-HT receptor that mediates facilitation of the NMDA depolarization? ii) is this 
a direct effect of 5-HT and if so what is the mechanism underlying the 
enhancement? iii) are there significant changes in the 5-HT response with aging? 
iv) do other G-protein coupled receptors whose activation enhances the NMDA 
depolarization share a common mechanism of action? In light of the evidence 
reviewed above, the following working hypotheses are proposed: 
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A. 5-hydroxyttyptamine selectively facilitates N-methyl-D-aspartate receptor 
induced depolarization of neocortical pyramidal (projection) neurons by activating 
5-HT2A receptors. Stimulation of 5-HT2A receptors activates phosphatidylinositol 
hydrolysis and as a consequence of this, the N-methyi-D-aspartate depolarization 
is enhanced. 
B. Facilitation of the N-methyi-D-aspartate response by 5-hydroxyttyptamine in 
neocortical . neurons is likely to decline with aging due to a loss of 5-HT2A 
receptors. 
C. Like 5-HT2A receptors, metabotropic glutamate receptors, muscarinic 
cholinoceptors and acadrenoceptors enhance the N-methyi-D-aspartate 
depolarization as a result of phosphatidylinositol hydrolysis. 
Specific objectives 
The specific objectives of this investigation are as follows: 
1. To develop a quantitative pharmacological assay to investigate the interaction 
between 5-HT and NMDA receptors in a rat neocortical slice preparation. 
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2. To characterize the 5-HT receptor subtype(s) mediating the NMDA facilitation. 
3. To study in detail the cellular mechanism by which 5-HT achieves its 
modulatory action. 
4. To investigate the interaction between 5-HT and NMDA in senescent rats and 
compare these results to those found in young adult rats. 
5. To explore the differences between 5-HT and other G-protein coupled 
neurotransmitter receptors with respect to the mechanism by which these agents 
facilitate the NMDA depolarization. 
CHAPTER2 
5-HT FACll..ITATES NMDA INDUCED DEPOLARIZATION: RECEPTOR 
CHARACTERIZATION 
2.1 Introduction 
In order to characterize the interaction between 5-HT and the depolarization 
of cortical neurons induced by NMDA, a stable pharmacological assay system was 
required. One approach would have been to use microelectrode recording from 
pyramidal neurons ( c.f. Reynolds et al., 1988). However, a shortcoming of this 
method is the time consuming nature of constructing dose-response curves for 
pharmacological analysis. Moreover, stable long term recordings would be 
necessary in order to reach equilibrium with low concentrations of antagonists. 
Finally, due to receptor desensitization (Araneda and Andrade, 1991), a large 
number of intracellular recordings would be required. 
An alternate approach to microelectrode recording was the use of "grease-
gap" recording from cortical wedges (Harrison and Simmonds, 1985; Burton et al., 
1987, Brugger et al. , 1990). This method proved quite convenient to quantitate 
receptor mediated effects. The method relies on the fact that current induced in 
the dendrites/cell body by an agent such as an EAA agonist can be measured as 
a voltage drop between the dendrite/cell body compartment and the axon 
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compartment if the resistance between the two compartments is increased by using 
sucrose (sucrose-gap) or silicon grease (grease-gap; Harrison and Simmonds, 1985). 
The responses recorded using the grease-gap technique depends on the neurons 
which project through the barrier and the density of the receptors on those neurons 
(Harrison and Simmonds, 1985). However, one of the disadvantages of this 
method is that small changes induced by an agonist (e.g. 5-HT1.J in those neurons 
may not yield a recorded potential difference (Mally eta/., 1991). This method 
allows electrophysiological measurement from a large population of cortical 
neurons, which is convenient for pharmacological analysis. Using this method, the 
5-HT receptor mediating facilitation of the NMDA depolarization was 
characterized. 
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2.2 Methods 
Procedures followed guidelines of the Canadian Council on Animal Care 
and the Institutional Animal Care Committee at Memorial University . 
2.2.1 Animals 
Male Sprague-Dawley rats 100-300 g were purchased from Charles River, 
Montreal, Quebec. The animals were communally housed in cages (5 per cage) 
at the animal care unit of the Health Sciences Centre, Memorial University of 
Newfoundland and kept on a 12 hour light/12 hour dark cycle with controlled 
humidity and temperature. Food (Purina Rat Chow) and water were provided ad 
libitum. 
2.2.2 Wedge preparation and recording 
Neocortical wedges from sensorimotor cortex were prepared, with slight 
modification, as described by Harrison and Simmonds (1985). Rats were 
anaesthetized with ether and killed with a heavy blow on the neck. The brain was 
rapidly removed into ice cold modified artificial cerebrospinal fluid (M-ACSF; for 
composition ofM-ACSF, see section 2.2.3). The tissue was then transferred dorsal 
side uppermost to a filter paper lying on an ice cold surface. The brain was 
blocked, blotted dry and fixed at its caudal end to a tissue holder using 
43 
cyanoacrylate glue (Instant Krazy Glue). Coronal slices 500 J.lm thick were cut at 
0-4°C using a Vibroslice (Campden Instrument Ltd., U.K.). The slices were 
transferred to an incubation chamber containing M-ACSF at room temperature 
bubbled with 95% 0 2 and 5% C02 . Six to 7 slices were retained starting slightly 
anterior to bregma (Paxinos and Watson, 1986) and proceeding caudally . 
Following 30 min incubation at room temperature (20 to 24 °C) in M-ACSF, the 
medium was replaced with normal ACSF (see section 2.2.3). 
After an additional 30 to 45 min incubation in normal ACSF, a slice was 
transferred to a petri dish containing ACSF, and divided on the midline. As shown 
in Fig. 2, a wedge of sensorimotor cortex (1.5 mm wide at the pial surface and 1 
mm wide at the corpus callosum) was prepared and mounted in a two compartment 
recording bath (Harrison and Simmonds, 1985). The larger part of the wedge 
containing the cell bodies was placed in one compartment while the corpus 
callosum, containing the projecting axons, was placed in the other (Fig. 3) . The 
two compartments were separated by a grease seal (high vacuum silicone grease, 
BDH) and each was perfused separately at 2 mllmin via a peristaltic pump (Gilson, 
Miniplus 2, U. K. or Masterflex Pump Cole-Parmer, USA) . The pump and 
solution reservoirs were electrically isolated from the bath usmg a dropper 
assembly to reduce noise. Agonist induced depolarization of the cell bodies was 
recorded with respect to the corpus callosum using Ag/ AgCl electrodes (HLA-003, 
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Figure 3. Schematic diagram of a neocortical wedge positioned m the two 
compartment grease gap recording chambers. CC: corpus callosum. For details 
see text. 
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Axon Instruments Inc., USA), embedded in 3o/o agar containing 1 M NaCl. The 
electrodes were connected to a high impedance amplifier (Intronix Technologies 
Corporation, Canada), filtered (0.2 Hz, 3 db down) and the recorded potential 
displayed on a Grass or Gould chart recorder. The filter was such that only slow 
depolarizations would be recorded. Depolarization of cortical neurons was 
recorded as a negative voltage deflection relative to corpus callosum. For clarity, 
potential deflections are shown as negative upward. 
2.2.3 Composition of ACSF 
Normal ACSF had the following composition (mM): NaCl 126, KCl 3.5, 
CaC12 2, MgC12 1.3, NaH2P04 1.2, NaHC03 25, glucose 11. In modified ACSF 
(M-ACSF), NaCl was replaced by iso-osmotic sucrose (252 mM). This improves 
slice viability by protecting neurons from cr toxicity (Agahjanian and Rasmussen, 
1989). ACSF was gassed with 95o/o 0/5% C02 and had a pH of 7.4 . Except 
where otherwise stated, normal ACSF was used throughout. 
2.2.4 Drug application 
Except as noted, drugs were dissolved in ACSF and applied via a 3 way tap 
system to the cell body containing compartment. Agonists were applied for 2 min 
at 20 min intervals unless otherwise noted. To reduce oxidation, 5-HT was diluted 
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in ACSF just prior to application. Antagonists were administered 30 to 40 min 
before addition of non-EAA agonists. Drug concentrations were calculated as the 
salt. Stock solutions were kept frozen until use. 
2.2.5 Analysis of data 
Depolarization amplitude was used to quantitate drug responses. The 
amplitude of agonist evoked potentials varied from one wedge to another, likely 
reflecting, in part, the effectiveness of the grease seal in isolating the 
compartments. Accordingly, each treatment in a wedge was normalized to percent 
of control, i.e. [(Treatment/Control) x 100]. Graphical analysis (Sokal and Rohlf, 
1969) revealed that the frequency distribution of agonist induced responses was not 
normally distributed unless the data were first transformed to a logarithmic scale 
( c.f. Fleming et a/., 1972). The normalized data were therefore transformed for 
analysis of geometric means. Repeated measures (control and treatment data from 
the same wedge) were analyzed by paired t tests. Multiple planned comparisons 
were analyzed by one-way analysis of variance (Instat, GraphPad Software) 
followed by the Bonferroni test if the F value was significant. The Bonferroni test 
ensures p values reflect experimentwise error rates. Data are presented as the 
antilog of the geometric mean. The standard error of the mean of logarithmic data 
is not symmetrical when retransformed so the larger value is presented. The "n" 
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value reported in figures and tables refers to number of wedges. Differences 
between means with "p" values less than 0.05 were considered significant. EC50 
and IC50 values were determined from the logistic dose response curves fitted 
using the Table Curve (Jandel Scientific, USA). 
2.2.6 Drugs 
The following drugs were used: carbamylcholine chloride, 5-
hydroxytryptamine bimaleate salt (5-HT), kainic acid, N-methyl-D-aspartate 
(NMDA), 1-oleoyl-2-acetyl-sn-glycerol (OAG), L-phenylephrine HCI, quisqualic 
acid, scopolamine HBr, tetrodotoxin (TTX), (Sigma); spiperone, ritanserin, (gift 
from Janssen); (+)-8-hydroxy-dipropylaminotetralin HBr (8-0H-DPAT), (±)-1-(2,5-
dimethoxy-4-iodophenyl)-2-aminopropane HCI (DOl), m-
trifluoromethylphenylpiperazine HCI (TFMPP), (Research Biochemicals Inc.); 
prazosin HCl (gift from Pfizer); methysergide, ICS 205-930 (gift from Sandoz). 
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2.3 Results 
2.3.1 Effects of 5-HT on NMDA depolarization 
Bath application of 5-HT (1 0 or 30 JJ.M; 2 to 5 min, n=S) did not alter the 
recorded potential (c.f. Mally eta/., 1991). Nonetheless, in keeping with previous 
findings (Mally eta/., 1991), co-application of 5-HT (10 JJ.M) and NMDA (50 JJ.M) 
for 2 min resulted in a depolarization significantly larger in amplitude than the 
NMDA control (Fig. 4). The response to NMDA returned to control level 
following wash. All effects of 5-HT were reversible within 20-40 min. Since 5-
HT did not induce a potential on its own, all non-EAA agonists were co-applied 
with an EAA agonist, unless stated otherwise. 
The dose-response relationship for NMDA using a fixed concentration of 5-
HT (30 JJ.M) is shown in Fig. SA. The magnitude of facilitation was concentration 
dependent with maximum enhancement occurring at 50 J.!M NMDA. This dose of 
NMDA yielded a submaximal depolarization which was reproducible for 10-12 hrs 
when NMDA was applied every 20 min. It was impossible to obtain a maximum 
for the NMDA dose-response curve, since responses with 100 J.!M NMDA or 
greater did not recover completely (Harrison and Simmonds, 1985). Accordingly, 
50 J.!M NMDA was used for all experiments unless noted otherwise. 
Construction of a dose response curve for 5-HT using repeated drug 
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applications in the same wedge proved unreliable due to prolonged desensitization 
following a single exposure (c.f. Araneda and Andrade, 1991; see Chapter 3). 
Only one concentration of 5-HT was therefore tested with each wedge. The 
concentration-response curve so constructed was not monotonic, i.e. the facilitation 
steadily increased from 1 to 30 J..LM 5-HT, but was reduced at 100 J..LM (Fig. SB). 
The smaller response observed with 100 J..LM 5-HT reflects multiple mechanisms 
of desensitization, which can be prevented with appropriate pharmacological agents 
(see Chapter 3). 
While most of the wedges used were from young adult rats, a few wedges 
from postnatal (P-7) rats were tested in order to determine the 5-HT facilitation. 
Receptors for 5-HT appear early in development as judged by the presence of 
receptor mRNA (Roth eta/., 1991). Although not studied in detail, facilitation of 
the NMDA depolarization by 5-HT was present at postnatal day 5 (earlier dates not 
tested). 
2.3.2 5-HT and EAA agonists 
In cortical slices prepared from cat, but not rat, 5-HT facilitates the 
quisqualate induced depolarization (Nedergaard eta!., 1987; Reynolds eta/., 1988). 
Quisqualate and kainate were therefore perfused to determine the generality of the 
NMDA 50 11M 
CJ 5-HT 1 0 JlM 
CJ 
_jo.2mV 
4min 
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Figure 4:. Facilitation of NMDA depolarization by 5-HT. NMDA depolarizes 
cortical neurons with respect to corpus callosum (left). Co-administration of 5-HT 
increases the amplitude of the NMDA response (centre). Recovery 20 min later 
(right). Upward deflection is negative. 
Figure 5. Magnitude of the 5-HT facilitation dose-dependently varies with NMDA 
and 5-HT concentration. A: Concentration-response curve for NMDA facilitation. 
Concentration of 5-HT was 30 J.LM throughout. Only one concentration ofNMDA 
and 5-HT was tested on a wedge. 6 to 8 wedges were tested at each dose. B: 
Concentration-response relationship for 5-HT facilitation ofNMDA depolarization. 
NMDA concentration was 50 J.LM. 5 to 15 wedges were used for each point. 
p < 0.001, treatment vs. control. 
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facilitation with respect to EAA receptor subtype. The response to each amino 
acid applied alone was similar to that described previously (Harrison and 
Simmonds, 1985). Co-application of 10 J..LM 5-HT with submaximal concentrations 
of quisqualate and kainate ( 5 and 1 0 J..LM, respectively) did not facilitate the 
response to either amino acid (102 ± 3%, n=9 and 104 ± 4%, n=6 respectively; 
Fig. 6). 
2.3.3 5-HT receptor antagonists 
The receptor subtype mediating the NMDA facilitation was examined by co-
applying 5-HT and NMDA in the presence of 5-HT receptor antagonists. To 
circumvent desensitization, each wedge was only exposed once to 30 J..LM 5-HT 
plus antagonist. As shown in Fig. 7, ritanserin and spiperone reduced 5-HT 
facilitation of the NMDA depolarization in a concentration dependent manner. The 
IC50 values for ritanserin and spiperone were 0.9 and 0.4 nM, respectively. 
Methysergide, 1 and 10 nM, also significantly reduced the facilitation (338 ± 43%, 
n=8) induced by 5-HT (204 ± 16%, n=6, p < 0.05 and 174 ± 8%, n=6, p < 0.01, 
respectively). The 5-HT facilitation was not reduced by ICS 205-930, a 5-HT3 
antagonist (Fig. 7). However, ICS 205-930 significantly reduced the NMDA 
depolarization to 72 ± 6% (n=6; p < 0.05) of the control. This was in sharp 
contrast to methysergide, ritanserin and spiperone which did not reduce the NMDA 
response. 
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Figure 6. Depolarization of cortical neurons by quisqualate and kainate is not 
enhanced by 5-HT co-administration. Control responses are at left, recovery 20 
min later at right. 
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Figure 7. 5-HT2A receptor antagonists dose-dependently reduce 5-HT facilitation. 
Antagonists were bath applied 30-40 min before 5-HT was tested. NMDA 
depolarization in the presence of antagonist was used as control. 6 to 8 wedges 
were used at each antagonist concentration. *, p < 0.05, **, p < 0.01, ***, p < 
0.001 (Bonferroni p values adjusted for multiple comparisons). 
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2.3.4 5-HT receptor agonists 
DOl TFMPP and 8-0H-DPAT were substituted for 5-HT to examme 
' ' 
effects of additional 5-HT receptor agonists on the NMDA depolar-ization (Fig. 8). 
DOl, a mixed 5-HT2A and 5-HT2c receptor agonist significantly and reversibly 
enhanced the NMDA response at 2 and 5 J-LM. However, at 10 J-LM DOl, there was 
no facilitation (85 ± 7%, n=5, not significant). TFMPP (5 J-LM; mixed 5-HT 18 and 
5-HT 2c agonist) did not significantly alter the response to NMDA. In these 
wedges, DOl (5 J-LM), applied after washing TFMPP, resulted in facilitation (240 
± 14%, n=4). 8-0H-DPAT (10 J-LM; 5-HT1A agonist) significantly reduced the 
amplitude of the NMDA depolarization (59± 9%, n=6, p < 0.01). This inhibition 
by 8-0H-DPAT persisted in the presence of TTX (0.5 J-LM) and was completely 
antagonized by spiperone (1 J-LM; n=6; not shown). 
2.3.5 Cholinergic and adrenergic agonists and antagonists 
Like 5-HT, muscarinic cholinoceptor and a.1-adrenoceptor agonists facilitate 
NMDA and glutamate evoked activity on cortical neurons (Metherate eta/., 1987; 
Mouradian eta/., 1991). Moreover, release of acetylcholine and norepinephrine 
might alter the response to 5-HT in the neocortex (Hansson et a/., 1990). 
Perfusion of carbachol (10 J-LM) and phenylephrine (10 J-LM) enhanced the NMDA 
evoked depolarization (178 ± 9%, n=6, p < 0.01; and 155 ± 7%, n=6, p < 0.001, 
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Figure 8. Effects of 5-HT receptor agonists on NMDA depolarization. Only DOl 
enhances the NMDA response. DPAT (8-0H-DPAT). **, p < 0.01, ***, p < 
0 .001 (agonist plus NMDA vs NMDA). 
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respectively), but neither agonist depolarized cortical neurons in the absence of 
NMDA ( c.f. Harrison and Simmonds, 1985). Facilitation observed with these 
agonists was blocked by scopolamine and prazosin respectively (data not shown). 
Interestingly, scopolamine and prazosin significantly reduced the NMDA 
depolarization (Fig. 9). However, neither antagonist significantly reduced the 
facilitation induced by 5-HT 30 !lM (Fig. 9). 
2.3.6 5-HT facilitation in tetrodotoxin 
The contribution of ongoing electrical activity to the 5-HT facilitation was 
evaluated by blocking fast Na+ currents with 0.3 !lM TTX. In contrast to previous 
reports (Harrison and Simmonds, 1985; Burton et a/., 1987), TTX consistently 
reduced the response to NMDA (Fig. 1 0). Despite this reduction, the facilitation 
induced by 10 and 30 !lM 5-HT persisted (Fig. 10). 
2.3. 7 5-HT facilitation in barium 
There is general agreement that the 5-HT2A receptor mediated depolarization 
results from a closure of K+ channels (see Anwyl, 1990 for review). In the nucleus 
accumbens, the depolarization resulting from activation of 5-HT 2A receptors is 
occluded by barium (North and Uchimura, 1989). In wedges perfused with 100 
!lM barium, the NMDA depolarization was reduced (52 ±18%, n=6, p < 0 .05), but 
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the facilitation with 30 JJ.M 5-HT persisted (230 ± 38%, n=6, p < 0.01). Clearly, 
the NMDA facilitation is not dependent on the 5-HT2A mediated depolarization. 
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Figure 9. Muscarinic cholinoceptor and a.1-adrenoceptor antagonists reduce the 
NMDA response, but not 5-HT facilitation. Scopolamine (10 nM~ n=6) and 
prazosin (1 ~M~ n=6) significantly reduce the NMDA response (NMDA vs NMDA 
plus antagonist, paired t test). When co-applied with 30 J.LM 5-HT, neither 
antagonist significantly reduces the facilitation. ***, p < 0.001. 
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Figure 10. Effect of TTX on NMDA depolarization and facilitation by 5-HT. 
TTX (0.3 J.LM) significantly reduces the NMDA depolarization (NMDA vs NMDA 
and TTX; paired t test). However, the facilitation by 5-HT persists (NMDA and 
TTX vs 5-HT, NMDA plus TTX; Bonferroni test). **, p < 0.01, ***, p < 0.001. 
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2.4 Discussion 
2.4.1 5-HT receptor subtype mediating NMDA facilitation 
Numerous 5-HT receptor subtypes are present in rat cerebral cortex. Those 
so far identified include 5-HT1M 5-HT18, 5-HT2A, 5-HT2c, 5-HT3, 5-HT4, 5-HT5, 5-
HT6 and 5-HT7 receptors (Kilpatrick eta/., 1987; Edwards eta/., 1991; see Palacios 
and Dietl, 1988; Zifa and Fillion, 1992; Hoyer eta/., 1994 for review). Of these 
receptors, the present findings are only compatible with activation of 5-HT2A 
receptors leading to facilitation of the NMDA depolarization. Methysergide, 
ritanserin and spiperone concentration-dependently reduce the response to 5-HT 
with subnanomolar concentrations reducing the facilitation by 50%. Although 
methysergide binds to several 5-HT sites, it is the 5-HT 2A and 5-HT 2c sites for 
which it demonstrates the highest affinity (Peroutka, 1988). These two receptors 
have considerable sequence homology, which explains the close affinity for many 
antagonists (Julius et al., 1990). Ritanserin exhibits greater selectivity than does 
methysergide, significant binding occurring only at 5-HT 2A and 5-HT 2c sites 
(Leysen et a/., 1985). Ritanserin also binds to dopamine-D2, acadrenoceptor, a 2-
adrenoceptor, and histamine (H1) sites, but with lower affinity than at 5-HT sites 
(Ley sen et al., 1985). Accordingly, ritanserin is not likely to result in significant 
antagonism at these receptors with the low concentrations employed . . Spiperone, 
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in contrast to methysergide and ritanserin, clearly differentiates between 5-HT 2A 
and 5-HT 2c receptors in both functional testing (Ki of 4 .3 nM and 6200 nM, 
respectively for inhibition of 5-HT stimulated phosphoinositide hydrolysis; Conn 
et a/., 1986) and in binding assays (Peroutka, 1988). In light of the results with 
methysergide and ritanserin, implicating a 5-HT receptor, and the effectiveness of 
spiperone in antagonizing the 5-HT facilitation, it is concluded that 5-HT 2A 
receptors mediate the enhancement of the NMDA response observed in these 
studies. 
DOl was the only 5-HT receptor agonist to mimic the 5-HT enhancement. 
DOl labels high affinity (guanyl nucleotide sensitive) 5-HT 2A sites located in rat 
neocortex (Appel et a/., 1990). In functional studies, DOl stimulates 
phosphoinositide hydrolysis in both choroid plexus and neocortex through 
activation of 5-HT 2A and 5-HT 2C receptors respectively (Conn and Sanders-Bush, 
1987). DOl is a partial agonist (Kagaya et a/., 1990) and consonant with that 
property, the maximum facilitation observed with DOl is smaller than that found 
with 5-HT, despite the latter's susceptibility to oxidation and uptake. As with 5-
HT, desensitization develops at elevated DOl concentrations (see Chapter 3). The 
NMDA response is reduced by 8-0H-DPAT, excluding consideration of 5-HT1A 
receptors in mediating the facilitation. TFMPP is an agonist at 5-HT m and 5-HT 2c 
receptors (Sills et a/., 1984; Conn and Sanders-Bush, 1987), but an antagonist at 
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cortical 5-HT 2A receptors (Conn and Sanders-Bush, 1987~ Neuman and Zebrowska, 
1992). The failure of TFMPP to enhance the NMDA depolarization lends further 
support to the proposition that 5-HT 2c receptors do not mediate the facilitation. 
It should be noted, the present finding that 5-HT 2A' but not 5-HT 1, receptor 
activation mediates the NMDA enhancement differs from that of Mally et a/. 
( 1991 ). They report (±) propranolol blocks 5-HT enhancement of the NMDA 
depolarization in mouse cortical wedges and suggest 5-HT 1 receptors mediate the 
response. However, propanolol is an antagonist at 5-HT 2A receptors (Hoyer eta/., 
1994) and at the concentration employed ( 40 J..LM) in their study, this could explain 
their observation. 
The presence of inhibitory 5-HT IA receptors likely accounts for the greater 
than expected potency of 5-HT2A antagonists observed in the present study (c.f. 
North and Uchimura, 1989). The present study suggests that application of 5-HT 
stimulates both 5-HT1A and 5-HT2A receptors and the resulting response, therefore, 
represents a balance between inhibition and excitation. In the presence of 5-HT 2A 
antagonists the inhibitory 5-HT IA action is unmasked. Lakoski and Aghajanian 
(1985) observed a similar phenomenon in vivo with iontophoretic application of 
ketanserin. In vitro studies reveal both 5-HT2A and 5-HT1A receptors are found on 
the same layer V neurons (Davies eta/., 1987~ Araneda and Andrade, 1991) which 
supports this hypothesis. Carbachol and phenylephrine stimulate phosphoinositide 
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hydrolysis in brain slices as does activation of 5-HT 2A receptors (Brown et a/., 
1984~ Nahorski, 1988), so it may not be surprising they exhibit comparable cellular 
effects including facilitation of NMDA depolarization. This commonality raises 
the question of whether 5-HT acts indirectly to release acetylcholine or 
norepinephrine, thereby enhancing the NMDA response. Moreover, lesioning 
forebrain cholinergic neurons reveals some 5-HT 2A binding sites are situated on 
cholinergic terminals (Palacios and Dietl, 1988). Nonetheless, such indirect action 
is doubtful because scopolamine and prazosin do not significantly reduce the 5-HT 
facilitation. 
2.4.2 Neurons contributing to the response 
Previously, neither binding nor in situ hybridization studies provided 
sufficient resolution to unequivocally localize 5-HT 2A receptors to interneurons or 
pyramidal (projection) neurons (Mengod et a/., 1990; Pompeiano et a/., 1994 ). 
However, it is clear that 5-HT 2A receptors are expressed by pyramidal neurons (see 
Chapter 6). Findings from intracellular recording studies on layer V neurons are 
so far consistent with a postsynaptic localization for 5-HT 2A receptors (Davies et 
al., 1987; Araneda and Andrade, 1991). Persistence of the 5-HT facilitation in 
TTX accords well with intracellular studies (Nedergaard et a/., 1986, 1987; 
Reynolds et a/., 1988). The known excitatory effects of 5-HT 2A receptor 
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stimulation (see Anwyl, 1990, for review) are not easily reconciled with a 
disinhibitory mechanism. Thus, in the absence of evidence for an indirect effect, 
it is likely that 5-HT2A receptors mediating the facilitation are situated on projection 
neurons (see Chapter 6). Moreover, these neurons are most likely layer V 
pyramidal neurons since: (i) layer V neurons form the largest group of projection 
neurons (Lorente De No, 1949), thus likely contributing substantially to the NMDA 
depolarization; and (ii) this region contains the highest concentration of 5-HT 2A 
binding sites (see Chapter 1 ). 
Other neurons, including intemeurons and nerve fibres (e.g. monoamme 
containing) in the vicinity of projection neurons, doubtless influence the NMDA 
depolarization through release of neurotransmitter or neuromodulatory substances. 
The significant reduction of the NMDA response observed with TTX, scopolamine, 
prazosin, and ICS 205-930 lends credence to this view. Liberation of cholinergic 
and adrenergic agonists is implied by the present findings with scopolamine and 
prazosm. Agonists may be released tonically, but more likely, are evoked by 
NMDA application (Lalies et a/., 1988). Conceivably, TTX and ICS 205-930 
reduce the NMDA response by decreasing the release of acety I choline, 
norepinephrine or other agonists (see below). Moreover, the effectiveness of 10 
nM ICS 205-930 in reducing the NMDA response suggests some form of 5-HT 
release is taking place. Liberated 5-HT does not directly enhance the NMDA 
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response through stimulating 5-HT 2A receptors though, smce methysergide, 
ritanserin and spiperone do not depress the NMDA depolarization. 
2.4.3 Tetrodotoxin sensitivity 
The TTX sensitive nature of the NMDA depolarization has not previously 
been reported in comparable studies on rat and mouse cortical wedges (Harrison 
and Simmonds, 1985~ Burton et a/., 1987). A plausible explanation for this 
discrepancy is the use of Mg++-free ACSF (Harrison and Simmonds, 1985; Burton 
et al., 1987), in contrast to Mg ++ containing ACSF in the present study . 
Enhancement of the NMDA depolarization by 5-HT and phenylephrine is 
eliminated following 1-2 hr wash in Mg ++-free ACSF (Chapter 5). Similarly, 
muscarinic depolarization of cortical neurons is abolished in Mg ++-free media (El-
Beheiry and Puil, 1990). Consequently, in Mg ++-free media, agonists which would 
normally confer TTX sensitivity to the NMDA depolarization are inactive. 
Thus, it is clear that activation of 5-HT2A receptors facilitates the NMDA 
response of neocortical projection neurons. However, the mechanisms responsible 
for the facilitation remain to be investigated. As one possibility, the desensitization 
of the 5-HT 2A receptor mediated response observed in this study could yield 
potential clues in understanding the mechanisms that underlie the facilitation. The 
following chapter deals with this issue. 
CHAPTER3 
MULTIPLE MECHANISMS OF 5-HT2A RECEYfOR DESENSITIZATION 
3.1 Introduction 
While characterizing enhancement of the NMDA depolarization of cortical 
neurons by 5-HT, it was observed that the 5-HT facilitation exhibited 
desensitization (Chapter 2). Desensitization is a widespread phenomenon in which 
initial exposure to an agonist results in decreased cellular responsiveness on second 
exposure. 5-HT receptors, like many other receptors, are susceptible to agonist 
induced desensitization. Thus, 5-HT2A receptors located on cortical pyramidal 
neurons (Araneda and Andrade, 1991; Ley sen eta/., 1989), cerebellar granule cells 
(Dillon-Carter and Chuang, 1989), facial motoneurons (Aghajanian, 1990) and 
platelets (Kagaya et al., 1990) undergo desensitization. Not with other receptors 
leading to activation of protein kinase C, desensitization of 5-HT 2A receptors results 
from feedback inhibition mediated by protein kinase C (Aghajanian, 1990; Roth 
eta/., 1986). Such inhibition may serve i) to protect cells from over stimulation, 
ii) as a modulatory substrate for other regulators of cellular activity . 
A second mechanism leading to loss of receptor mediated responsiveness is 
internalization or sequestration of receptors by which hydrophilic agonists are 
prevented access to receptors. 
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Sequestration of f3-adrenoceptors has been 
extensively studied (Waldo eta/., 1983; Towes et al., 1984; Kassis eta/., 1986). 
Sequestration of f3-adrenoceptors occurs in the presence of high concentrations of 
agonist (Waldo eta/., 1983). Sequestration of 5-HT4 receptors has been recently 
demonstrated (Ansanay eta/., 1992), but sequestration of 5-HT 2A receptors has not 
been reported (see Roth eta/., 1990 for review). 
In light of the above studies and observations and to better understand the 
phenomenon, the present study was undertaken to examine the mechanisms 
underlying desensitization of cortical 5-HT 2A receptors. 
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3.2 Methods 
3.2.1 Wedge preparation and recording 
Wedges from rat sensorimotor cortex were prepared for recording and 
analyzed as described in section 2.2.2 and 2.2.5. 
3.2.2 ACSF composition and drug application 
ACSF composition in the bathing medium and drug application were as 
described in section 2.2.3 and 2.2.4 with the exception of the following drugs: 
phorbol diacetate, oleoacetylglycerol, staurosporine and calmidazolium were 
dissolved in dimethylsulfoxide (1 00%) and diluted in ACSF. Dimethylsulfoxide 
(0.05%, vol/vol, the largest concentration following dilution) alone did not alter the 
NMDA depolarization. Phorbol diacetate and oleoacetylglycerol were perfused for 
20 min whereas staurosporine, calmidazolium, chlorpromazine, amiloride and 
concanavalin A were perfused for 40 min before addition of agonists. 
3.2.3 Drugs and chemicals 
The following drugs were used: calmidazolium, concanavalin A, 1-oleoyl-2-
acetyl-n-glycerol (oleoacetylglycerol), 4f3-phorbol 12,13-diacetate (phorbol 
diacetate), and staurosporine were obtained from Sigma; amiloride HCI (gift from 
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Merck Sharp & Dohme Research Lab.); chlorpromazine HCl (gift from Rhone-
Poulenc Pharma Inc). 
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3.3 Results 
3.3.1 Desensitization of 5-HT response 
In keeping with previous observations (Chapter 2), co-administration of 5-
HT (1 0 ~M) and NMDA reversibly enhanced the NMDA depolarization of rat 
cortical neurons by 229 ± 8% (n=18). However, on second exposure 40 min later, 
this was reduced to 151 ± 6%, n=6; (Fig. 11, upper panel) thus demonstrating the 
presence of desensitization. Qualitatively similar results were obtained when the 
concentration of 5-HT was raised to 100 ~M, but with the additional feature that 
the initial enhancement was smaller in amplitude than that observed with 10 JlM 
5-HT (Fig. 12, lower panel). 
Time course of recovery from desensitization following initial exposure to 
10 JlM 5-HT is shown in Fig. 12. Each cortical wedge was exposed to 5-HT 
twice, the second application occurring 40, 80 or 120 min following the first. Only 
at 120 min did the 5-HT response return to the control level. In contrast to the 5-
HT facilitation, the depolarization evoked by NMDA alone did not exhibit 
desensitization (Fig. 12). 
3.3.2 Staurosporine reduces desensitization 
To evaluate the contribution of protein kinase C to the observed 
Figure 11. Facilitation of NMDA depolarization by 5-HT undergoes 
desensitization. Upper panel: NMDA induced depolarization is facilitated by 10 
J.LM 5-HT. On second exposure to 5-HT 40 min later, the magnitude of the 
facilitation is reduced. Note the depolarization evoked by NMDA alone is 
relatively unchanged. Lower panel: desensitization also takes place when 100 J.LM 
5-HT is employed. Note the magnitude of the facilitation is smaller than that 
observed with 10 J.LM 5-HT. 
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Figure 12. Time course of recovery from desensitization. Each wedge was 
exposed to 5-HT twice, separated by intervals of 40, 80, 120 min (0). Applying 
NMDA alone (e) does not result in desensitization. Error bars for the NMDA 
responses are smaller than the symbol. The 5-HT data are from 20 wedges at time 
0, 10 wedges at 40 min and 5 wedges at each time point thereafter. NMDA data 
averaged from 10 wedges. •, p < 0.05, ••, p < 0.01, 5-HT vs 5-HT at time 0. 
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desensitization, staurosporine, an inhibitor of protein kinase C (Tamaoki et al., 
1986; Davis et a/., 1992) was employed. Perfusion of staurosporine (1 0 nM) was 
followed by a test concentration of 5-HT. After a further 40 min the same 
concentration of 5-HT was reapplied. In this manner, a concentration response 
curve was generated for 5-HT in the presence of staurosporine and compared with 
untreated wedges (Fig. 13). On first exposure to 5-HT, staurosporine significantly 
potentiated 5-HT enhancement of the NMDA depolarization at all 5-HT 
concentrations except 30 J..LM (Fig.13A). While the potency and efficacy of 5-HT 
was enhanced, staurosporine did not eliminate the apparent loss of facilitation in 
efficacy at elevated 5-HT concentrations. Moreover, the inflection point for the 
decline was shifted to the left (Fig. 13A). Staurosporine alone did not alter the 
NMDA depolarization. 
Facilitation of the NMDA depolarization (Chapter 2) and desensitization 
were also observed when DOl (5 J..LM) was substituted for 5-HT (Table II). As 
with 5-HT, pretreatment with staurosporine potentiated DOl enhancement of the 
NMDA depolarization. However, in the case of DOl, staurosporine entirely 
prevented the desensitization observed on second exposure (Table II). 
3.3.3 Protein kinase C activators prevent 5-HT facilitation 
If inhibition of protein kinase C potentiates the 5-HT facilitation, activators 
Figure 13. Bath perfusion with staurosporine potentiates 5-HT facilitation. A. On 
first exposure to 5-HT in the presence of staurosporine (0~ ST) the facilitation is 
potentiated compared to the response in control wedges (e). Note, staurosporine 
shifts both the maximal facilitation and the inflection point for decline of 
facilitation to the left. B. On second exposure to 5-HT, staurosporine continues to 
potentiate the 5-HT facilitation. The potentiated response is smaller at each dose 
compared to A, but the difference does not reach significance. 5 to 18 wedges were 
used at each concentration of 5-HT. *, p < 0.05, **, p < 0.01 and ***, p < 
0.001; 5-HT plus staurosporine vs. 5-HT. 
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Table ll. Potentiation of DOl facilitation by staurosporine 
Drug NMDA depolarization (% of Control) 
First exposure Second exposure 
DOI5J..lM (n=6) 263 ± 1 0% 178 ± 16%8 
DOI5J..lM 
+ Staurosporine (n=6) 339 ± 11 %b 331 ± 19%b 
a p < 0.01, DOl, first exposure vs. second exposure; 
b p < 0.05, DOl vs. DOl + Staurosporine. 
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Figure 14. Activation of protein kinase C blocks the 5-HT facilitation. Bath 
perfusion with phorbol diacetate (PD~ 3 J..LM) or oleoacetylglycerol (OAG~ 50 J..LM) 
did not alter the magnitude of the NMDA depolarization, whereas they both 
completely blocked the 5-HT facilitation . Staurosporine (ST) fully restored the 
facilitation. 6 to 8 wedges were used for each treatment. *, p < 0.05 , phorbol 
diacetate and oleoacetylglycerol with and without staurosporine. 
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of protein kinase C should reduce it. To test this prediction, protein kinase C was 
stimulated with phorbol diacetate (3 f..!M) and oleoacetylglycerol (50 f..!M~ Agopyan 
and Agopyan, 1991; Singer et a/., 1990; Lai et al., 1990). Neither phorbol 
diacetate or oleoacetylglycerol altered the NMDA depolarization (Fig. 14). 
However, both agents eliminated the facilitation observed with 5-HT 30 f..!M, an 
effect that was prevented by prior treatment with staurosporine (10 nM; Fig. 14). 
3.3.4 Concanavalin A and desensitization 
Concanavalin A prevents sequestration of several receptor types (see section 
3.4). Exposure to concanavalin A (100 nM) significantly potentiated the 
facilitation observed with 100 f..!M 5-HT (Fig. 15), but not lower 5-HT 
concentrations (i .e. 165 ± 19%, n=4; 289 ± 10%, n=4 at 10 f..!M and 30 f..!M 5-HT 
respectively). The NMDA depolarization in the absence of 5-HT was not altered 
by concanavalin A (1 03 ± 5%; n=S). Concanavalin A reportedly increases 
intracellular pH through an amiloride sensitive mechanism (Mironov, 1992). A rise 
in intracellular pH might potentiate the 5-HT response by a mechanism other than 
preventing receptor sequestration (see section 3.4). As shown in Fig. 15, amiloride 
reduced the 5-HT facilitation in the presence of concanavalin A in a concentration-
dependent manner. However, amiloride also blocked the 5-HT facilitation in the 
absence of concanavalin A (Fig. 15). Amiloride alone at 1 mM, but not 1 0 f..!M, 
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significantly enhanced the NMDA depolarization (150 + 17%, n=5; p < 0.001; Fig. 
15). 
3.3.5 Calmodulin antagonists and desensitization 
Despite significant potentiation of the 5-HT (1 00 f..LM) response observed 
with concanavalin A and staurosporine, wedges pretreated with both agents 
exhibited some desensitization (Fig. 16). Since activation of 5-HT 2A receptors 
increases intracellular Ca++ (Berridge, 1987), a Ca++-dependent binding protein such 
as calmodulin might participate in desensitization. This possibility was tested using 
the calmodulin antagonists, calmidazolium and chlorpromazine (Chuprun et a/., 
1991 ; Masson eta/., 1992). As shown in Fig. 16, neither calmidazolium nor 
chlorpromazine significantly altered 5-HT (1 00 f..LM) facilitation of the NMDA 
response; however, they fully prevented desensitization on second exposure to the 
agent. Moreover, when the 5-HT facilitation was potentiated with concanavalin A, 
calmidazolium remained effective in eliminating desensitization on second exposure 
(Fig. 16). 
3.3.6 Heterologous desensitization 
Carbachol and phenylephrine also facilitate NMDA receptor mediated 
depolarization of cortical neurons (Chapter 2) . Like 5-HT, application of 
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Figure 15. Concanavalin A (CON A; 100 nM) potentiates 5-HT (100 J.LM) 
facilitation of NMDA depolarization. Amiloride (AMLD) reduces the facilitation 
in a dose dependent manner. Amiloride also blocks the 5-HT facilitation in the 
absence of concanavalin A. 5 to 6 wedges were used for each treatment. *, p < 
0.05, 5-HT with and without amiloride; **, p < 0.01, concanavalin A plus 5-HT 
with and without amiloride; ***, p < 0.001, concanavalin A plus 5-HT vs 5-HT. 
cj), p < 0.001, NMDA plus amiloride vs. NMDA control. 
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phenylephrine ( 10 J..LM) and carbachol ( 10 J..LM) produced homologous 
desensitization as evidenced by a decreased response on second exposure 40 min 
following first exposure (190 ± 6% vs 161 ± 5%, n=5, and 214 ± 38% vs 176 ± 
30%, n=6 with phenylephrine and carbachol respectively) but the reduction was not 
statistically significant. When 5-HT 30 J..LM was co-applied with NMDA, followed 
by phenylephrine 20 min later, no change in the phenylephrine facilitation was 
observed (Fig. 17). However, when I 00 J..LM 5-HT was applied first, the 
subsequent response to phenylephrine was reduced. Allowing 40 min to lapse 
between exposure to 5-HT and phenylephrine, no desensitization was evident. 
Similar results were obtained when 10 J..LM carbachol was substituted for 
phenylephrine (Fig. 18). 
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Figure 16. Calmodulin antagonists calmidazolium (CAL; 1 ~M) and 
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AFTER 5-HT 100 ,uM 
l2ZJ PE 1 0 ,u.M 
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Figure 17. 5-HT induces heterologous desensitization of a 1-adrenoceptor mediated 
facilitation. Desensitization of phenylephrine (PE) facilitation of the NMDA 
depolarization following prior exposure to 5-HT and NMDA is dependent on the 
concentration of 5-HT and the time between exposure to 5-HT and phenylephrine 
•••, p < 0.001, phenylephrine plus NMDA vs. NMDA control. 
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Figure 18. 5-HT induces heterologous desensitization of muscarinic cholinoceptor-
mediated facilitation. Desensitization of carbachol (CCH) facilitation of the 
NMDA depolarization following prior exposure to 5-HT and NMDA is dependent 
on concentration of 5-HT and time between exposure to 5-HT and carbachol ***, 
p < 0.001, carbachol plus NMDA vs. NMDA control. 
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3.4 Discussion 
The present results reveal 5-HT receptor mediated enhancement of the 
NMDA depolarization undergoes acute desensitization. This is apparent on first 
exposure to the agonist when compared to wedges treated with staurosporine or 
concanavalin A. The 5-HT facilitation also undergoes long term desensitization, 
which becomes apparent on second exposure to agonist. Finally, 5-HT receptor 
activation results in heterologous desensitization of a 1-adrenoceptors and 
muscarinic cholinoceptors. In contrast, the depolarization induced by NMDA alone 
showed neither desensitization nor modification by protein kinase C activators and 
inhibitors, concanavalin A, or calmodulin antagonists. This suggests that 
desensitization reflects changes at 5-HT receptors and/or their associated 
transduction pathways. Furthermore, since the desensitization observed with DOl 
is similar in many respects to that found with 5-HT, the desensitization likely 
results in large part from an alteration in the 5-HT zA receptor and its second 
messenger pathway . This suggestion is in keeping with observations on the 
neuronal depolarization mediated by 5-HT ZA receptors on cortical neurons. This 
depolarization also undergoes desensitization on repeated exposure to an agonist 
(Araneda and Andrade, 1991). 
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3.4.1 Apparent acute desensitization resulting from protein kinase C activation 
Two types of acute desensitization were operative, one sensitive to protein 
kinase C, the other sensitive to concanavalin A. Thus, activating protein kinase C 
with oleoacetylglycerol or phorbol diacetate totally suppressed the 5-HT 
facilitation. This action appears to be specific in that pretreatment with the protein 
kinase C inhibitor, staurosporine, restores the facilitation. On the other hand, 
inhibiting protein kinase C with staurosporine potentiates the 5-HT and DOl 
enhancement. Consistent with this finding, another protein kinase C inhibitor, 1-
( 5 -isoquinolinesulfony 1 )-2-methy I piperazine (H-7), potentiates acety !choline 
facilitation of the NMDA depolarization in hippocampal neurons (Markram and 
Segal, 1992). Potentiation, following protein kinase C inhibition, IS congruous 
with 5-HT2A mediated responses at facial motoneurons, smooth muscle, and 
platelets (Aghajanian, 1990; Roth et al., 1986; Kagaya et a/., 1990). Although 
staurosporine is not selective with respect to protein kinase C inhibition (IC50 = 2.7 
nM for protein kinase C vs. 6.7 nM for protein kinase A; Ruegg and Burgess, 
1989), when taken together with the phorbol diacetate and oleoacetylglycerol data, 
the most parsimonious explanation is that activation of protein kinase C contributes 
to desensitization of the 5-HT zA receptor mediated enhancement. 
In facial motoneurons, activation of protein kinase C reduces the agonist 
response, but not agonist independent activation of the G-protein coupled to the 5-
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HT receptor. Thus, the receptor appears to be phosphorylated by protein kinase 
C (Aghajanian, 1990). Consistent with this view, the presumptive intracellular 
domains of the 5-HT 2A receptor have three regions with homology to protein kinase 
C consensus sequences for phosphorylation (Roth et al., 1990). However, protein 
kinase C also phosphorylates the inositol 1,4,5-triphosphate (IP3) receptor (Worley 
eta!., 1987). Activation of the IP3 receptor releases intracellular Ca++ (Berridge, 
1987). It may be that a rise in intracellular Ca++ is essential for 5-HT facilitation 
of the NMDA depolarization at cortical neurons as has been suggested for 
muscarinic cholinoceptor facilitation of NMDA induced depolarization at 
hippocampal neurons (c.f. Markram and Segal, 1991, 1992 and also see Chapter 
5). Accordingly, phosphorylation of the IP3 receptor might well contribute to 
blockade of the 5-HT facilitation. 
Whether the 5-HT2A receptor and/or the IP3 receptor are phosphorylated, the 
present results are consistent with the notion that agonist induced protein kinase 
C activation results in negative feedback to reduce 5-HT 2A receptor mediated 
responses (Aghajanian, 1990; Roth et a/., 1986). However, additional cellular 
processes, unrelated to 5-HT 2A receptor activation, may also regulate protein kinase 
C associated with 5-HT facilitation. Since the present results with staurosporine 
do not distinguish between these possibilities, this issue should be left open and the 
processes referred to as "apparent" acute desensitization. 
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3.4.2 Acute desensitization resulting from receptor sequestration 
Staurosporine only partially reversed desensitization at higher 5-HT 
concentrations. Indeed, in the presence of staurosporine there remains a 
concentration-dependent decline in the facilitation at elevated 5-HT concentrations; 
also, the inflection point for the decline is shifted to the left. This suggests the 
potentiated response promotes development of additional desensitization. In 
contrast to staurosporine, concanavalin A potentiated the 5-HT enhancement at 100 
JlM, but not at lower concentrations. Concanavalin A prevents desensitization of 
5-HT 4 (Ansanay et a/., 1992), kainate, glutamate receptor (see Lin and Levitan, 
1991) and P-adrenoceptor mediated responses (Toews eta/. 1984). In the case of 
P-adrenoceptors, concanavalin A reduces desensitization by preventing receptor 
sequestration or internalization which normally takes place at elevated agonist 
concentrations (Waldo et a/., 1983). Concanavalin A could well potentiate the 5-
HT 2A response by preventing sequestration. 
However, an alternative explanation is possible. Concanavalin A elevates 
intracellular pH (Mironov and Lux, 1991), which, by increasing the affinity of the 
IP3 receptor for IP3, could increase release of intracellular Ca++ (Joseph et a/., 
1989). Elevated Ca++ would potentiate 5-HT enhancement of the NMDA 
depolarization (see Chapter 5). Moreover, increased intracellular Ca++ mimics 
muscarinic cholinoceptor mediated enhancement of the NMDA depolarization in 
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hippocampal neurons (Markram and Segal, 1991, 1992). Amiloride, an inhibitor 
of the Na+-Ir-antiporter (Schellenberg eta/., 1983; Siffert and Akkerman, 1987) 
occludes the pH effect of concanavalin A (Mironov, 1992) and indeed a dose-
dependent decline in the concanavalin A effect on the 5-HT response was observed 
during application of amiloride. However, the response to 5-HT alone was also 
suppressed. These results suggest that the pH lowering effect of amiloride may 
well explain loss of the 5-HT enhancement, but not the potentiation due to 
concanavalin A. If the effect of concanavalin A is simply on intracellular pH, it 
should potentiate the 5-HT facilitation at all 5-HT concentrations. That 
concanavalin A only potentiates the response to 5-HT at 100 Jl.M implies it is 
selective for desensitization occurring at high agonist concentrations. This finding 
is compatible with the present result that decline of the 5-HT enhancement shifts 
to the left when the facilitation is potentiated by staurosporine. This would be 
expected for a receptor that undergoes response-dependent sequestration and 
therefore it is concluded that cortical 5-HT ZA receptors undergo internalization. 
Clearly, appropriate binding studies are necessary to confirm this conclusion. 
3.4.3 Long tenn desensitization 
Exposure to 5-HT and DOl resulted in long term desensitization as 
evidenced by the smaller response on second exposure to the agonist. Long term 
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desensitization induced by DOl is abolished by staurosporine, whereas it is 
eliminated by calmodulin antagonists, but not staurosporine in the case of 5-HT. 
This might reflect different consequences of 5-HT zA receptor activation by full and 
partial agonists and/or that a 5-HT receptor other than the 5-HT zA subtype 
contributes to long term desensitization, e.g. the 5-HT lA receptor subtype. Since 
the IP 3 receptor is phosphorylated by Ca ++ calmodulin-dependent protein kinase II 
(Worley et a/., 1987), this is clearly a site worthy of further investigation in this 
regard. 
3.4.4 Heterologous desensitization 
Muscarinic cholinoceptors, a 1-adrenoceptors and 5-HT2A receptors all couple 
to phospholipase C and the resulting second messenger cascade (Chuang, 1989), 
which may account for their common action in facilitating NMDA depolarization 
(Chapter 2) and producing homologous desensitization. The present finding that 
5-HT produces heterologous desensitization of the phenylephrine and carbachol 
mediated facilitation suggests 5-HT2A, a 1-adrenoceptors, and muscanntc 
cholinoceptors are located on the same cortical neurons. Given common second 
messengers and location on common neurons, the question arises as to how 
selectivity between activated receptors is maintained. In this study, heterologous 
desensitization differed from homologous desensitization in both duration of action 
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and concentration of 5-HT at which it was elicited. These results suggest 5-HT 2A 
receptors, acadrenoceptors and muscarinic cholinoceptors receptor are functionally, 
if not physically, compartmentalized. Whether these receptors functionally couple 
to the same or different NMDA receptors and the mechanism underlying 
heterologous desensitization remains to be determined. 
The mechanism responsible for heterologous desensitization could be 
important for it may shed light on another question~ i.e. does the 5-HT 2A receptor 
mediated facilitation of the NMDA depolarization depend on activating a PLC-PI 
dependent response? This issue is dealt with in the following chapter. 
CHAYfER4 
MYO-INOSITOL REDUCES 5-HT:zA RECEPTOR INDUCED HOMOLOGOUS 
AND HETEROLOGOUS DESENSITIZATION 
4.1 Introduction 
In the preceding experiments (Chapter 3), the 5-HT, but not the NMDA 
component of the facilitation was shown to undergo homologous desensitization. 
In addition, prior exposure to elevated concentrations of 5-HT resulted in 
heterologous desensitization of a 1-adrenoceptor and muscarinic cholinoceptor 
induced facilitation of the NMDA response. Although multiple mechanisms 
contribute to homologous desensitization of 5-HT 2A receptors, the mechanism 
underlying 5-HT induced heterologous desensitization was not identified. 
In the hippocampus, carbachol, likely acting via a second messenger 
following stimulation of phosphoinositide hydrolysis, induces delayed loss of firing 
(Pontzer and Crews, 1990; Pontzer eta/., 1992). Exogenous myo-inositol enhances 
this response and reduces its variability by ensuring substrate availability (Pontzer 
et a/., 1992). An adequate source of inositol is crucial to the synthesis of 
phosphoinositides and maintenance of signalling (Chuang, 1989). Since activation 
of cortical 5-HT 2A, acadrenoceptors and muscarinic cholinoceptors also stimulates 
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PLC-PI (Chuang, 1989; Fisher et a/., 1992), exhaustion of substrate could explain 
5-HT induced heterologous desensitization. Therefore, the effect of exogenous 
myo-inositol on the 5-HT induced facilitation and heterologous desensitization was 
examined. 
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4.2 Methods 
The methods for wedge preparation, recording, drug application and data 
analysis were identical to those described in section 2.2 and 3.2. Myo-inositol 
(obtained from Sigma) was dissolved in water, diluted in ACSF and perfused 
throughout. 
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4.3 Results 
4.3.1 Potentiation of 5-HT facilitation by myo-inositol 
In keeping with previous findings (Chapters 2 and 3), co-application of 5-
HT (10 or 30 J.LM) with NMDA significantly and reversibly enhanced the NMDA 
depolarization of rat cortical neurons, whereas little or no facilitation was observed 
when 100 J.LM 5-HT was employed (Fig. 19). Perfusing I 0 mM myo-inositpl did 
not alter the NMDA depolarization (89 ± 5% of control), whereas it potentiated the 
5-HT facilitation (Fig. 19). The magnitude of the potentiation by myo-inositol 
increased linearly (r=0.9986, r=0.9972) as a function of 5-HT concentration (Fig. 
19B). The slope of the resulting linear regression differed significantly from zero 
(F=350, p=0.034). Holding the concentration of 5-HT constant at 30 J.LM, the 
potentiation varied with myo-inositol concentration (Fig. 20). 
4.3.2 Myo-inositol and heterologous desensitization 
Like 5-HT, co-application of carbachol or phenylephrine with NMDA 
resulted in a significant facilitation of the NMDA depolarization. This facilitation 
was absent when I 00 J.LM 5-HT was co-applied with NMDA 20 min earlier (Fig. 
21 ). Perfusing 10 mM myo-inositol produced a small potentiation of the carbachol 
and phenylephrine induced facilitation and eliminated 5-HT induced heterologous 
desensitization (Fig. 21). 
Figure 19. Myo-inositol potentiates 5-HT facilitation of NMDA depolarization. 
A: co-application of 5-HT (100 J.LM) with NMDA (50 J.LM) marginally increases 
amplitude of the NMDA depolarization (upper panel). Perfusing 10 mM myo-
inositol (lower panel) potentiated the facilitation. Recovery (right; upper and lower 
panel) 20 min later. B: concentration-response relationship for 5-HT facilitation 
(left ordinate) in the absence (open circles) and presence of 10 mM myo-inositol 
(filled circles). The difference between the two curves (potentiation) is plotted 
below (closed triangles; right ordinate). Data from 4 to 7 wedges were averaged 
for each point. ** ~ p < 0.01 and ***, p < 0.001, 5-HT vs. myo-inositol plus 5-HT. 
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Figure 20. Myo-inositol concentration-response relationship. 5-HT concentration 
was constant at 30 J.LM. Potentiation is the difference in response with and without 
myo-inositol. Each point is averaged from 4 to 7 wedges. 
Figure 21. Myo-inositol eliminates 5-HT induced heterologous desensitization. 
Carbachol (10 J..LM) and phenylephrine (10 J..LM) facilitate the NMDA 
depolarization. Exposure to 100 J..LM 5-HT 20 min before co-administration of 
carbachol or phenylephrine with NMDA significantly (n=5, *, p < 0.02) reduces 
the facilitation by the latter (heterologous desensitization). Perfusion of 10 mM 
myo-inositol prevents loss of response. 5 to 6 wedges per treatment. Open bars 
are control response obtained without prior exposure to 5-HT. ***, p < 0.001, 
myo-inositol vs control (without myo-inositol). 
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4.4 Discussion 
4.4.1 Myo-inositol and 5-HT facilitation 
Incubated brain slices exhibit lower inositol levels than fresh brain tissue 
unless maintained in medium containing I 0 mM inositol (Sherman et a/., 1986). 
Moreover, perfusing myo-inositol results in greater inositol phosphate formation 
following carbachol stimulated phosphoinositide hydrolysis (Pontzer et a/., 1992). 
The 5-HT facilitation is mediated via 5-HT 2A receptors (Chapter 2) and activation 
of cortical 5-HT2A receptors leads to PLC-PI response (Chuang, 1989~ Fisher eta/., 
1992). If the facilitation depends on 5-HT 2A receptors activating the PLC-PI 
response, then perfusion with myo-inositol could potentiate the 5-HT facilitation 
simply by increasing phosphoinositide substrate availability. This suggestion is in 
keeping with the findings that: 1) magnitude of the potentiation increases linearly 
with 5-HT concentration and~ 2) potentiation varies with myo-inositol 
concentration. 
Cortical 5-HT zA receptors might undergo receptor internalization or 
sequestration which is a concentration dependent phenomenon (Chapter 3). 
Mechanistically, the large potentiation induced by myo-inositol at 100 JlM 5-HT 
is difficult to reconcile with 5-HT 2A receptors undergoing sequestration. Moreover, 
linearity of the potentiation is inconsistent with myo-inositol acting via multiple 
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mechanisms dependent on 5-HT concentration. Instead, it is likely that substrate 
availability and/or a product of phosphoinositide hydrolysis influences 5-HT 2A 
receptor sequestration. Thus, substrate exhaustion, favoured by the absence of 
exogenous myo-inositol, would lead to receptor sequestration. Clearly, appropriate 
binding studies are necessary to resolve this point. 
4.4.2 Myo-inositol prevents heterologous desensitization 
The observation that myo-inositol also potentiates the carbachol and 
phenylephrine induced facilitation implies that activation of 5-HT 2A' ac 
adrenoceptors, and muscarinic cholinoceptors might results in facilitation through 
activation of identical second messenger pathways. Moreover, the observation that 
5-HT induces heterologous desensitization suggests that cortical projection neurons 
(pyramidal cells) share overlapping populations of these receptors (Chapter 3). 
Thus, depletion of phosphoinositide substrate by 5-HT could well account for the 
observed heterologous desensitization. Consistent with this interpretation are the 
findings that: 1) myo-inositol potentiation increases with 5-HT concentration and; 
2) only at the highest 5-HT concentration employed (100 fJ.M), i.e. where the 
greatest depletion of substrate is expected, is heterologous desensitization present 
(Chapter 3). 
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In conclusion, perfusing cortical wedges with myo-inositol reduces 
homologous and heterologous desensitization. More important, these data further 
implicate involvement of PLC-PI response and the resulting second messenger 
cascade in the novel interaction between 5-HT 2A and NMDA receptors. The 
exclusion of protein kinase C involvement in the facilitation suggests the other 
pathway, i.e., IP3-Ca++ may underlie the 5-HT facilitation. 
CHAPTERS 
5-BT2A RECEPTOR MEDIATED FACILITATION OF THE NMDA 
DEPOLARIZATION: THE ROLE OF Ca++ 
5.1 Introduction 
5-HT acting at 5-HT2A receptors facilitates the NMDA depolarization of 
cortical projection (pyramidal) neurons by a direct action on those neurons (see 
Chapter 2). Although activation of 5-HT2A receptors produces a small decrease in 
the resting K+ conductance and reduces the slow afterhyperpolarization (Davies et 
a/., 1987; Araneda and Andrade, 1991), the facilitation is unrelated to these effects 
as it is observed in the presence of K+ channel blockers, under voltage clamp 
conditions, and is not mimicked by agents which alone block the slow 
afterhyperpolarization (Reynolds et al., 1988; see Chapter 3). The 5-HT 2A receptor 
is a member of the G-protein coupled receptor superfamily and in common with 
a number of other such receptors is positively coupled to phospholipase C (see 
section 1.2.6). In cortical neurons, facilitation of the NMDA depolarization by 5-
HT likely results as a consequence of activating phospholipase C since myo-
inositol: I) potentiates the facilitation in a concentration dependent manner; 2) 
reduces homologous desensitization of the 5-HT2A response and; 3) eliminates 
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heterologous desensitization of the carbachol and phenylephrine induced facilitation 
(see Chapter 4). 
Stimulation of phospholipase C leads to the production of diacylglycerol and 
inositol 1, 4, 5 triphosphate (IP3) (Berridge, 1993). Diacylglycerol in tum activates 
protein kinase C; in hippocampal neurons and Xenopus oocytes, stimulation of 
protein kinase C or introduction of the catalytic subunit of protein kinase C 
facilitates the NMDA response (Aniksztejn et a/., 1991, 1992~ Kelso eta/., 1992). 
On the other hand, at cortical neurons, activation or inhibition of protein kinase C 
does not alter the depolarization induced by NMDA (Chapter 3). 
The IP3 produced by phospholipase C acts at IP3 receptors on smooth 
endoplasmic reticulum to release Ca++ stored at this site (Taylor and Richardson, 
1991 ~ Berridge, 1993; Pozzan et a/., 1994 ). This rise in Ca ++ mediated by IP 3 is 
thought to be essential for facilitation of the NMDA depolarization mediated by 
muscarinic cholinoceptors (Markram and Segal, 1992). If a similar mechanism 
accounts for the 5-HT 2A facilitation at cortical neurons, then agents which raise the 
concentration of intracellular Ca ++ without increasing IP 3 should also facilitate the 
NMDA depolarization. In order to test this hypothesis, a series of structurally 
unrelated agents, which share in common an ability to elevate intracellular Ca++, 
were employed. Thapsigargin, a naturally occurring sesquiterpene lactone 
(Thastrup et a/., 1990), cyclopiazonic acid, an indole tetramic acid metabolite of 
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Aspergillus and penicillium (Seidler et a/., 1989), and A23187 were chosen for 
study. The mechanism(s) by which these agents increase intracellular Ca++ does 
not involve the generation of IP3. Rather, thapsigargin and cyclopiazonic acid 
selectively inhibit the endoplasmic reticulum Ca++ -ATPase (Thastrup et a/., 1990; 
Verma eta/, 1990; Mason eta/., 1991) and A23187 induces the formation of 
divalent cationic ionophores (Pressman, 1976). 
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S.l Methods 
5.2.1 Wedge preparation and recording 
Wedges from sensorimotor cortex were prepared for recording and analyzed 
as described in section 2.2.2 and 2.2.5. 
S.l.l ACSF composition and drug application 
ACSF composition and drug application were as described in sections 2.2.3, 
2.2.4, and 3 .2.2 with the following additions: thapsigargin, cyclopiazonic acid and 
A23187 were applied for 3 min (1 min alone prior to NMDA application and 2 
min with NMDA). Increasing the perfusion time to 3 min for thapsigargin, 
cyclopiazonic acid and A23187 was found to produce a large, consistent facilitation 
when compared to the 2 min perfusion time used for 5-HT. The longer exposure 
time was therefore employed in all experiments. Thapsigargin, cyclopiazonic acid, 
A23187, BAPT A-AM and staurosporine were dissolved in dimethylsulfoxide and 
diluted in ACSF. Chlorpromazine and BAPTA-AM were perfused for 40 min 
before addition of agonists. Tetrodotoxin (0.1-0.3 J.LM) was perfused throughout 
to minimize indirect effects. An antagonist cocktail consisting of D,L-AP3, 
scopolamine, ritanserin and prazosin was perfused 40 min before addition of 
agonists. 
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5.2.3 Drugs and chemicals 
2-amino-3-phosphonopropionic acid (D,L-AP3), Bis-(o-aminophenoxy)-
ethane-N,N,N',N', tetraacetic acid aminoethoxy (BAPTA-AM) and thapsigargin 
were from Calbiochem. Calcium ionophore A23187, cyclopiazonic acid, kainic 
acid, myo-inositol and nifedipine were obtained from Sigma. Drug concentrations 
were calculated as the salt. Stock solutions were kept frozen until use. 
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5.3 Results 
5.3.1 Effects of thapsigargin, cyclopiazonic acid and A23187 on the NMDA 
depolarization 
Perfusing NMDA depolarized cortical neurons and in keeping with previous 
observations (Chapters 2 and 3), 5-HT facilitated the NMDA depolarization (Fig. 
22). Perfusing 100 nM thapsigargin alone did not alter the recorded potential (data 
not shown), but when combined with NMDA, it reversibly facilitated the NMDA 
depolarization (Fig. 22). 
Like 5-HT and thapsigargin, cyclopiazonic acid and A23187 also facilitated 
the NMDA depolarization without modifying the potential when perfused alone. 
The concentration-response curves for the thapsigargin, cyclopiazonic acid and 
A23187 induced facilitation are shown in Fig. 23 . Except for differences in 
potency and a greater efficacy for A23187, the curves are remarkably similar. All 
three agents facilitated the NMDA depolarization in a concentration dependent 
manner up to a maximum, followed by loss of the facilitation at the highest 
concentration. 
5.3.2 Calmodulin antagonism and the All 187 facilitation 
Loss of the facilitation at elevated concentrations of A23187, thapsigargin 
- NMDASOJ.LM 
- 5-HT30 J.LM 
c::J Thapsigargin 1 00 nM 
_j2mv 
4 min 
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Figure 22. Facilitation of NMDA depolarization by 5-HT and thapsigargin. 
NMDA depolarizes cortical neurons with respect to corpus callosum (left). 
Administration of 5-HT {upper panel) and thapsigargin (lower panel) facilitates the 
NMDA response. Recovery 20 min later. 
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Figure 23. The concentration-response relationship for thapsigargin, cyclopiazonic 
acid and A23187. NMDA concentration was 50 J.LM. 5 to 8 wedges were tested 
at each concentration. **, p < 0.01; ***, p < 0.001; NMDA vs treatment. 
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and cyclopiazonic acid may represent some form of desensitization, perhaps 
triggered by the large increase in intracellular ca++ concentration expected with 
these agents (Kennedy, 1989). Calmodulin is activated by a rise in intracellular 
ca++ (Erondu and Kennedy, 1985) and one form of desensitization of the 5-HT2A 
facilitation in cortical neurons is blocked by calmodulin antagonists (Chapter 3). 
Perfusing chlorpromazine I ~M, a calmodulin antagonist, for 40 min before 
exposure to A23187 and NMDA partially reduced loss of the facilitation (Fig. 24). 
A similar effect was observed when 20 ~M cyclopiazonic acid and 0.3 ~M 
thapsigargin were substituted for A23187 (data not shown). Other drugs which 
alter the 5-HT2A receptor desensitization including staurosporine and myo-inositol 
did not alter loss of the facilitation observed with A23187 (data not shown). 
5.3.3 Facilitation is selective for the NMDA depolarization 
Application of 5-HT facilitates the NMDA depolarization, but not that 
induced by quisqualate and kainate (see Chapter 2). When cyclopiazonic acid (1 0 
~M) was perfused with a submaximal concentration of quisqualate or kainate (5 
J..LM), no facilitation of the depolarization took place (1 03 ± 4%, n=4 and 92 ± 
4%, n=3 respectively, Fig. 25). Further trials revealed cyclopiazonic acid (20 J..LM, 
n=2) also failed to facilitate the depolarization induced by quisqualate (data not 
shown). 
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Figure 24. Calmodulin antagonist chlorpromazine reduces loss of A23187 
facilitation. Chlorpromazine (CPZ) did not affect the NMDA depolarization. 4 to 
5 wedges were used for each treatment. *, p < 0.05~ treatment vs 3 J.LM 
A23187. 
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Figure 15. Depolarization of cortical neurons by quisqulate (Quis) and kainate 
(KA) is not enhanced by cyclopiazonic acid (CPA) administration. 
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5.3.4 Effects related to tnmsmitter release 
In cortical wedges, the amplitude of the NMDA depolarization is influenced 
by release of acetylcholine and norepinephrine (Chapter 2). Despite the presence 
of TTX, increasing the concentration of intracellular Ca ++ in nerve-terminals and 
varicosities might increase the release of transmitters/modulators that facilitate the 
NMDA depolarization on pyramidal neurons, i.e. the facilitation could be indirect. 
To test this possibility, A23187, cyclopiazonic acid and thapsigargin were applied 
in the presence of a "Cocktail" consisting of prazosin (1 JJ.M), scopolamine (10 
nM), D,L-AP3 (50 JJ.M) and ritanserin (I 0 nM) to antagonize acadrenoceptors, 
muscarinic cholinoceptors, metabotropic glutamate receptors and 5-HT 2A receptors, 
respectively. Stimulation of all these receptors is known to facilitate the NMDA 
depolarization (see Chapters 2 and 7). Perfusing this antagonist cocktail reduced 
the amplitude of NMDA depolarization (Fig. 26). Moreover, the magnitude of the 
facilitation in the presence of thapsigargin, cyclopiazonic acid and A23187 was 
reduced when compared to the control facilitation (Fig. 26), although in all cases 
facilitation remained significant. 
5.3.5 ca++ dependence of the facilitation 
Omitting Ca++ from the ACSF significantly reduces the 5-HT and 
norepinephrine induced phosphoinositide hydrolysis in cortical slices (Kendall and 
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L:]CONTROL -WITH COCKTAIL 
NM DA 501-'M TGO. 11-'M CPA20#J.M A23187 0.51o't.4 
Figure 26. A cocktail consisting ofTTX (0.3 JlM), scopolamine (10 nM), prazosin 
(1 JlM), ritanserin (1 0 nM) and D,L-AP3 (50 JlM) reduced, but did not abolish the 
facilitation by thapsigargin ( TG), cyclopiazonic acid (CPA) and A23187. 5 to 
6 wedges were used for each treatment. *, p < 0.05~ **, p < 0.01~ ***, p < 
0.001; cocktail vs cocktail plus drug. 
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Nahorski, 1984). Similarly, omitting Ca++ from the ACSF eliminates the 
phenylephrine induced facilitation of the NMDA depolarization (see Chapter 7). 
As shown in Fig. 27, when 5-HT was applied with NMDA during perfusion with 
Ca ++ free ACSF (no added Ca ++) throughout:. the facilitation was eliminated. In 5 
wedges so treated, the average response amplitude was 99 ± 6% of the NMDA 
control. Perfusing BAPTA-AM, a Ca++ chelator which is only effective in 
chelating intracellular Ca++ (Niesen et a/., 1991) leads to the same result, i.e. the 
5-HT facilitation was eliminated (110 ± 7% of control, n=5, Fig. 27). Perfusing 
BAPTA-AM also reduced the amplitude of the NMDA depolarization (61 ± 6%, 
n=5, p < 0.05). Perfusing thapsigargin in Ca++ free ACSF or in the presence of 
BAPTA-AM yielded results similar to those obtained with 5-HT, i.e. in both cases 
the facilitation was eliminated (Fig. 27). 
5.3.6 Nifedipine blocks facilitation of the NMDA depolarization 
Ca ++ can enter neurons through a variety of voltage- and receptor- operated 
channels (Kullman et a/., 1992). The L-type Ca++ channel is present on cortical 
pyramidal neurons and is blocked by nifedipine (Sayer eta/., 1992). As illustrated 
in Fig. 28, nifedipine concentration-dependently reduced the 5-HT and the A23187 
induced facilitation. Similar results were obtained when 30 nM thapsigargin and 
10 JJ.M cyclopiazonic acid were substituted for A23187 (data not shown). 
Ca ++ Free ACSF 
-BAPTA AM 50 J.!M 
-
Ca ++Free ACSF 
c:::J 
BAPTAAM 50 J.!M 
NMDASO JlM 
- 5-HT 30 JlM 
c:::J Thapsigargin 1 00 nM 
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_j2mV 
4min 
Figure 27. Perfusion of either Ca++ free ACSF (no added Ca++) or BAPTA-AM 
eliminates 5-HT and thapsigargin facilitation. 
Figure 28. Nifedipine reduces the facilitation by 5-HT and A23187 in a 
concentration-dependent manner. 5 to 6 wedges were used at each concentration. 
••, p < 0.01 ~ * **, p < 0.001 ; nifedipine vs control. 
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5.3. 7 Mg++ free medium does not eliminate the NMDA facilitation 
The NMDA receptor ionophore exhibits a voltage-dependent conductance 
which is dependent on Mg++. If the facilitation results from altering the Mg++ 
sensitivity (Chen and Huang, 1992), then removal of Mg ++ should abolish the 
facilitation . When 5-HT was applied after perfusing the tissue for 1 hr with Mg ++ 
free ACSF the facilitation was abolished (1 00 ± 1% of control, n=6; Fig. 29). The 
phenylephrine facilitation exhibited a similar Mg++ sensitivity (99 ± 9%, n=6). In 
contrast, the A23187 induced facilitation persisted in Mg ++ free ACSF (318 ± 43% 
of control, n=4~ Fig. 29B). 
A 
Mg++ Free ACSF 
NMDA50J..LM 
NMDA10J..lM 
- 5-HT30 J..LM 
-
B Mg++ Free ACSF 
__ _,..___ _ _ 
NMDA10J..LM 
c:::J A23187 0.5 J..LM 
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_j2mv 
4min 
_j2mV 
4 min 
Figure 29. Effect of perfusing Mg++ free ACSF (no added Mg++) on the 5-HT and 
A23187 facilitation. A. 5-HT facilitates NMDA depolarization (upper panel), 
whereas this facilitation is absent in Mg ++ free medium (lower panel). B. A23187 
facilitation persists in Mg ++ free medium. 
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5.4. Discussion 
The major findings of this study are: I) thapsigargin, cyclopiazonic acid, and 
A23187 induce facilitation of the NMDA depolarization, which, in part, is likely 
a direct effect and which mimics the 5-HT facilitation~ 2) antagonism of 
calmodulin reduces loss of facilitation that occurs at elevated concentrations of 
agents used to raise intracellular ca++~ 3) both extracellular and intracellular ca++ 
are critical for the facilitation observed in the present study; 4) the facilitation does 
not involve modification of the Mg ++ dependent voltage sensitivity of the NMDA 
receptor ionophore. Therefore, the present study supports the hypothesis that 5-
HT, acting at 5-HT2A receptors (see section 5.1), elevates intracellular Ca++ which 
accounts for the NMDA facilitation. However, a major question remains, namely 
how does an elevation of intracellular Ca++ translate into facilitation of the NMDA 
response? 
Thapsigargin and cyclopiazonic acid both rruse the concentration of 
intracellular Ca++ by inhibiting an endoplasmic reticulum Ca++-ATPase necessary 
to fill the IP3 sensitive Ca++ pool (Thastrup eta/., 1990; Verma eta/., 1990; Mason 
et al., 1991 ). This pool, located in the smooth endoplasmic reticulum, displays a 
constant leak of Ca++ so that inhibiting the pump results in loss of Ca++ from the 
storage site (Pozzan et al., 1994). Thapsigargin and cyclopiazonic acid differ in 
their action from receptors coupled to phospholipase C in that the rise inCa++ they 
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induce is not accompanied by a rise in inositol 1 ,4,5 triphosphate (Thastrup et a/., 
1990; Jackson et a/., 1988). Except for a difference in potency, the facilitation 
induced by thapsigargin and cyclopiazonic acid is remarkably similar, consistent 
with a common mechanism of action. On the other hand, A23187 demonstrates 
greater efficacy with respect to facilitating the NMDA response than does 
thapsigargin or cyclopiazonic acid. This likely reflects the mechanism by which 
A23187 increases intracellular Ca++. A23187 forms divalent selective cation 
ionophores which allow Ca ++ to enter the cytosol from the extracelluar space as 
well as from Ca++ containing intracellular organelles (Pressman, 1976; Pozzan et 
a/., 1994). A23187 may also raise the level of Ca++ indirectly by stimulating 
phosphoinositide hydrolysis (Fisher and Agranoff, 1981; Brammer et al., 1988; 
Brammer and Weaver, 1989), although it exhibits a different pattern of inositol 
polyphosphate formation than do receptors coupled to phospholipase C (Baird and 
Nahorski, 1990). 
5.4.1 Are the effects of thapsigargin, cyclopiazonic acid and A23187 direct? 
Critical to understanding how thapsigargin, cyclopiazonic acid and A23187 
facilitate the NMDA depolarization is knowing whether the facilitation induced 
by these agents results indirectly through transmitter/modulator release. In cortical 
wedges, scopolamine and prazosin significantly reduce the amplitude of the NMDA 
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depolarization, suggesting that tonic or more probably phasic release of 
acetylcholine and norepinephrine results in enhancement of the NMDA response 
(Chapter 2). Thus, thapsigargin, cyclopiazonic acid and A23187 might simply 
enhance the postsynaptic NMDA response by raising the concentration of Ca++ in 
presynaptic terminals and varicosities thereby increasing transmitter/modulator 
release (c.f. Markram and Segal, 1991). Indeed, the observation that a mixture of 
receptor antagonists dramatically reduces the facilitation strongly suggests that 
transmitter/modulator release contributes substantially to the facilitation observed 
with thapsigargin, cyclopiazonic acid, and A23187. Moreover, it could be argued 
that the significant facilitation remaining in the presence of the antagonists mixture 
might result from the action of yet another transmitter/modulator for which an 
antagonist was not present. Although such an interpretation cannot be excluded 
it appears improbable. 
First, the concentration-response curves for thapsigargin, cyclopiazonic acid, 
and A23187 are quite similar, i.e., the facilitation rises to a peak after which it 
rapidly returns to the control value. If the facilitation resulted solely from 
transmitter/modulator release, it is hard to account for the shape of the 
concentration-response curve. However, an increasing contribution of an 
inhibitory transmitter, i.e. GABA, could account for this reduction and cannot be 
ruled out. Thus, if the mechanism was simply enhanced transmitter/modulator 
132 
release then the facilitation might be expected to show a plateau or perhaps a 
continuous increase rather than a return to baseline. Agonist induced facilitation 
up to 700o/o has been observed with 5-HT (see Chapter 3) demonstrating that larger 
responses than those observed with thapsigargin, cyclopiazonic acid and A23187 
are possible. 
Second, the 5-HT facilitation, but not that due to A23187, is eliminated 
when the tissue is perfused with Mg ++ free ACSF. As suggested below, this may 
reflect the importance of Mg ++ in G-protein coupling and not for the facilitation per 
se. If this is the case, then the facilitation induced by A23187 in Mg ++free ACSF 
is incompatible with release of a G-protein coupled transmitter/modulator being 
solely responsible for the facilitation. Indeed, the reduction in A23187 facilitation 
in Mg ++ free ACSF that took place when compared to the facilitation in the 
presence of Mg ++ may reflect loss of the G-protein receptor contribution. 
Third, neither the carbachol nor the 1 S,3R-ACPD facilitation are eliminated 
1n Ca++ free ACSF (see Chapter 7). Moreover, nifedipine does not block the 
1 S,3R-ACPD facilitation (Chapter 7). However, the facilitation induced by 
thapsigargin and A23187 is absent in Ca ++ free ACSF or in the presence of 
nifedipine. Thus, if the primary action of thapsigargin and A23187 is enhanced 
transmitter/modulator release then it is surprising that the facilitation is eliminated 
in Ca ++ free ACSF or nifedipine. 
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An alternative explanation to account for the dramatic reduction of the 
facilitation in the presence of the antagonist mixture is that the antagonists 
effectively shift the concentration-response curve of thapsigargin, cyclopiazonic 
acid, and A23187 to the right. In the absence of the antagonists, the facilitation 
due to agonist release might add to the facilitation induced by thapsigargin, 
cyclopiazonic acid, and A23187. Indeed, there may be a supradditive effect since 
a rise in intracellular Ca++ can shift activation of phospholipase C to the left 
(Eberhard and Holz, 1988; Rhee et a/., 1991 ). Thus, although part of the 
facilitation is obviously indirect, there also appears to be a component attributable 
to a direct action on postsynaptic neurons. 
5.4.2 Necessity for external Ca++ and rise of internal Ca++ 
In this study, omission of extracelluar Ca++ eliminated the NMDA 
facilitation induced by both 5-HT and thapsigargin. Furthermore, nifedipine 
blocked the 5-HT, thapsigargin, cyclopiazonic acid, and A23187 mediated 
facilitation in a concentration-dependent manner. The concentration of nifedipine 
employed in the present study is in keeping with the concentration necessary to 
block voltage-dependent (L-type) Ca++ channels in pyramidal neurons (Sayer eta/., 
1992). Taken together, these observations suggest that Ca++ influx through voltage-
dependent Ca++ channels is crucial for the facilitation mediated by 5-HT, 
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thapsigargin, cyclopiazonic acid and A23187. The a 1-adrenoceptor mediated 
facilitation induced by phenylephrine shows similar characteristics (Chapter 7), 
whereas the facilitation induced by the mGluR agonist 1S,3R-ACPD is insensitive 
to such treatment (Chapter 7). Thus, the requirement for Ca++ entry through 
voltage-dependent Ca ++ channels is not necessary for the facilitation per se, but 
instead depends on the drug or agonist used to induce the facilitation. 
Presumably the voltage-dependent channels were activated by the NMDA 
depolarization since all of the present experiments were done in the presence of 
TTX. Holding the membrane potential constant at the resting membrane potential, 
as under voltage clamp protocol, would therefore, be expected to abolish the 5-HT, 
thapsigargin, cyclopiazonic acid, and A23187 induced facilitation. However, 5-HT 
is effective in facilitating NMDA induced inward currents in cortical neurons under 
voltage clamp conditions (Reynolds et a/., 1988) and the same is true for A23187 
at hippocampal neurons (Markram and Segal, 1991). This apparent inconsistency 
of the present observations with those of Reynolds et a/. ( 1988) and Markram and 
Segal (1991) may reflect: 1) limited space clamp of cortical and hippocampal 
neurons; 2) that the facilitation requires only low frequency opening of voltage-
dependent Ca ++ channels which might take place at potentials near the resting 
membrane potential or; 3) that nifedipine blocks a voltage-independent Ca++ 
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channel that is important for the facilitation. In whole cell recording from primary 
cortical cultures where the space clamp is likely to be better than in slices, 5-HT 
remains effective in facilitating NMDA currents (Virgo and Neuman, unpublished 
observations), suggesting that a problem with space clamp may not account for the 
apparent discrepancy. Clearly, this requires further investigation. Despite the 
above, nifedipine will be assumed in the following to act on voltage-dependent 
Ca ++ channels. 
5-HT2A receptor mediated PI hydrolysis is very sensitive to extracelluar Ca++ 
(Kendall and Nahorski, 1984; Wojcikiewicz et a/.,1993; Yang eta/., 1994) which 
would account for loss of the 5-HT facilitation in the present investigation. The 
importance of Ca ++ entry through voltage-dependent Ca ++ channels to PI hydrolysis 
has yet to be demonstrated. Alternatively, Ca ++ entry through voltage-dependent 
Ca ++ channels might : 1) amplify signal transduction at phospholipase C (Eberhard 
and Holz, 1988); 2) modulate Ca ++ release from IP 3 sensitive and /or ryanodine 
sensitive Ca++ stores (Henzi and MacDermott, 1992) or; 3) add to the nse m 
intracellular Ca++ resulting from NMDA and 5-HT2A receptor activation. 
Unlike 5-HT, thapsigargin, cyclopiazonic acid, and A23187 are all capable 
of raising the concentration of intracellular Ca ++ in the absence of extracelluar Ca ++ 
(Pozzan et a/., 1994). However, such a rise without a contribution from 
extracelluar Ca ++ is obviously insufficient to facilitate the NMDA response. 
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Facilitation of the NMDA depolarization may be triggered by a threshold 
concentration of intracellular Ca++ and several sources may contribute to reaching 
the threshold. 
That a rise in intracellular Ca++ is indeed essential for the NMDA facilitation 
is revealed by the observations made with BAPT A-AM. Perfusing BAPT A-AM 
eliminated the NMDA facilitation independent of the agent used to induce the 
facilitation. Presumably by buffering the rise of intracellular Ca ++ (Niesen et a/., 
1991 ), the threshold for inducing the facilitation (see above) could not be reached. 
Similar observations have been made with respect to the NMDA facilitation in 
hippocampal neurons induced by carbachol and A23187 (Markram and Segal, 
1991, 1992). In these studies, the facilitation was eliminated by the diffusion of 
BAPT A from the intracellular electrode. 
In contrast to a rise in intracellular Ca ++ facilitating the NMDA 
depolarization, it has been reported that elevated intracellular Ca ++ causes a 
decrease in NMDA receptor activity in cultured hippocampal neurons (Legendre 
et al., 1993~ Vyklicky, 1993) and in cultured spinal neurons (Mayer and 
Westbrook, 1985, 1987~ Mayer eta/., 1987). In these studies, intracellular Ca++ 
was increased via entry through the NMDA receptor ionophore or voltage-
dependent Ca++ channels and thus differs somewhat from the manner in which 
intracellular ca++ was raised in the present investigation, i.e. in part from release 
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of Ca++ from intracellular organelles. It is thus possible that both an increase and 
a decrease in the NMDA response could be mediated by a rise in Ca ++ depending 
on how the Ca ++ concentration is elevated and of course on how the change in 
NMDA response is affected. Differences in tissue preparation, i.e. slice vs cultured 
neurons (c.f. Markram and Segal, 1991), is unlikely to account for the difference, 
since 5-HT facilitation has been observed in cultured cortical neurons (Virgo and 
Neuman, unpublished observations). Further experiments are required to resolve 
this issue. 
In this investigation, removal of extracellular Ca++ failed to alter the NMDA 
depolarization, whereas buffering intracellular Ca++ reduced the response. It is 
likely that in Ca++ free medium neuronal membranes are depolarized 
(Frankenhaeuser and Hodgkin, 1957), and as a consequence, the NMDA response 
would be enhanced as the inward current produced by NMDA receptor activation 
would be increased. However, the expected cholinergic and noradrenergic 
contribution (see Chapter 2) would be reduced in the above medium, i.e. there 
would be decreased release and the effect of released norepinephrine would be 
blocked (see Chapter 7). Therefore, the net effect is that the NMDA response 
remains unchanged in Ca++ free medium. On the other hand, the cholinergic and 
noradrenergic component would be eliminated due to buffering of internal Ca++ by 
BAPT A-AM (see above). This would lead to a reduction of the NMDA response. 
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5.4.3 Role of calmodulin in loss of the Al3187 facilitation 
Application of 1 J!M A23187 maximally facilitated the NMDA response, 
whereas the next highest concentration tested, 3 J!M, reduced the facilitation. 
Chlorpromazine, but not staurosporine or myo-inositol, prevented the reduction. 
These results suggest that the rise in intracellular Ca++ activates calmodulin (Erondu 
and Kennedy, 1985) which in turn reduces the facilitation. Calmodulin is reported 
to be a cytosolic Ca++ receptor in neurons (see Gnegy, 1993). Each molecule of 
this ubiquitous regulatory protein has four Ca ++ binding sites with dissociation 
constants in the low micromolar range. When the concentration of Ca ++ rises into 
this range, the four binding sites are subsequently occupied and calmodulin 
becomes a multifunctional activator (Kennedy, 1989). Following activation, 
calmodulin binds with different proteins and alters their function. One of these 
proteins, calmodulin dependent kinase II (CaM kinase II), is the predominant Ca++ 
dependent protein kinase in the cortex (Erondu and Kennedy, 1985). This enzyme 
has relatively wide ranging effects and can phosphorylate several neural proteins 
(Hanson and Schulman, 1992). Whether reduction of the facilitation is due to 
phosphorylation of the NMDA receptor complex initiated by CaM kinase II or 
other calmodulin dependent enzymes remains to be determined. Previously, 
calmodulin antagonists were found to reduce long term desensitization of the 5-
HT2A receptor mediated facilitation (Chapter 3). It remains possible that the 
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activation of calmodulin induced by A23187 and the 5-HT 2A receptor result in 
similar cellular actions. 
5.4.4 Is the facilitation dependent on altering the Mg++ dependence of the NMDA 
receptor? 
Reducing the Mg++ dependence of the NMDA response (Nowak eta/., 1984) 
could account for the facilitation observed in the present investigation and indeed 
has been proposed to account for the facilitation of the NMDA response observed 
in trigeminal neurons as a result of protein kinase C phosphorylation (Chen and 
Huang, 1992). As expected (Nowak eta/., 1984), omission of Mg++ from the 
ACSF results in a substantial increase in the magnitude of the NMDA 
depolarization of cortical neurons (unpublished observations). Such omission 
eliminates the 5-HT and phenylephrine induced facilitation, whereas the A23187 
facilitation is present, albeit smaller in magnitude. From these observations it is 
concluded that the facilitation per se is not dependent on Mg++, i.e., it does not 
result from altering the voltage-dependent blockade of the NMDA receptor 
ionophore by Mg++ (c.f. Nedergaard eta/., 1987). 
Activation of G-protein complexes does not occur without Mg++ 
(Birnbaumer et a/., 1990; Litosh, 1990). Furthermore, removal of extracelluar 
Mg++ depresses muscarinic cholinoceptor mediated responses (Gur:witz and 
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Sokolovosky, 1980; Aronstam eta/., 1985) including muscarinic depolarization of 
neocortical neurons (El-Behiry and Puil, 1990). Thus, the Mg++ dependence ofthe 
5-HT and phenylephrine induced facilitation likely reflects the regulatory role of 
Mg ++ on signal transduction of G-protein coupled receptors. Although this is a 
likely explanation, presumably this occurs following a reduction of the 
concentration of intracellular Mg ++ and this remains to be confirmed. 
Figure 30 is a cartoon summarizing the results of the present investigation 
and speculating on how facilitation of the NMDA depolarization may take place 
at cortical pyramidal neurons. The rise in Ca ++ is envisioned as being the common 
mechanism resulting from 5-HT 2A receptor activation as well as from the action of 
thapsigargin, cyclopiazonic acid and A23187, which leads to facilitation of the 
NMDA depolarization. External Ca++ is necessary and enters the cell through 
voltage-dependent Ca ++ channels or at the least through a nifedipine sensitive Ca ++ 
channel. Ca ++ is presumed to activate a kinase or phosphatase which regulates the 
NMDA receptor ionophore by controlling the phosphorylation state of the NMDA 
receptor or that of a nearby protein, which in turn regulates the NMDA receptor 
(see Chapter 8 for further discussion on this point). Most importantly, this calcium 
mediated facilitation of the NMDA receptor is likely to be a common pathway for 
neurotransmitters regulating NMDA receptors and thus synaptic plasticity in 
neocortex. 
Figure 30. A hypothetical model that illustrates the mode of action by 5-HT, 
thapsigargin, cyclopiazonic acid and A23187. Although the drugs have different 
mechanisms of action, they share in common an ability to raise intracellular Ca ++ 
that accounts for facilitation of the NMDA depolarization. Abbreviations: 5-HT 2A, 
5-HT 2A receptor; Ga., a subunit of G-protein; PLC, phospholipase C; PIP:z, 
phosphatidyl inositol 4,5-biphosphate; DAG, diacylglycerol; NMDA-R, NMDA 
receptor. 
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CHAPTER6 
S-HT1A RECEPTOR MEDIATED FACILITATION IN SENESCENT RATS 
6.1 Introduction 
There is considerable interest in understanding conditions that underlie age 
related loss in cognitive functions such as memory and learning. Although much 
of this interest has focused on the forebrain cholinergic system (Barthus et a/., 
1982), there is a growing awareness that 5-HT may also participate in these 
processes (Altman and Normile, 1988~ V anderwolf, 1992). Notwithstanding the 
conflicting literature in this area (Altman and Normile, 1988~ Robson eta/., 1993), 
numerous age-related modifications of the central serotonergic system have been 
reported that could contribute to cognitive deficits. These include changes in fibre 
morphology, transmitter and metabolite levels, and ligand binding assays for 5-
HTIB and 5-HT2A receptors (Battaglia eta/., 1987~ Gozlan eta/., 1990~ Marcussen 
et a/., 1984~ Robson et a/., 1993 ~ van Luijtelaar et a/., 1992). A recent report also 
suggests that coupling between cortical 5-HT 2A receptors and G-proteins is reduced 
with aging (Robson eta/., 1993). Age-related change in cortical 5-HT2A receptors 
may be of particular interest with regard to cognitive deficits. These receptors are 
concentrated in the frontal cortex (Pazos et a/., 1985) and influence the firing 
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patterns of cortical projection neurons (Neuman and Zebrowska, 1992). 
Paradoxically, DOl induced wet dog shakes (a behaviour mediated by 5-
HT2A receptors), increases with aging (Gower and Gobert, 1992; Robson et al., 
1993). However, the 5-HT 2A receptors involved in this response are located in the 
spinal cord (Fone eta/., 1989) and as such, may not reflect modification at cortical 
sites. At the cellular level, age-related alteration in functional activity of 5-HT 2A 
receptors has not previously been investigated in the frontal cortex. Assessing 
functional activity is particularly important for G-protein coupled receptors, such 
as the 5-HT 2A receptor. Signal transduction associated with this family of receptors 
often yields considerable amplification, i.e. the receptors demonstrate receptor 
reserve (Kenakin, 1993). A reduction in receptor number may not therefore, 
translate into a significant loss of responsiveness. 
As expected from the 5-HT2A receptor/effector system (see Chapters 2 and 
3), there are numerous sites at which functional activity may be regulated following 
ligand binding. With regard to facilitation of the NMDA depolarization induced 
by 5-HT ligands, the 5-HT component, but not the NMDA component is subject 
to several forms of desensitization. This desensitization is influenced by protein 
kinase C activation, availability of the inositol biphosphate precursor myo-inositol, 
calmodulin activation, and receptor sequestration (Chapters 3 and 4). Age-related 
processes, aside from reducing the maximum number of 5-HT 2A receptors, might 
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modify cellular or extracelluar regulation of these receptors at one or more sites 
resulting in loss of functional activity. The objective of this study was to examine 
the 5-HT 2A receptor mediated facilitation of the NMDA depolarization in frontal 
cortex from young adult and senescent rats and compare these findings with the 
facilitation induced by activating a 1-adrenoceptors, muscarinic cholinoceptors (see 
Chapter 2) and metabotropic glutamate receptors (see Chapter 7). In addition, this 
study was an attempt to confirm the evidence that 5-HT2A receptors are located on 
cortical pyramidal neurons. 
146 
6.2 Methods 
6.2.1 Electrophysiology 
Wedges of sensorimotor cortex from young adult (3-6 months) and 
senescent (22-34 months) male Fisher 344 rats and young (1-2 months) Sprague-
Dawley rats (both from Charles River, Montreal, Quebec) were prepared for 
recording and analyzed as described in section 2.2.2 and 2.2.5. 
6.2.1.1 ACSF composition and drug application 
ACSF composition in the bathing medium and drug application were as 
described in section 2.2.3, 2.2.4, 3.2.2 and 4.2 with the following additions: 
chelerythrine was perfused for 30 min before 5-HT application, bicuculline, 2-0H 
saclofen, and tetrodotoxin were perfused throughout. Drug concentrations are 
given as the salt. Stock solutions were kept frozen until use. 
6.2.1.2 Drugs and chemicals 
The following drugs were used: chelerythrine (Alomone Labs)~ 1S,3R ACPD 
and 3-amino-2-(4-chlorophenyl)-2-hydroxypropyl) sulfonic acid, 2-0H saclofen 
{Tocris Neuramin)~ bicuculline (Sigma) . 
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6.2.2 In situ hybridization histochemistry 
For in situ hybridization experiments, Fisher (senescent, 22-30 months, n=3; 
young adult, 3-6 months, n=3) and Sprague-Dawley rats (3 and I2 months) were 
used. Rats were anaesthetized with ether then sacrificed by decapitation. The 
brains were removed and immediately frozen on dry ice. Brain sections, 10 Jlffi 
thick, were cut on a cryostat, mounted onto subbed slides and stored frozen until 
needed. 
Before hybridization, sections were brought to room temperature, fixed with 
4% paraformaldehyde for 30 min, and rinsed in the following solutions: I) one 
rinse in ribonuclease-free H20 (I mL diethyl pyrocarbonate/I L deionized water 
then autoclaved)~ 2) 5 min in 0.25 M HCl; 3) 5 min in phosphate buffered saline 
(PBS)~ 4) 7.5 min in proteinase K (I Jlg/mL H20); 5) 5 min in PBS; 6) 5 min in 
O.OIM triethanolamine (pH 8.0)~ 7) 2 X 5 min in PBS. The sections were then 
incubated in a prehybridization solution (50% formamide, 0.6 M NaCl, I 0 mM 
Tris buffer [pH 7.5], I mM ethylenediamine tetraacetic acid, 50 Jlg/ml heparin, IO 
mM dithiothreitol, 500 Jlg/ml tRNA, 0.2% Tween 20, 100 Jlg/mL salmon sperm 
DNA) for one hour in a humid chamber at 42°C. Probes were 3' end-labelled with 
f'S] d-ATP (Dupont Canada, NEN Research Products) to a specific activity 
ranging between 2.4x106 and 6.7x106 cpm/pmol using a terminal transferase kit 
(Dupont Canada). Sections were incubated at 42°C for I8-22 hours in 100 J.1L of 
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hybridization solution containing the radiolabelled oligonucleotide (2 X 106 
cpm/slide). Sections were rinsed in 2X sodium chloride/sodium citrate (SSC) at 
room temperature, 2X SSC at 55°C, 0.2X SSC at 55°C and then air dried for 2-3 
hrs before dipping in emulsion. 
Slides were dipped in autoradiographic emulsion (Kodak NTB-2) mixed 1: 1 
with 600 mM ammonium acetate ( 42-45°C), dried for at least 2 hrs and stored in 
the dark at 4°C for 10 days, three weeks or five weeks then developed in Kodak 
D-19 (2 min), rinsed in H20 (30 sec) and fixed with Kodak fixer (4 min). The 
sections were washed in H20, counterstained with cresyl violet, dehydrated, 
coverslipped with Permount and viewed under bright- and clarkfield microscopy. 
The antisense probe used to detect mRNA for the 5-HT2 receptor was a 
commercially available (Dupont Canada) mixture of three oligonucleotides 
complementary to the bases 3-51, 721-770 and 811-858 of the 5-HT2 receptor 
mRNA (Pritchett et a/., 1988). A computer search revealed these sequences were 
unique for the 5-HT 2A receptor. Combining 3sS-labelled and unlabelled 
oligonucleotide in a 1:10 ratio and using the resulting mixture for hybridization 
served as a control. This control was employed on slides containing sections 
adjacent to those exposed to antisense probes. 
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6.l.l.1 Quantitative analysis 
Silver grains over cells were quantitated ustng bright and dark field 
microscopy (X40 objective) coupled to an image analysis system (Bioquant, R & 
M Biometrics). Pyramidal and non-pyramidal neurons in layer V were studied by 
analyzing every identifiable cell in a digitized image field. Image enhancement 
processing was used to facilitate the visualization and identification of cells under 
bright field illumination. Only those cells with a visualized nucleus were analyzed 
and each cell was identified on the basis of position, shape, Nissl staining intensity 
and size. The borders of identified cells were outlined using a cursor coupled to 
the computer and a graphics table (Summasketch II, Summagraphics). Using 
darkfield illumination the number of silver grains within the border of each soma 
was determined and normalized to grains/100 J.Lm2 . Four to five fields/section were 
used for statistical analysis. The background density of silver grains was 
determined from regions that lacked cell bodies. Analysis of variance and the post 
hoc Tukey-Kramer multiple comparisons test were used to analyze the results. 
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6.3 Results 
6.3.1 FJectrophysiology 
In keeping with previous observations (Chapter 2), co-perfusion of 30 J.LM 
5-HT and NMDA for 2 min reversibly enhanced the NMDA depolarization in 
wedges prepared from young adult Fisher 344 rats (Fig. 31 ). In contrast, 30 J.LM 
5-HT did not facilitate the NMDA depolarization in wedges from senescent 
animals (Fig. 31 ). Concentration response data for the 5-HT facilitation in young 
adult and senescent rats are shown in Fig. 32. Amplitude of the NMDA 
depolarization was smaller in senescent rats compared to young adults, but this 
difference did not reach statistical significance (0.51 + 0.07 mV, n=17, vs. 0.75 + 
0.11 mV, n=17; p=0.075, two tailed t test). 
Application of 5-HT presumably activates all 5-HT receptor subtypes present 
in the cortical wedge. At least one of these receptors, the 5-HT lA subtype, reduces 
the amplitude of the NMDA depolarization (Chapter 2). DOl, an agonist at 5-HT 2A 
and 5-HT 2c receptors, was substituted for 5-HT to ascertain whether the absence 
of facilitation reflected a loss of 5-HT 2A receptor signal transduction or an 
enhanced contribution from an inhibitory 5-HT receptor. Although DOl facilitated 
the NMDA depolarization in wedges from young adult rats, no such facilitation 
was observed in wedges prepared from senescent rats (Fig. 33). 
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Agonists at other receptors that activate phospholipase C, including 
carbachol, 1S,3R ACPD (Chapter 7), and phenylephrine also facilitate the NMDA 
depolarization in cortical wedges (Chapter 2). As expected, 10 J.LM carbachol, 50 
J.LM 1S,3R ACPD, and 10 J.LM phenylephrine significantly enhanced the NMDA 
depolarization in wedges from young adult rats. However, in contrast to 5-HT, the 
facilitation induced by these agonists in wedges from senescent rats was not 
significantly different from that in the younger animals (Fig. 33). 
Receptor binding assays suggest that 5-HT 2A receptors are present on cortical 
neurons in senescent rats (Battaglia eta/., 1987; Gozlan eta/., 1990; Robson eta/., 
1993). The absence of functional activity could then represent some form of 
receptor desensitization. Activating protein kinase C with phorbol ester or 
oleoacetylglycerol is particularly effective in eliminating the 5-HT facilitation, an 
action inhibited by staurosporine (Chapter 3). When wedges from senescent 
animals were perfused with 10 nM staurosporine for 40 min, 30 J.LM 5-HT induced 
a significant facilitation of the NMDA depolarization (Fig. 34A). Amplitude of the 
resulting facilitation was such that it did not differ significantly from that observed 
in wedges from young adult rats in the presence of staurosporine (Fig. 34B). 
Staurosporine exhibits only marginal selectivity for protein kinase C tn 
comparison to other kinases (Ruegg and Burgess, 1989). Chelerythrine (1 J.LM), 
a specific protein kinase C inhibitor (Herbert et a/. 1990), also restored . the 5-HT 
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YOUNG ADULT 
• 
SENESCENT 
• 
NMDA 50 Jl.M _j1mV 
• 5-HT30 Jl.M 4 min 
Figure 31. 5-HT facilitates NMDA depolarization of cortical neurons in young 
adult, but not in senescent rats. Cortical wedges from young adult and senescent 
rats, upper and lower panel respectively. Control response to SO J.1M NMDA (left). 
Perfusion of 30 J.1M 5-HT and NMDA (centre). Recovery 20 min later (right). 
Upward deflection is negative. 
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Figure 32. Concentration-response relationship for 5-HT facilitation of NMDA 
depolarization in young adult and senescent rats. NMDA concentration was 50 
J.1M. 5 to 8 wedges were used for each concentration. ***, p < 0.001. 
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Figure 33. Differential action of DOl, carbachol and phenylephrine and 1S,3R-
ACPD. DOl facilitates the NMDA depolarization only in the young adult group, 
whereas carbachol, phenylephrine and IS,3R-ACPD facilitate the NMDA 
depolarization in both groups. 5 to 6 wedges were used for each measurement. 
***, p < 0.001. 
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facilitation in 4 wedges from 2 senescent rats (Fig. 34B). In a further 2 wedges 
from a 34 month old rat, chelerythrine failed to alter the NMDA response. 
Concanavalin A, calmodulin antagonists, and myo-inositol also reduce 
desensitization of the 5-HT2A receptor/effector system (Chapter 3 and 4). Perfusing 
wedges with 100 nM concanavalin A, 1 ~M calmidazolium or 1 ~M 
chlorpromazine failed to reestablish the 5-HT facilitation in senescent rats despite 
some potentiation of the facilitation in young adult rats (Table Ill). As expected 
(Chapter 4), perfusion with 10 mM myo-inositol potentiated the facilitation in 
wedges from young adult rats (Fig. 35). However, in wedges from senescent rats 
myo-inositol did not restore the facilitation (Fig. 35). It has been suggested that 
5-HT 2A receptors in the frontal cortex are located on GABAergic intemeurons 
(Mengod et a/., 1990~ Morilak et a/., 1993). However, as shown in Fig. 36, 
application of 30 ~M 5-HT in the presence of 10 ~M bicuculline, 10 ~M 2-0H 
saclofen (blockers of GABAA and GABA8 receptors respectively) and 0.2 ~M 
tetrodotoxin (TTX~ to prevent paroxysmal depolarizing shifts) resulted in 
facilitation of the NMDA depolarization (215 + 22%, n=4). The combination of 
bicuculline, 2-0H saclofen and TTX did not did not alter the NMDA 
depolarization (98 + 11%, n=4 ). 
A Chelerythrine 1 J!M 
-
Staurosporine 1 0 nM 
-
NMDA 50 J.LM 
• 5-HT 30 JJ.M 
_j1mV 
4 min 
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Figure 34. Staurosporine and chelerythrine restore the 5-Hf facilitation in 
senescent rats. A: tracings showing 5-HT facilitates the NMDA depolarization in 
wedges from senescent rats during perfusion with 1 J.LM chelerythrine (upper trace) 
or 10 nM staurosporine (lower trace). B: averaged data for staurosporine in young 
adult and senescent rats and for chelerythrine in senescent rats. 5 to 6 wedges 
were used for each measurement. • • •, p < 0. 001, staurosporine and chelerythrine 
vs. senescent control. 
8 
400 
c=JYOUNG ADULT RATS .. SENESCENT RATS 
z 
0 200 
~ 
<( 
N 
0: 
~ 
0 
a.. 
w 
0 
<( 
0 
~ 
z 
100 
5-HT 30 ,aM + 
ST 10 nM 
CT 1 ,aM 
+ + + + 
+ + 
+ 
157 
158 
TABLE ill. Effects of Concanavalin A, calmidazolium and chlorpromazine on 5-
HT facilitation 
DRUG 
5-HT 100 J.LM 
+ Concanavalin A 1 00 nM 
+ Calmidazolium 1 J.LM 
+ Chlorpromazine 1 J.LM 
NMDA depolarization (% of control) 
Senescent Young adult 
110 ± 6% (n=6) 141 ± 16% (n=5) 
138 ± 18% (n=7) 380 ± 43% (n=4)*** 
128 ± 10% (n=5) 204 ± 13% (n=5) 
138 ± 8.5% (n=4) 275 ± 38% (n=4)* 
Concanavalin A prevents receptor sequestration (Lin and Levitan, 1991; Chapter 
3), whereas calmidazolium and chlorpromazine are calmodulin antagonists 
(Chupran eta/., 1991; Masson et al., 1992). Statistical comparisons were by one 
way analysis of variance followed by Bonferroni test. All treatments were 
compared with 5-HT 100 J.LM (control). ***, p < 0.001, 5-HT vs. 5-HT + 
concanavalin A. *, p < 0 .05, 5-HT vs 5-HT + chlorpromazine. 
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Figure 35. Concentration-response relationship for 5-HT facilitation in young adult 
and senescent rats in the presence of 10 mM myo-inositol. S to 8 wedges were 
used for each point. ***, p < 0.001. 
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Figure 36. GABAA and GABA8 antagonists do not eliminate the 5-HT facilitation. 
Traces from a cortical wedge prepared from a young Sprague-Dawley rat perfused 
with mixture as shown. TTX was added to prevent paroxysmal depolarizing shifts 
in the presence of GABA receptor antagonism. 
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6.3.2 In situ hybridization 
Localization of cortical 5-HT2A receptors was investigated using a labelled 
probe for 5-HT 2A receptor mRNA. In situ hybridization in both young adult and 
senescent rats resulted in cell labelling in cortical layers II to VI of the 
sensorimotor cortex with most labelled cells located in layers II and V (Fig. 37). 
On the other hand, mixing labelled and unlabelled probe (1 : 1 0) resulted in 
background loss of label (data not shown). Visualization of cells labelled by the 
antisense probe revealed that only a subset of pyramidal cells were labelled (Fig. 
38). Further quantitative analysis of silver grains was made in layer V, the area 
containing the highest density of label in senescent and young adult animals. 
Within animal statistical analysis revealed a significantly greater density of grains 
over pyramidal cells than background regions, whereas non-pyramidal cells did 
not differ from background labelling (Table IV). The analysis also revealed that 
the density of grains present over pyramidal cells was significantly greater than 
over nonpyramidal cells {Table IV). 
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Figure 37. Bright (A) and clarkfield (B) photomicrographs of the frontal/parietal 
cortex showing the distribution of silver grains after in situ hybridization 
histochemistry with 35S-labelled antisense probe for 5-HT zA receptor mRNA in the 
various layers of adult Sprague-Dawley rat cortex. Sagittal section. Scale bar is 
500 JJ.M. 
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Figure 38. Bright field photomicrograph (high magnification) of the frontal/ 
parietal cortex showing localization of 5-HT2A mRNA in layer V of senescent rat 
(26 months old). Solid arrows point to labelled pyramidal cells. The open arrow 
points to a nonlabelled pyramidal cell . Scale bar is 50 f.lM . 
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TABLE IV. Density of grains ( Mean ± SEM) over different cell types or 
background region. The number of cells analyzed is indicated in parentheses. 
Animal Cell type (grains/ 100 Jlm2) 
Background Pyramidal Non-pyramidal 
Young adult, 
Fisher 3.4±0.5 {n=6) 9.2±1.0 (n=6f• 5.6±1.1 (n=8)' 
Young adult, S.D. 2.4±0.2 (n=5) 6.8±0.9 (n=9)* 3 .6±0.9(n= 1 0) 
26 month, Fisher 6.9±0.7 (n=5) 14.7±2.2 (n=7)* 7.7±1.0 (n=6)' 
30 month, Fisher 3.4±0.2 (n=5) 6.6±0.7 (n=11)* 3.7±0.7(n=13)" 
Fisher, Fisher 344 rat. S.D., Sprague-Dawley rat. All within animal one way 
ANOV As indicate significant differences between the groups. In all cases, post 
hoc Tukey tests show that the density of grains over pyramidal cells is significantly 
different from controls and non-pyramidal cells while that over non-pyramidal cells 
is not different from background. *, p < 0.05, pyramidal cells vs background or 
non-pyramidal cells;**, p < 0.01, pyramidal cells vs background or non-pyramidal 
cells. ', p < 0.05, non-pyramidal cells vs pyramidal cells; ", p < 0.01, non-
pyramidal cells vs pyramidal cells. 
165 
6.4 Discussion 
The major findings from this investigation are: I) the presence of 5-HT 2A 
receptor mRNA in pyramidal neurons from both young adult and senescent rats; 
2) selective loss of 5-HT2A signal transduction with senescence; 3) restoration of 
the 5-HT 2A facilitation following inhibition of protein kinase C. 
In interpreting the results of this study it should be noted that only young 
adult (6 months) and senescent rats (22 to 34 months) were compared. None of 
the wedges from senescent rats tested showed signs of facilitation, unless perfused 
with a protein kinase C inhibitor. Had animals at intermediate ages been tested, 
evidence for a gradual loss of function might have been obtained. Accordingly, 
when reference is made to loss of function in senescent rats, it should be 
understood that this loss could be complete at ages significantly younger than those 
tested. 
6.4.1 5-HT2A receptors are located on pyramidal neurons 
An important consideration in understanding the apparent loss of 5-HT2A 
receptor mediated signal transduction is the cellular localization (frontal cortex) of 
the 5-HT 2A receptors which mediate facilitation of the NMDA depolarization. 
Grease-gap recording only registers depolarization of neurons whose axons pass 
through the grease seal. As discussed (see Chapter 2), projection neurons meet this 
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requirement (pyramidal neurons in layers II/III and V and some neurons in layer 
VI~ Lorente De No, 1949), whereas interneurons do not. This does not, however, 
preclude tonic or phasic transmitter/modulator release from nerve terminals or 
interneurons contributing to the depolarization of projection neurons, and 
consequently, having an influence on the potential recorded (see Chapter 2). Thus, 
depending on whether 5-HT acts directly or indirectly on projection neurons, the 
deficit observed in cortical wedges from senescent rats might reflect i) loss of 5-
HT 2A receptor associated signal transduction or ii) loss of effectiveness of the 
indirectly acting agent. 
The presence of silver grains over pyramidal neurons, but not intemeurons, 
of the frontal cortex following in situ hybridization with 35S-labelled probe for 5-
HT 2A receptor mRNA suggests that 5-HT 2A receptors are present on projection 
neurons and that 5-HT does indeed act directly. This should not be taken to 
preclude the possibility that functional 5-HT 2A receptors do not exist on 
interneurons or perhaps, glial cells. The presence of 5-HT 2A mRNA in human 
pyramidal neurons has also been observed by Burnet (P.W.J. Burnet, Department 
of Neuropathology, Oxford University, personal communication). The commercial 
probe utilized in this study contains three antisense oligonucleotide sequences for 
the 5-HT 2A receptor, thereby greatly increasing the probability of detection. Of 
course, the presence of a particular mRNA is not in itself proof that the protein is 
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expressed. However, the presence of 5-HT2A receptor mRNA on projection 
neurons is consistent with the high density of 5-HT 2A binding sites in layers III and 
V (Pazos eta/., 1985) and with the electrophysiological and the pharmacological 
evidence for a direct action of 5-HT on layer V pyramidal neurons (see Chapter 
2). 
In piriform cortex, electrophysiological (Sheldon and Aghajanian, 1990) and 
immunohistochemical (Morilak et a/., 1993) evidence indicates the presence of 5-
HT 2A receptors on GABAergic interneurons. Activation of these receptors leads 
to the appearance of inhibitory post synaptic potentials on pyramidal neurons in 
layer II of piriform cortex (Sheldon and Aghajanian, 1990). In contrast, recordings 
from pyramidal neurons in frontal and cingulate cortex do not reveal either 
inhibitory- or excitatory post synaptic potentials following application of 5-HT 
(Araneda and Andrade, 1991; Davis eta/., 1987; Nedergaard eta/., 1987; Reynolds 
et a/., 1988; Tanaka and North, 1993). Cellular responses attributable to 5-HT2A 
receptor activation on pyramidal neurons, including membrane depolarization 
(Araneda and Andrade, 1991; Davies eta/., 1987; Tanaka and North, 1993) and 
facilitation of the NMDA depolarization (Nedergaard eta/., 1988; Reynolds eta/., 
1988; Chapter 2) are not blocked by TTX, consistent with 5-HT having a direct 
action. Were 5-HT to act indirectly through a GABAergic mechanism (Mengod 
et a/., 1990; Morilak et a/., 1993 ), the mixture of GAB AA and GABA8 receptor 
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antagonists should have eliminated the 5-HT facilitation. The smaller amplitude 
of the facilitation observed during perfusion of this mixture can be attributed to 
TTX, which alone reduces the amplitude of the 5-HT facilitation (Chapter 2) and 
decreases phosphoinositide hydrolysis (Gurwitz and Sokolovsky, 1987). 
Further evidence for a direct action by 5-HT comes from studies on 
heterologous desensitization of muscarinic cholinoceptors induced by prior 
application of 5-HT (Chapters 3 and 4). This heterologous desensitization results 
from depleting substrate for phospholipase C, since it is prevented by perfusing 
myo-inositol (Chapter 4 ), the substrate precursor. The presence of substrate 
dependent heterologous desensitization and its reversal by myo-inositol argues 
strongly that muscarinic cholinoceptors and 5-HT 2A receptors are co-localized on 
the same neurons. The finding that muscarinic cholinoceptor stimulation facilitates 
the NMDA depolarization (Chapter 2) and that muscarinic cholinoceptors are 
present in abundance on pyramidal neurons (Van der Zee et a/., 1993) provides 
compelling evidence for the presence of 5-HT 2A receptors on pyramidal neurons. 
From the above it is concluded that 5-HT 2A receptors are located on 
projection neurons and, as a consequence, 5-HT acts directly to facilitate the 
NMDA depolarization. These results are not easily reconciled with a recent report 
on localizing 5-HT 2A receptors using antibodies raised against a sequence of the 5-
HT 2A receptor (Morilak et a/., 1993 ). The presence of antibody labelling in regions 
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such as the piriform cortex is consistent with electrophysiological evidence 
(Sheldon and Aghajanian, 1990) but, as discussed above, failure to observe label 
on projection neurons is not. Moreover, autoradiography reveals extensive 5-HT2A 
ligand binding in the rat frontal cortex (Gozlan et a/., 1990; Pazos et a/., 1985) 
whereas 5-HT 2A immunoreactive neurons in the same area are rather sparse 
(Morilak et a/., 1993). These discrepancies remain to be clarified. 
6.4.2 Mechanism(s) underlying loss of 5-HT1A receptor activity 
The cellular mechanism(s) responsible for facilitation of the NMDA 
depolarization of cortical neurons is (are) unknown, although the involvement of 
PKC and calmodulin have been excluded (Chapters 3 and 4). However, a rise in 
intracellular Ca++ is necessary (Chapter 5). Buffering intracellular Ca++ eliminates 
agonist induced facilitation, whereas agents which raise intracellular Ca++, such as 
thapsigargin and cyclopiazonic acid, facilitate the NMDA response (Chapter 5). 
This commonality in mechanism, along with the present observation that the 
facilitation induced by carbachol, phenylephrine and 1S,3R ACPD is unchanged 
in wedges from senescent rats, implies that the loss observed with 5-HT and DOl 
relates to a deficit in signal transduction associated with the 5-HT 2A receptor and 
not with a process distal to this stage, e.g. at the NMDA receptor. Preliminary 
investigation (Neuman and Zhang, unpublished observations) indicates that the 
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deficit in 5-HT 2A signal transduction is also present in situ. Accordingly, loss of 
the 5-HT 2A response observed in vitro cannot, for example, be attributed simply to 
damage sustained during wedge preparation. 
Consistent with the age-related decline in NMDA receptor binding in the 
cortex (Tamaru et a/., 1991 ), a smaller though not statistically significant NMDA 
depolarization was observed in wedges from senescent rats. When the 5-HT 
concentration is held constant, the facilitation varies with NMDA concentration 
(Chapter 2). Accordingly, the smaller NMDA depolarization could contribute to 
loss of the facilitation. However, the facilitation restored during perfusion of the 
protein kinase C inhibitors did not differ significantly between wedges prepared 
from young adult and senescent rats, making it unlikely a decline of the NMDA 
response contributes significantly to the deficit. 
Whether 5-HT 2A receptors are functional or not, they are present on cortical 
neurons in senescent rats judging from ligand binding studies (Battaglia et a/., 
1987; Gozlan eta/., 1990; Robson eta/., 1993). Loss of 5-HT 2A receptor signal 
transduction could then simply reflect receptor desensitization. This desensitization 
does not involve agonist induced receptor internalization, calmodulin dependent 
long term desensitization, or substrate depletion to judge from the failure of 
concanavalin A, calmodulin antagonists, and myo-inositol respectively, to 
reestablish the facilitation (Chapters 3 and 4). On the other hand, restoration of the 
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facilitation during perfusion with staurosporine and chelerythrine clearly implicates 
a major role for protein kinase C in accounting for the loss of signal transduction. 
Phorbol ester or oleoacety lglycerol induced activation of protein kinase C does not 
alter the NMDA evoked depolarization of cortical neurons, whereas it does 
eliminate the 5-HT facilitation (Chapter 3). Stimulation of 5-HT 2A receptors with 
5-HT or DOl also leads to activation of protein kinase C, which in turn inhibits 5-
HT 2A signal transduction (Aghajanian, 1990; Chapter 3). Feedback inhibition by 
protein kinase C is in keeping with the presence of protein kinase C consensus 
sequences on the 5-HT 2A receptor (Roth eta/., 1990). Staurosporine, although a 
potent inhibitor of protein kinase C (1Cs0=2.7 nM; Tamaoki eta/., 1986), is far 
from being selective (Ruegg and Burgess, 1989). Chelerythrine, on the other hand, 
has an ICso for protein kinase C (0.66 J.LM) which is over two orders of magnitude 
lower than its ICso for other protein kinases (Herbert et a/., 1990). Given the 
selectivity of chelerythrine and supportive data with staurosporine, it is suggested 
that inhibition of protein kinase C accounts for restoration of the 5-HT facilitation. 
The lack of response to chelerythrine in the oldest rat tested, 34 months, may 
indicate an additional age-related decline in signal transduction unrelated to protein 
kinase C. 
Selective activation of protein kinase C could arise as a result of excessive 
5-HT release in wedges prepared from senescent rats. Turnover of cortical 5-HT 
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increases in senescent rats (Gozlan eta/., 1990~ Robson et al., 1993; van Luijtelaar 
eta/., 1992), perhaps as a consequence of declining 5-HT 18 autoreceptors (Gozlan 
eta/., 1990~ Murphy and Zelman, 1989), or degenerating 5-HT containing fibres 
(van Luijtelaar et a/., 1992). Chronic overstimulation of 5-HT 2A receptors could 
activate protein kinase C resulting in feedback inhibition sufficient to reduce the 
number of operative 5-HT 2A receptors below the threshold necessary to initiate 
facilitation. Phosphorylation of the 5-HT2A receptor might account for the 
suggested uncoupling of the receptor from G-proteins (Robson et a/., 1993). In 
this model the receptors are immediately available for stimulation once the 
inhibitory feedback is removed, i.e., once protein kinase C is blocked. Depending 
on the level of 5-HT released, limited receptor internalization could take place, 
accounting for the decline in 5-HT 2A binding observed in some studies (Battaglia 
et a/., 1987; Gozlan et a/., 1990). 
An alternative suggestion compatible with the present observations is that 
the inhibition by protein kinase C, feed-forward inhibition in this case, results from 
heterologous regulation by another transmitter/modulator that activates protein 
kinase C. Unlike homologous overstimulation (vide supra), this model must 
account for selectivity with respect to the protein kinase C mediated loss of the 5-
HT facilitation. However, preliminary observations reveal that cortical muscarinic 
cholinoceptors (Kong and Neuman, personal communication), metabotropic 
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glutamate receptors (Chapter 7), and a 1-adrenoceptors show little or no sensitivity 
to activation of protein kinase C by phorbol diacetate, at least with respect to their 
ability to facilitate NMDA depolarization. Thus altered activation of one of these 
receptors, their associated second messenger cascade, or indeed another receptor 
which stimulates protein kinase C could account for selective loss of the 5-HT 2A 
receptor mediated facilitation without reducing the ability of other modulators (see 
above) to facilitate the NMDA response. Of course, it remains to be demonstrated 
that activation of a receptor that stimulates protein kinase C heterologously 
regulates activity of 5-HT 2A receptors. 
In conclusion, the experiments in this study strongly support the hypothesis 
that 5-HT 2A receptors are expressed in cortical pyramidal neurons and that 5-HT 
facilitation of the NMDA response is a direct consequence of receptor activation. 
Furthermore, signal transduction mediated by 5-HT 2A receptors may be significantly 
impaired with aging. 
CHAPTER 7 
METABOTROPIC GLUTAMATE RECEPTORS MEDIATE FACILITATION 
OF THE NMDA DEPOLARIZATION: A COMPARISON WITH THE 5-HT2A 
RECEPTOR 
7.1 Introduction 
As demonstrated in the preceding studies (Chapters 2, 3 and 4), projection 
neurons (mainly pyramidal cells; Lorente de No, 1949) of the cerebral cortex are 
depolarized by NMDA and this depolarization is facilitated following activation of 
5-HT2A receptors. 5-HT2A induced facilitation likely occurs through a mechanism 
dependent on activating PLC-PI and the resulting second messenger cascade. This 
is consistent with the evidence suggesting that activation of G-protein coupled 
receptors, which utilize the PLC-PI pathway for their signal transduction 
mechanism, facilitate responses to NMDA in hippocampus (Markram and Segal, 
1992). If the PLC-PI response provides a common pathway for enhancement of 
the NMDA depolarization then metabotropic glutamate receptors, which stimulate 
the PLC-PI pathway, should behave in a similar manner. 
The metabotropic glutamate receptor (mGluR) is another member of the G-
protein receptor superfamily that contains receptor subtypes which couple 
positively to phospholipase C (Masu eta/., 1993; Bockaert and Fagni, 1993). Thus 
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mGluRI and the mGluRS have been shown to activate phospholipase C (Abe et 
a/., 1992; Tanabe eta/., 1992). These receptors differ in regional abundance and 
pharmacological characteristics (Abe et a/., 1992; Schoepp and Conn, 1993; 
Shigemoto et a/., 1992). mGluR agonists facilitate NMDA receptor mediated 
responses in hippocampal CAl neurons (Aniksztejn eta/., 1991, 1992; Harvey et 
al., 1993), rat olfactory cortex (Collins, 1993), neonatal spinal motoneurons (Birse 
et a/., 1993), and in Xenopus oocytes expressing rat brain RNA (Kelso et a/., 
1992). However, the mechanism underlying the facilitation is not uniform across 
preparations. Facilitation of the NMDA response is mediated by protein kinase C 
in Xenopus oocytes (Kelso et al., 1992), whereas at hippocampal neurons, there is 
evidence for and against such involvement (Aniksztejn et a/., 1991, 1992; Harvey 
and Collingridge, 1993). In this study, the interaction between NMDA and mGluR 
agonists was investigated in neocortical neurons along with possible mechanisms 
underlying the interaction. Receptor desensitization and Ca++ sensitivity of the 
interaction were also studied. This study allows a comparison to be made between 
two G-protein coupled receptors (5-HT2A and mGluR) identified as facilitating the 
NMDA response. 
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7.2 Methods 
Wedge preparation, recording, ACSF composition, drug application and 
analysis of data were as described tn sections 2.2., 3.2., 4.2 and 5.2 with the 
following exception: 2-amino-3-phosphonopropionic acid (D,L-AP3) and 2-amino-
4-phosphonobutyric acid (D,L-AP4) were perfused 40 min before addition of 
agonists. The ACSF contained 0.1 11M TTX to reduce indirect effects. 
7.2.1 Drugs and chemicals 
Arachidonic acid, bis-(o-aminophenoxy)-ethane-N,N,N',N', tetraacetic acid 
(BAPT A), 8-bromo-adenosine cyclic 3',5'-hydrogen phosphate monosodium salt (8-
bromo-cAMP), 8-bromo-guanosine 3',5'-hydrogen phosphate monosodium salt (8-
bromo-cGMP) were obtained from Sigma. 1 S,3R-1-aminocyclopentane-1 ,3-
dicarboxylic acid {1 S,3R-ACPD) was from Tocris Neuramin. 2-amino-3-
phosphonopropionic acid (D,L-AP3) and 2-amino-4-phosphonobutyric acid (D,L-
AP4 ), bis-( -o-aminophenoxy )-ethane-N ,N ,N' ,N' ,tetraacetic acid aminoethoxy 
(BAPTA-AM) were from Calbiochem. 6-cyano-7-nitroquinoxaline-2,3-dione 
(CNQX) was a gift from Ferrosan. 
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7.3 Results 
7.3.1 mGiuR receptor agonists selectively facilitate NMDA depolarization 
Quisqualate is an agonist at both the mGluR and a-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid (AMPA) receptor (Schoepp et a/., 1990). 
Neurons in cortical wedges are depolarized by 1 0 JJ.M quisqualate (Harrison and 
Simmonds, 1985; see Chapter 2) likely reflecting activation of AMPA receptors. 
However, no depolarization of cortical wedges was observed when 1 J.!M 
quisqualate was perfused alone (data not shown). Nevertheless, 1 J.!M quisqualate 
reversibly facilitated the NMDA depolarization (192 ± 13%, n=6; p< 0.01, Fig. 
39). Blocking AMPA and kainate receptors with 4 J.!M CNQX in the presence of 
20 JJ.M glycine, to protect the NMDA receptor (Thomson, 1990), did not prevent 
facilitation by 2 J.!M quisqualate (158 + 6%, n=4, p<0.05), although the NMDA 
depolarization alone was significantly reduced by this treatment (65 ± 6%, n=5, p 
< 0.01 ). Unlike 10 JJ.M quisqualate, concentrations of 1 S,3R-ACPD (1 0-200 J.LM) 
did not result in depolarization. Application of 1 S,3R-ACPD reversibly enhanced 
the NMDA depolarization (Fig. 39). Substituting 10 J.!M kainic acid for NMDA 
did not result in facilitation by 50 JJ.M 1 S, 3R-ACPD (1 01 ± 2%, n=5; Figure 39). 
As shown in Fig. 40, facilitation of the NMDA response by 1 S,3R-ACPD varied 
in a concentration dependent manner with an EC50 of 16 JJ.M. 
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In contrast to the facilitation induced by activation of 5-HT 2A, muscarinic 
and a 1-adrenoceptors (Chapter 2) a second exposure to 1 S,3R-ACPD 40 min after 
the first did not reveal homologous desensitization (Fig. 40). Absence of 
desensitization allowed a close examination of the facilitation produced by 1S,3R-
ACPD. Concentration-response curves for NMDA were obtained with and 
without 1S,3R-ACPD, employing the same wedge throughout. To allow ready 
comparison between wedges, the data from each wedge was normalized with the 
largest response (50 J..LM IS,3R-ACPD plus 50 J..LM NMDA) equal to 100%. When 
examined in this manner, apparently 1 S,3R-ACPD shifted the NMDA concentration 
response curve to the left. (Fig. 41). Dose-ratios for 25 and 50 11M 1 S,3R ACPD 
were 0.83 and 0.63 respectively and were linear for the concentration range 
employed (0 to 50 J..LM ACPD~ F statistic = 594~ Fig. 41 insert). Changes in the 
maximum response could not be ascertained due to loss of the NMDA response 
following perfusion with elevated concentrations of NMDA (Harrison and 
Simmonds, 1985). 
7.3.2 Antagonism of the 1S,3R-ACPD facilitation 
D,L-AP3 and D,L-AP4 antagonize metabotropic glutamate receptor mediated 
phosphoinositide hydrolysis (Schoepp et a/., 1990). Bath application of D,L-AP3 
(0.1 to 50 J..LM) and D,L-AP4 (1 to 100 J..LM) did not alter the NMDA 
D 
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NMDA 50 J.LM 
D Quisqualate 1 J.LM 
• 1 S, 3R-ACPD 50 J.LM 
= Kainate 10 JlM 
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Figure 39. mGluR agonists facilitate the NMDA, but not the kainate induced 
depolarization of cortical neurons. NMDA (upper two panels) or kainate (lower 
panel) were applied every 20 min. Quisqualate and 1 S,3R-ACPD facilitate NMDA 
depolarization (upper panels) whereas the kainate depolarization is not facilitated 
by 1S,3R-ACPD (lower panel). Data from 3 wedges. Voltage calibration is 2 mV 
for upper panels, 1 m V for lower panel. 
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• Second exposure 
1 0 100 
1 S,3R-ACPD (JJ.M) 
Figure 40. Concentration-dependent facilitation of the NMDA depolarization 
induced by 1S,3R-ACPD and lack of desensitization. Each wedge was exposed 
to the same concentration of 1 S,3R-ACPD plus 50 ~M NMDA two times separated 
by 20 min. Note there is only a small reduction (not significant) in the facilitation 
on second exposure. 5 to 8 wedges used for each concentration. 
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Figure 41. Concentration-dependent facilitation of the NMDA depolarization 
induced by 1S,3R-ACPD. Concentration response curves are shown for NMDA 
and 1S,3R-ACPD. Responses are expressed as a% of maximum. Values are the 
mean ± SEM from 3 separate experiments. 
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depolarization (98 ± 2%, n= 1 0). However, both agents reduced 1 S,3R-ACPD 
facilitation of the NMDA response in a concentration-dependent manner (Figure 
42A). The IC50 values for D,L-AP3 and D,L-AP4 were 0.24 and 4.4 J.LM 
respectively. Varying the concentration of 1S,3R-ACPD in the presence of D,L-
AP3 (Fig. 42B) and D,L-AP4 (not shown) revealed that the antagonism was not 
competitive. 
7.3.3 Facilitation by lS,JR-ACPD does not exhibit desensitization 
The lack of homologous desensitization observed with 1 S,3R-ACPD 
prompted us to investigate other agents which modify desensitization of 5-HT 2A 
receptors (Chapter 3 and 4 ). Prolonged perfusion with 3 J.LM phorbol diacetate did 
not significantly depress the IS, 3R-ACPD facilitation (Table V) compared to the 
same treatment in the presence of staurosporine. Similarly, perfusing 10 nM 
concanavalin A or 1 J!M chlorpromazine failed to alter the facilitation induced by 
30 J!M 1 S,3R-ACPD (Table V). 
In addition to homologous desensitization, the facilitation induced by 
carbachol and phenylephrine is subject to heterologous desensitization (Chapters 
3 and 4 ). This form of desensitization results from substrate depletion following 
exposure to a high (100 J.LM) concentration of 5-HT (Chapter 4). As shown in Fig. 
43, the 1 S,3R-ACPD induced facilitation was also eliminated by exposure to 100 
J!M 5-HT. On the other hand, perfusing wedges with 10 mM myo-inositol, which 
Figure 42. Antagonism of the 1S,3R-ACPD facilitation. A. D,L-AP3 and D,L-
AP4 reduce the 1 S,3R-ACPD facilitation in a concentration dependent manner. 
NMDA depolarization in the presence of antagonists was used as control. 4 to 6 
wedges were used at each antagonist concentration. ***, p < 0.001. B. Dose 
response curves are shown for 1S,3R-ACPD, D,L-AP3 1 J.l.M and 10 J..LM. Both 
concentrations produced non competitive antagonism. Values are from 5 separate 
experiments. 
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Table V. Effects of phorbol diacetate, staurosporine, concanavalin A and 
chlorpromazine on 1 S,3R-ACPD facilitation. 
Drugs 
1 S,3R-ACPD (30 J.LM) 
+ Phorbol diacetate (3 J.LM) 
+ Staurosporine (1 0 nM) 
+ Concanavalin A ( 100 nM) 
+ Chlorpromazine ( 1 J.LM) 
NMDA depolarization (% of control) 
266 ± 24% (n = 8) 
228 ± 21% (n = 5) 
2 71 ± 19% ( n = 5) 
260 ± 18% (n = 5) 
251 ± 22% (n = 4) 
Statistical comparisons were performed by one-way analysis of variance followed 
by Bonferroni test. All treatments were compared with 1S,3R-ACPD (control) 
except phorbol diacetate which was compared with staurosporine. Neither group 
was significantly different. 
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Figure 43. 1S,3R-ACPD (50 J.LM) facilitation before and after 5-HT (100 J..LM). 
IS,3R-ACPD facilitation was eliminated after 5-HT application. 4 wedges were 
used in each treatment. ***, p < 0.001, NMDA vs NMDA +1S,3R-ACPD. 
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enhances availability of substrate for agonist induced phosphoinositide hydrolysis 
(Fain and Berridge, 1979; Pontzer and Crews, 1990; Chapter 4), resulted in a 
significant potentiation of the 1S,3R-ACPD induced facilitation (379 ± 12%, n=4, 
p < 0.05). 
In addition to coupling to phospholipase C, mGluRs also couple to 
phospholipase A2 and adenylate cyclase (Aramori and Nakanishi, 1992). 
Moreover, arachidonic acid and cyclic AMP have been implicated in the 
enhancement of NMDA responses (Miller et al., 1992; Cerne et al., 1993). 
However, application of arachidonic acid or 8-bromo-cAMP or 8-bromo-cGMP 
(permeable analogues of cAMP or cGMP) failed to facilitate the NMDA 
depolarization (Fig. 44 ). 
7.3.4 Ca++ dependence of the lS,JR-ACPD mediated facilitation 
A rise in intracellular Ca ++ is thought to underlie facilitation of the NMDA 
response induced by 5-HT in cortical neurons (Chapter 5) and by acetylcholine in 
hippocampal neurons (Markram and Segal, 1992). To investigate the importance 
of external Ca++ for the facilitation, 1S,3R-ACPD was applied following (40-60 
min) perfusion with Ca++ free ACSF. This treatment did not reduce the 1S,3R-
ACPD or carbachol induced facilitation of the NMDA response (Fig. 45A). On 
the other hand, the facilitation induced by 5-HT and phenylephrine was abolished 
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during perfusion with Ca ++ free ACSF (Fig. 45). Addition of 100 ~M BAPTA to 
the nominally Ca++ free ACSF gradually eliminated the 1 S,3R-ACPD mediated 
facilitation (75 ± 7%, n=4, p < 0.05; Fig. 46, upper panel) over the course of one 
hour. Ca++ influx through voltage operated Ca++ channels is necessary for the 5-HT 
facilitation (Chapter 5). Although 10 ~M nifedipine significantly reduced the 
NMDA response (73 ± 15%, n=6; p < 0.05), the facilitation induced by 30 ~M 
1S,3R-ACPD was not eliminated (221 ± 8%, n=4; p < 0.05; Fig. 46, middle panel). 
Finally, the importance of intracellular Ca++ to the facilitation was examined by 
perfusing cell permeant BAPT A-AM. BAPT A is formed by desterification of 
BAPTA-AM inside the cell (Niesen et al., 1991). BAPTA-AM (50 ~M) eliminated 
the 1 S,3R-ACPD induced facilitation (Fig. 46, lower panel). BAPT A-AM did not 
alter the NMDA depolarization (97 ± 2.5%, n=5). 
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Figure 44. Arachidonic acid (AA; 10 J..LM), 8-bromo-cAMP (20 J..LM), or 8-bromo-
cGMP (20 J..LM) do not mimic the facilitation induced by I S,3R-ACPD. Each agent 
was co-applied with 50 J..1M NMDA for 2 min. 4 to 5 wedges were used for each 
treatment. 
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Figure 45. Effect of Ca++ free ACSF (no added Ca++) on 5-HT, phenylephrine 
(PE), 1 S,3R-ACPD and carbachol (CCH) facilitation . A. Only 1 S,3R-ACPD and 
CCH facilitation persisted in the absence of extracelluar Ca++. B. Average data 
for 5-HT, PE, 1 S, 3R-ACPD and CCH. 4 to 6 wedges were used in each case. 
***' p < 0.001. 
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Figure 46. Effect of BAPTA., nifedipine and BAPTA-AM on 1 S.,3R-ACPD 
facilitation. I S.,3R-ACPD facilitation was reduced on first exposure and eliminated 
on second exposure following addition of BAPTA to Ca++ free ACSF (upper 
panel). Note the NMDA depolarization was also dramatically reduced. Nifedipine 
failed to eliminate 1 S,3R-ACPD facilitation (middle panel). Unlike BAPTA, 
BAPTA-AM eliminated the IS,3R-ACPD facilitation completely on first exposure 
(lower panel). 4 to 5 wedges were used in each condition. 
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7.4 Discussion 
7 .4.1 Characterization of the 1 S,JR-ACPD facilitation 
The present experiments demonstrate that application of the mGluR agonists 
quisqualate and 1 S,3R ACPD selectively facilitate the depolarization of cortical 
neurons induced by NMDA. The facilitation was manifest as a 1S,3R-ACPD 
concentration dependent shift of the NMDA concentration-response curve to the 
left. Moreover, the facilitation was observed at concentrations of quisqualate and 
1S,3R-ACPD at which neither agonist produced an overt depolarization on its own. 
Although not examined in detail (see section 7.3 .1 ), the order of potency appears 
to be quisqualate > 1S,3R-ACPD. 1S,3R-ACPD is a selective agonist at mGluR 
(Palmer eta/., 1989~ Irving eta/., 1990), whereas quisqualate is an agonist at both 
AMPA and metabotropic receptors (Murphy and Miller, 1989). However, in the 
presence of an AMPA/kainate antagonist, quisqualate remains effective in 
facilitating the NMDA response. The smaller than expected facilitation observed 
with CNQX doubtless reflects loss of a small contribution from the AMP A 
receptor activation. Quisqualate enhances formation of inositol polyphosphates 
along with Ca ++ entry and mobilization, in part, through its action on AMP A 
receptors (Baird et a/., 1991 ~ Murphy and Miller, 1988). 
The facilitatory response induced by 1S,3R-ACPD was antagonized 
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noncompetitively by both D~L-AP3 and D~L-AP4. Neither antagonist altered the 
depolarization induced by NMDA in the absence of 1S,3R-ACPD indicating that, 
under the conditions of the present experiments, there was insufficient transmitter 
release in the wedges to activate mGluR and facilitate the NMDA response. This 
is not the case for other receptors in cortical wedges, e.g. both scopolamine and 
prazosin significantly reduce the amplitude of the NMDA depolarization (Chapter 
2). Surprisingly~ the IC50 values for D,L-AP3 and D,L-AP4 antagonism of the 
1 S,3R-ACPD facilitation are orders of magnitude lower than previously reported 
for mGluR mediated responses (Schoepp et a/., 1990; Schoepp and Conn, 1993). 
Whether this reflects the nature of the response examined, i. e. phosphoinositide 
hydrolysis versus facilitation of the NMDA depolarization, is not clear. D,L-AP3 
and D,L-AP4 are reportedly weak partial agonists (Schoepp et a/., 1990~ Schoepp 
and Conn, 1993). However, within the concentration range of D,L-AP3 and D,L-
AP4 examined, no partial agonism was observed with respect to facilitating the 
NMDA response. 
In keeping with observations on hippocampal neurons (Aniksztejn et a/., 
1991, 1992; Harvey and Collingridge, 1993 ), spinal neurons (Bleakman et al., 
1992) and Xenopus oocytes (Kelso et a/., 1992) , the above observations are 
compatible with quisqualate and 1 S,3R-ACPD acting at mGluR to facilitate the 
NMDA depolarization. Presumably the mGluR mediating the facilitation acts 
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directly on projection neurons passing through the grease seal (see Chapter 2) since 
the facilitation was present in nominally Ca ++ free ACSF containing tetrodotoxin. 
mGluR couple through G-proteins to ion channels and a variety of second 
messenger systems including phospholipase C and D, adenylate cyclase (both 
positive and negative coupling) and arachidonic acid (Schoepp and Conn, 1993). 
Activation of phospholipase C or adeny late cyclase as well as application of 
arachidonic acid has been shown to result in facilitation of the NMDA response in 
different brain regions (Markram and Segal, 1992; Chapter 3; Cerne et a/., 1993; 
Miller et a/., 1992). However, our observations demonstrate that in cortical 
wedges 8-bromo-cAMP, 8-bromo-cGMP and arachidonic acid are unable to 
substitute for 1 S,3R-ACPD in evoking a facilitation. These findings are 1n 
agreement with data from CAl hippocampal neurons (Harvey and Collingridge, 
1993). Involvement of phospholipase D is also unlikely since L-AP3 is a full 
agonist at mGluR that couples to phospholipase D (Boss and Conn, 1992). 
7.4.2 Potentiation of 1S,3R-ACPD facilitation by myo-inositol 
On the positive side, myo-inositol potentiates the 1 S,3R-ACPD facilitation, 
whereas prior exposure to 5-HT eliminates it. Both results are consistent with the 
hypothesis that activation of phospholipase C is critical for the facilitation (Chapter 
2). Myo-inositol is a precursor of phosphoinositide 4,5-biphosphate, the_ substrate 
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for phospholipase C (Berridge, 1993). Brain slices incubated in ACSF exhibit 
lower inositol levels than fresh brain tissue unless 10 mM myo-inositol is present 
(Sherman et al., 1986). Enhancing substrate availability by perfusing hippocampal 
slices with myo-inositol results in greater inositol phosphate formation following 
carbachol stimulated phosphoinositide hydrolysis (Pontzer and Crews, 1990). As 
with the 1 S,3R-ACPD facilitation, the NMDA facilitation mediated by receptors 
employing phospholipase C for signal transduction at cortical neurons IS 
potentiated by myo-inositol (see Chapter 4). On the other hand, stimulating 
phospholipase C with high concentrations of an agonist such as 5-HT, presumably 
reducing substrate availability in the process (Fain and Berridge, 1979), results in 
heterologous desensitization of the carbachol and phenylephrine facilitation at 
cortical neurons. This desensitization is prevented by addition of 10 mM myo-
inositol to the perfusion medium (see Chapters 3 and 4). Thus, the potentiation by 
myo-inositol and the heterologous desensitization induced by 5-HT is entirely 
consistent with the 1 S,3R-ACPD facilitation resulting as a consequence of 
stimulating phospholipase C. Moreover, the EC50 value for the 1 S,3R-ACPD 
facilitation (16 J.LM) is in good agreement with the EC50 values reported for 1 S,3R-
ACPD stimulated phosphoinositide hydrolysis in primary cerbrocortical cultures (15 
J.LM; Birrell and Marcoux, 1993) and neonatal rat cerebral cortex slices (16 J.LM~ 
Challiss et a/., 1994). Finally, D,L-AP3 and D,L-AP4 noncompetitively inhibit 
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mGluR induced phosphoinositide hydrolysis in cortical tissue (Schoepp et al., 1990, 
and 1990a) and it seems reasonable to conclude that these antagonists behave in 
a similar manner in the present study. 
7 .4.3 Involvement of PLC signal transduction 
Of the mGluR so far identified, only the mGluRl and the mGluR5 subtypes 
couple to phospholipase C (Abe et al., 1992~ Aramori and Nakanishi, 1992~ 
Schoepp and Conn, 1993~ Tanabe et al., 1992). The mGluR5 subtype is 
abundantly present in the cerebral cortex (Abe et al., 1992; Minakami et al., 1993), 
whereas the mGluR1 subtype is found at a much lower level. Agonist potency 
(quisqualate> 1 S,3R-ACPD) for both receptors is similar to observations in the 
present experiments (Abe et al., 1992; Aramori and Nakanishi, 1992). Chinese 
hamster ovary cells transfected with mGluR1 or mGluR5 are insensitive to L-AP3, 
suggesting that L-AP3 acts at a site separate from the mGluR or that another 
mGluR, which remains to be identified, couples positively to phospholipase C. 
Assuming the first case is correct, the present observations cannot distinguish 
between the mGluRl and mGiuR5 with respect to the subtype mediating the 
facilitation in cortical wedges. 
Phosphoinositide specific phospholipase C plays a crucial role in initiating 
the surface mediated signal transduction by generating second messenger 
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molecules, diacylglycerol, and inositol 1 ,4,5-triphosphate (Wojcikiewicz et a/., 
1993). Catalytic activation of phospholipase Cis dependent on Ca++ concentration 
and results accumulated during the last few years clearly indicate that there are a 
number of distinct variants of phospholipase C which have been purified, cloned 
and sequenced (Rhee et a/., 1991). Carbachol, norepinephrine, and 5-HT 
stimulated PI hydrolysis in cortical slices exhibit different requirements for external 
Ca++ (Kendall and Nahorski, 1984). Furthermore, 1S,3R-ACPD has been shown 
to stimulate phosphoinositide hydrolysis that is not dependent on extracelluar Ca++ 
(Birrell and Marcoux, 1993). The distinct Ca++ sensitivity associated with the 
different receptors with respect to the NMDA facilitation presumably indicates 
different phospholipase C subtype(s) are involved in signal transduction rather than 
that the Ca ++ requirements for the facilitation differ in a significant manner between 
receptors. 
7.4.4 Role of external and internal ca++ 
The effectiveness of BAPTA-AM tn eliminating the 1S,3R-ACPD 
facilitation clearly suggests that an intracellular Ca ++-dependent process is necessary 
for the facilitation. 1 S,3R-ACPD raises intracellular Ca++ by generating inositol 
1,4,5 triphosphate which then acts to release Ca++ from the smooth endoplasmic 
reticulum (Irving et a/., 1990; Berridge, 1993 ). It is proposed that the inositol 1 ,4,5 
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triphosphate evoked release of Ca++ is responsible for the facilitation and that 
BAPTA-AM acts to buffer this rise inCa++, thus preventing the facilitation from 
taking place. This is consistent with the muscarinic cholinoceptor mediated 
facilitation in the hippocampus which is blocked by BAPT A applied through the 
recording electrode (Markram and Segal, 1992). No evidence was obtained in the 
present experiment for involvement of the other arm of PI pathway, i.e., 
diacy I glycerol stimulated protein kinase C. Phorbol diacetate did not occlude the 
1S,3R-ACPD facilitation and staurosporine did not block it. This is in keeping 
with the 1 S,3R-ACPD induced facilitation of the NMDA response in the 
cerebellum (Kinney and Slater, 1993), but differs from reports on the 1 S,3R-ACPD 
facilitation in Xenopus oocytes and hippocampal neurons (Kelso et a/., 1992; 
Aniksztejn eta/., 1991, 1992). 
In contrast to the requirement for a rise in inracellular Ca ++, the 1 S,3R-
ACPD facilitation does not require external Ca++. This is consistent with reports 
that 1S,3R-ACPD induced phosphoinositide hydrolysis is not dependent on 
extracelluar Ca ++ (Birrell and Marcoux, 1993; Challiss et a/., 1994 ). Insensitivity 
to external Ca ++ also suggests that Ca ++ entry through the NMDA receptors channel 
is not important for the facilitation. 
1S,3R-ACPD acting at mGluR blocks voltage dependent Ca++ channels (L-
type) in cortical pyramidal neurons thereby occluding the blockade by nifedipine 
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(Sayer eta/., 1992). In keeping with these observations, nifedipine did not reduce 
the 1S,3R-ACPD facilitation . In this regard, the facilitation mediated by 5-HT2A 
receptors is quite distinct in that it is blocked in a concentration-dependent manner 
by nifedipine (Chapter 5). Clearly, further investigation is required to resolve these 
differences. 
In this study, changes in the NMDA response were not observed initially as 
demonstrated (see Chapter 5) in the presence of Ca++ free medium containing 
BAPTA-AM. However, the NMDA response was reduced following multiple 
exposures to the agonist. A plausible explanation for this discrepancy is that the 
membrane depolarization and loss of the cholinergic and noradrenergic components 
induced by the Ca++ free medium are no longer operative (Chapter 5). Therefore, 
the addition of BAPT A-AM in the medium would not change the NMDA response 
initially. However, the subsequent reduction is likely due to the continuous 
perfusion of BAPTA-AM which could further reduce the concentration of internal 
Ca++ (see Chapter 5). This alteration in internal Ca ++ might account for the 
subsequent reduction of the NMDA depolarization in Ca++ free medium with 
BAPTA-AM. 
7.4.5 18, 3R-ACPD facilitation and homologous desensitization 
An interesting difference between the present findings and previous results 
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with 5-HT2A, acadrenoceptor, and muscanmc cholinoceptor agonists is the 
apparent lack of homologous desensitization of mGluR (Chapter 3). Moreover, 
activating protein kinase C totally eliminates the 5-HT induced facilitation by an 
action on the 5-HT2A receptor (see Chapter 3). Despite reports of protein kinase 
C regulating mGluR responses (Manzoni eta/., 1990, 1991), no evidence for 
potentiation or suppression of the facilitation by inhibiting or stimulating protein 
kinase C was observed. Thus, in cortical neurons the feedback regulation of 
metabotropic receptors by protein kinase C is absent. Consistent with this view, 
the mGluR1 and mGluR5 sequences reveal only low probability consensus 
sequences for protein kinase C phosphorylation (Kemp and Pearson, 1990). 
In conclusion, the present findings suggest that the IS,3R-ACPD facilitation 
in the cortex is dependent on phospholipase C signal transduction and a rise in 
intracellular Ca ++. In this regard, the mGluR induced facilitation closely resembles 
that induced by other G-protein coupled receptors which couple positively to 
phospholipase C. 
CHAPTERS 
GENERAL DISCUSSION AND FUTURE DIRECilONS 
The above investigations have furnished new insights into the functional 
interaction between NMDA receptors and 5-HT2A receptors and other G-protein 
coupled receptors positively coupled to PLC in rat neocortex. The major findings 
of this research are summarized as follows: 
1. Activation of 5-HT 2A receptors selectively facilitates the NMDA induced 
depolarization of cortical projection (pyramidal) neurons and this is likely to be a 
direct effect since, at least in layer V, 5-HT 2A receptors are located on pyramidal 
neurons. 
l. Among the consequences of activating 5-HT 2A receptors is a nse m 
intracellular Ca++. This event likely accounts for the facilitation. Moreover, the 
results suggest that protein kinase C, calmodulin, arachidonic acid, cyclic AMP and 
cyclic GMP are not responsible for the facilitation. 
3. 5-HT 2A receptor stimulated signal transduction is selectively altered during 
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aging~ activation of protein kinase C is thought to underlie this alteration. This is 
consistent with evidence for negative feedback regulation of 5-HT 2A receptors by 
protein kinase C. However, feed-forward regulation of protein kinase C by another 
transmitter/modulator cannot be excluded. 
4. Like 5-HT2A receptors, activation of muscanmc cholinoceptors, ac 
adrenoceptors and mGluR facilitate NMDA responses in cortical neurons. All of 
these receptors appear to induce the facilitation through the IP 3-Ca ++ pathway. 
Unlike 5-HT2A receptors, these other receptors are insensitive to activation of 
protein kinase C, at least with respect to the NMDA facilitation. Although a rise 
in Ca ++ appears to underlie the facilitation induced by these receptors, the 
importance of external Ca ++ and entry through voltage dependent Ca ++ channels 
varies from receptor to receptor. The action of these receptors is summarized in 
Fig. 47. 
How a rise in intracellular Ca ++ is followed by NMDA facilitation is not 
understood. A number of processes might account for facilitation of the NMDA 
response. The rise in intracellular Ca++ probably activates various protein kinases 
and phosphatases which could regulate the NMDA receptor (Wang et al., 1994; 
Wang and Salter, 1994; Lieberman and Mody, 1994). 
Figure 47. Schematic diagram of 5-HT2A, <X1-adrenoceptor, mGluR and muscarinic 
cholinoceptor stimulated pathways that account for the NMDA facilitation. 
Abbreviations: IP 3R, inositol 1 ,4,5 triphosphate receptor~ Ga, a subunit of G-
protein; DAG, diacylglycerol; PKC, protein kinase C. 
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Protein kinase C has been implicated in the enhancement of the NMDA 
response in hippocampus, trigeminal neurons and Xenopus oocytes (Aniksztejn et 
a/., 1991, 1992~ Chen and Huang, 1992; Kelso eta/., 1992; Durand eta/., 1992). 
Protein kinase C in some cases phosphorylates NMDA receptors thereby enhancing 
current flow through the channel (Chen and Huang, 1992~ Kelso et a/., 1992~ 
Durand et a/., 1992). However, there is no evidence for such a mechanism in the 
case of neocortical projection neurons (see Chapters 3, 4, 6 and 7). Protein kinase 
C does influence 5-HT 2A receptors, since protein kinase C inhibitors potentiate the 
NMDA facilitation (Chapters 3 and 6). This suggests that 5-HT2A receptors 
undergo phosphorylation that is blocked by these inhibitors as has been observed 
at 5-HT 2A receptors in other parts of the central nervous system (Aghajanian, 1990; 
Marek and Aghajanian, 1994 ). Similarly, protein kinase C inhibition potentiates 
cholinergic facilitation at hippocampal neurons (Markram and Segal, 1992). 
Calmodulin does not appear to be important for the facilitation in neocortex, 
whereas it may be involved with long term desensitization of 5-HT 2A receptors (see 
Chapter 3) and the biphasic nature of the facilitation observed with thapsigargin, 
cyclopiazonic acid and A23187 (Chapter 5) 
Recently, tyrosine kinase and a number of phosphatases have been shown 
to regulate NMDA receptor function (Wang and Salter, 1994; Wang eta/., 1994; 
Lieberman and Mody, 1994). Involvement of tyrosine kinase in the 5-HT2A 
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facilitation is unlikely, since genistein, an inhibitor of this enzyme, is ineffective 
in enhancing or blocking the 5-HT facilitation (Rahman and Neuman, unpublished 
observations). Inhibition of protein phosphatases 1 and 2A with calyculin A 
enhances the peak NMDA current, but does not shift the NMDA concentration-
response curve (Wang et al., 1994). On the other hand, 5-HT and IS,3R-ACPD 
both shift the NMDA concentration-response curve to the left. Moreover, agonist 
induced facilitation of the NMDA response, up to 700%, is far greater than the 
increase in NMDA current induced by tyrosine kinase or phosphatases (Wang and 
Salter, 1994; Wang et a/., 1994). Clearly, further study is required to establish 
how the NMDA response is enhanced. 
Significance of 5-HT2A receptor mediated facilitation 
1. Neocortical plasticity 
NMDA receptors are the key elements in many aspects of central nervous 
system plasticity (Malenka and Nicoll, 1993). Endogenous modulators such as 
acetylcholine, glutamate acting at mGluR, noradrenaline and 5-HT may play an 
important role in influencing synaptic plasticity dependent on NMDA receptors. 
Acetylcholine, noradrenaline and I S,3R-ACPD, for example, facilitate development 
of long term potentiation (Bear and Singer, 1986; Brocher et al., 1992; Schoepp 
and Conn, 1993), whereas 5-HT, acting at 5-HT2A receptors, produces long lasting 
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changes in cortical NMDA responses (Reynolds et a/., 1988). Whether 5-HT 2A 
receptor activation can facilitate long term potentiation in cortical neurons has not 
been examined. However, it would be surprising if this were not the case. 
Consistent with this notion, it appears that 5-HT plays an important role in 
processes underlying memory and learning in behaving animals (Altman and 
Normalie, 1988). 
2. Motor control 
5-HT is thought to have an important role in motor function (Jacobs, 1991; 
Jacobs and Fornal, 1993~ Jacobs, 1994). It is well established that axons of 
pyramidal neurons project to regions of the brain such as the basal ganglia, the 
brainstem and the spinal cord to control motor output (Lorente De No, 1949). 
Clearly, in the presence of NMDA receptor activation, 5-HT could increase the 
gain of motor output. However, only a subset of pyramidal neurons was observed 
to contain 5-HT2A receptor mRNA, so it remains to be established that such control 
takes place. Activation of 5-HT2A receptors also facilitates glutamate evoked 
activity of facial motoneurons (McCall and Aghajanian, 1979). Thus, it is 
interesting to speculate that 5-HT acting at 5-HT2A receptors could play an 
important role in controlling motor output at multiple levels of the neuroaxis. 
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3. Cortical arousal 
In recent years, a growing body of evidence suggests that atropine resistant 
neocortical low voltage fast activity is dependent on the ascending 5-HT system 
in freely moving rats (see section 1.2.1 0). However, classical 5-HT 2A antagonists 
such as ritanserin, ketanserin, mianserin, pirenperone and methysergide are 
ineffective in blocking this activity (V anderwolf, 1988; Watson eta/., 1992). 
In contrast, in urethane anaesthetized rats, 5-HT 2A receptors are responsible 
for cortical desynchronization induced by noxious stimulation (Neuman and 
Zebrowska, 1992). A functional interaction between NMDA and 5-HT 2A receptors 
is thought to account for the desynchronization since classical 5-HT 2A receptor 
antagonists such as ritanserin and cinanserin block this activity. These findings are 
in accord with the present investigation in which similar antagonists significantly 
reduced the 5-HT 2A receptor mediated facilitation of the NMDA depolarization of 
cortical neurons. 
There is an obvious discrepancy between the observations of V anderwolf 
and colleagues (Vanderwolf, 1988; Watson eta/., 1992) and those ofNeuman and 
Zebrowska (1992). One way to resolve these differences is to consider the 
involvement of 5-HT2A receptors to be state dependent. Under urethane 
anaesthesia, which is similar to slow wave sleep, the burst-pause pattern of cortical 
unit discharges likely results from NMDA receptor activation (Armstrong-James 
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and Fox, 1986) and the bursting is enhanced by 5-HT 2A receptor mediation (see 
section 1.2.1 0, Chapter 1 ). On the other hand, in awake animals, cortical firing 
might be dependent on AMP A receptors and the cortical desynchronization could 
be associated with some other excitatory effect of 5-HT. This is in agreement with 
the evidence that 5-HT fails to facilitate the AMPA component of neocortical 
EPSP, whereas it does facilitate the NMDA component (Reynolds et a/., 1988). 
Therefore, state dependency of the NMDA component could explain the variation 
in effectiveness of 5-HT 2A receptor antagonists in awake vs anaesthetized animals. 
Finally, in man, 5-HT2A receptor antagonists have little effect on the waking EEG 
but they do increase the duration of slow wave sleep (Idzikowski et a/., 1986), a 
finding in keeping with the above interpretation. 
5-HTlA recepton in therapeutics 
5-HT2A receptors have been postulated as targets for numerous drugs with 
potential for the treatment of a variety of neuropsychiatric disorders. For example, 
most antidepressants (tricyclic antidepressants, selective serotonin reuptake 
inhibitors and monoamine oxidase inhibitors) down-regulate 5-HT 2A receptors 
(Stahl, 1994). Given the findings presented in this thesis on the loss of 5-HT 2A 
receptor function during aging, one wonders whether a similar loss may take place 
during treatment with antidepressants. This remains to be investigated. In keeping 
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with this suggestion, ritanserin, a selective 5-HT 2 receptor antagonist has shown 
promise as an antidepressant (Sleight et a/., 1991 ). 
Clinical evidence also suggests that blockade of 5-HT 2A receptors by 
ritanserin and clozapine alleviate the negative symptoms of schizophrenia, an effect 
which may account for the action of atypical neuroleptics (Siever eta/., 1991; 
Meltzer and Nash, 1991). Moreover, risperidone, a combined 5-HT2A and 
dopamine receptor antagonist is effective in treating both positive and negative 
symptoms of schizophrenia (Megnes et a/., 1994). 
There is abundant experimental data that 5-HT 2A receptors play a critical 
role in the mechanism of action of hallucinogenic drugs such as lysergic acid 
diethylamide (LSD) and phenylisopropylamine (Glennon eta/., 1985; Titeler eta/., 
1988; Sadozt et a/., 1989). There is some controversy as to whether these actions 
can be explained by agonist or antagonist actions (Pierce and Peroutka, 1988; 
Glenon, 1990), however, the balance of evidence suggests that most classical 
hallucinogens, such as LSD, act as agonists at 5-HT2A receptors (Leonard, 1994). 
A secondary role of 5-HT2c receptors in this mechanism has also been suggested 
(Titeler et a/., 1988; Glennon, 1990). 
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Some outstanding issues with respect to S-HT2A receptor activity 
5-HT 2A receptors exhibit some unusual properties which remam to be 
explained. 
1. S-HT2A recepton in physiological vs pathological conditions 
Leysen (1990) has proposed that 5-HT2A receptors receive low levels of 
stimulation during normal physiological conditions and only really function in 
emergency or pathological conditions. Evidence supporting this hypothesis comes 
from behavioral data following administration of 5-HT 2A receptor agonists and 
antagonists along with the down-regulation of 5-HT 2A receptors observed with both 
agonists and antagonists (see Leysen, 1990; Leysen and Pauwels, 1990 for review). 
Certainly the results presented in this thesis make it clear that 5-HT 2A receptors 
exhibit multiple and overlapping forms of desensitization, particularly when 
compared to the mGluR responsible for the NMDA facilitation that exhibits only 
heterologous desensitization. Several findings are inconsistent with Leysen's 
hypothesis, e. g. acute administration of 5-HT2A receptor antagonists block cortical 
desynchronization in vivo (Neuman and Zebrowska, 1992) and ritanserin increases 
slow wave sleep in humans (Idzikowski et a/., 1986; Sharpley et a/., 1990) 
suggesting that 5-HT 2A receptors are indeed active in physiological conditions such 
as sleep. Moreover, as revealed previously (see Chapter 6) lack of response to 5-
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HT 2A receptor stimulation could simply reflect age related changes in the animals 
used. 
l. Atypical down-regulation of 5-HTlA recepton 
Chronic administration of 5-HT 2A antagonists and, in some cases, a single 
injection, leads to down-regulation and behavioral desensitization instead of up-
regulation and behavioral supersensitivity of 5-HT 2A receptors (Conn and Sanders-
Bush, 1987a; Leysen and Pauwels, 1990). The down-regulation reflects loss of a 
functional response which cannot be simply accounted for by a down-regulation 
in 5-HT 2A binding sites. Atypical down-regulation has been suggested to arise as 
a result of constitutive activity of 5-HT2AI2C receptors (agonist independent PI 
hydrolysis) and novel properties of 5-HT 2AI2C receptor antagonists (Barker et a/., 
1994; Sanders-Bush, 1994). Sanders-Bush (1994) has suggested that 5-HT2Af2c 
receptor antagonists are of two types: 1) inverse agonists that block basal 
constitutive activity of the receptor (i.e PI hydrolysis) as well as blocking 5-HT 
effects; 2) neutral antagonists that block only 5-HT effects. The inverse agonists 
were found to initiate down-regulation suggesting a novel signal transduction 
pathway involved with these receptors (Barker eta/., 1994; Sanders-Bush, 1994). 
Although the findings of Sanders-Bush and colleagues may account for atypical 
down-regulation, the constitutive activity of 5-HT 2A receptors does not appear to 
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be of functional importance. Thus, there was no evidence that 5-HT 2A receptor 
antagonists decreased the NMDA response in the absence of exogenous agonists 
(see Chapter 2). A decrease would be expected if constitutive activity contributed 
to the facilitation, although a decrease in the NMDA response, had it occurred, 
could have resulted from either blocking the action of released 5-HT at 5-HT 2A 
receptors or constitutive activity. 
Future directions 
The present investigation has raised several issues which should be addressed in 
future studies. They are as follows: 
1. Despite the usefulness of cortical wedges in investigating 5-HT function, 
they have a number of limitations which include i) the development of long lasting 
desensitization, and ii) possible indirect effects. To further investigate the role of 
5-HT, a fresh start should be made by employing whole cell recording from 
acutely dissociated cortical neurons. This should minimize possible indirect 
actions, allow visualization of the cells and reduce desensitization of 5-HT 2A 
receptors by allowing brief application of agonists. 
2. From the present investigation, it is concluded that the IP 3-Ca ++ pathway 
215 
underlies the NMDA facilitation. However, with the methods employed in the 
present investigation, it was impossible to evaluate the role of IP3. Thus, to 
establish a coherent picture of 5-HT facilitation, the role of the IP3 receptor in 
regulating the NMDA current should be examined using whole cell recording. To 
accomplish this, caged IP 3 released with ultraviolet irradiation could be used. 
3. How a rise in intracellular Ca++ is translated into facilitation of the NMDA 
response remains to be answered. Manipulation of intracellular Ca++ by various 
Ca ++ mobilizing agents should be examined in dissociated neurons. Furthermore, 
kinetics of the expected rise in intracellular Ca ++ during the NMDA facilitation 
needs to be addressed. 
4. Presuming that phosphorylation of the NMDA receptor or nearby site is 
responsible for the facilitation, does such a phosphorylation in tum influence 
divalent cation and polyamine sites on the NMDA receptor? Whether these sites 
have an impact on the NMDA facilitation remains to be answered. 
S. In senescent rats, activation of protein kinase C is responsible for loss of the 
facilitation. When and how this process develops is worthy of further examination. 
Are there losses in cognitive function which parallel loss of the 5-HT 2A receptor 
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function? An investigation to examine this hypothesis would facilitate a clearer 
understanding of 5-HT and its role in cognitive function. 
6. As evident in this thesis, 5-HT2A receptors and 5-HT1A receptors produce 
opposite effects on the NMDA depolarization. Both receptors are located on the 
same neurons (see Chapter 1) and yet the 5-HT2A receptor effect dominates. This 
suggests there may be a significant functional interaction between these receptors. 
This issue should be addressed. 
Answers to these questions may contribute to a better understanding of the 
physiology and pharmacology of serotonergic transmission and functional 
transmitter interactions in the neocortex. Most importantly, understanding actions 
and interactions of these neurotransmitters may facilitate the elucidation of 
potential targets for novel drug therapies for neuropsychiatric disorders and age 
related cognitive deficits. 
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